Mechanistic insights into alpha-Synuclein neuronal toxicity: misfolding, serine phosphorylation and interactions with Rab GTPases by Yin, Guowei
Mechanistic insights into alpha-Synuclein neuronal 
toxicity: misfolding, serine phosphorylation and 








zur Erlangung des mathematisch-naturwissenschaftlichen Doktorgrades 
"Doctor rerum naturalium" 




















Mitglied des Betreuungsausschusses (Referent): Prof. Dr. Christian Griesinger 
NMR-basierte Strukturbiologie, Max-Planck-Institut für biophysikalische Chemie 
 
Mitglied des Betreuungsausschusses (Koreferent): Prof. Dr. Gerhard Braus 
Mikrobiologie und Genetik, Georg-August-Universität Göttingen 
Mitglied des Betreuungsausschusses: Prof. Dr. André Fischer 
European Neuroscience Institute Göttingen 
Mitglied des Betreuungsausschusses: Prof. Dr. Markus Zweckstetter 
NMR-basierte Strukturbiologie, Max-Planck-Institut für biophysikalische Chemie 
 
 





I hereby declare that this dissertation has been written independently and with no other 









Alpha-Synuclein(αS), a protein abundant in presynaptic neurons, has been found as the 
major component of Lewy bodies, the neuronal inclusion identified as the hallmark of 
Parkinson’s disease (PD). αS adopts intrinsically disordered conformation under 
physiological conditions and possesses a high propensity for assembling into oligomers 
and fibrils during the pathological process of PD. Although the pathology of PD is still 
elusive, several lines of evidence with respect to the neuronal toxicity, cellular 
physiology, and protein structure indicate that αS plays an important role in the 
development of PD and affects the normal cellular functions. In this dissertation we 
study the molecular mechanisms of serine phosphorylation, the interaction with Rab-
GTPases and the aggregates structure of αS. 
Phosphorylation is a major posttranslational modification of αS. Approximately 
90% of αS in LB is phosphoylated at Ser129, but the pathological role of 
phosphorylation has still not been determined. Ser87 is also an important serine 
phosphorylation site located at NAC region. To understand the mechanisms of 
phosphorylation, we investigate phosphorylation kinetics and the effects of 
phosphorylation on αS aggregation. Real-time NMR spectroscopy is employed to study 
the phosphorylation kinetics of the Ser87 and Ser129 of αS. With the aid of the residue-
specific resolution provided by NMR spectroscopy we reveal that the three familial 
mutations A30P, E46K, and A53T do not change the phosphorylation kinetics of Ser87 
but slightly modify the kinetics of Ser129. At the same time, under the conditions of our 
assay, we also identify that PLK2 and PLK3 are capable of phosphorylating αS at 
Ser129 with high selectivity and efficiency. Furthermore, we find that phosphorylation 
 
of Ser129 by PLK3 and the phosphorylation mimicking mutants (P128E/S129E and 
M127E/P128E/S129E) do not affect the aggregation propensity of αS.  
Rab GTPases are important for the regulation of vesicle trafficking in eukaryotic 
cells. Rab1, Rab3a, and Rab8a were suggested to protect against αS-induced cellular 
toxicity in different model systems. Focusing on molecular mechanisms involved in the 
interplay between Rab proteins and αS, we firstly identify that both the GDP- and 
GppNHp-bound Rab8a bind to the C-terminus of αS. However, αS has a higher affinity 
to Rab8a(GDP) than Rab8a(GppNHp). Secondly, the positively charged C-terminal 
peptide of Rab8a is found to reproduce the binding of full-length Rab8a to αS, 
suggesting that a charge complementation between the C-terminal of both proteins is 
important for the interaction. Furthermore, we have assigned Rab8a in the GDP-bound 
state and find that in addition to the C-terminus the Switch I region of Rab8a serves as a 
binding site for the αS C-terminus. Since the conformation of switch regions is highly 
dependent on nucleotide binding, this finding elucidates the binding preference for the 
GDP-bound state. Furthermore, Rab8a enhances the aggregation of αS in both 
oligomerization and fibril formation. Rab1b and Rab3a do not bind to αS but they can 
also significantly enhance the fibril formation of αS. Taken together, our results 
demonstrate a tight interplay between αS and Rab proteins at the molecular level.      
   Furthermore, αS aggregates, namely oligomers and fibrils, are highly 
associated with PD pathology. We perform solution NMR based hydrogen/deuterium 
(H/D) exchange to detect the fibril core of E46K and A53T αS fibrils. These two 
mutations do not cause drastic changes to the fibril core structures in comparison to wt-
αS and a conserved core region has been suggested for wt-αS and the three familial 
mutants. Furthermore, we optimize the H/D exchange method to detect the 
conformation of compounds-stabilized αS oligomers. Our results suggest that the 
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“Involuntary tremulous motion, with lessened muscular power, in parts not in 
action and even when supported; with a propensity to bend the trunk forwards, and to 
pass from a walking to a running pace: the senses and intellects being uninjured.”                    
– James Parkinson, “An Essay on the Shaking Palsy”, 1817.  
The symptoms of what we now call Parkinson’s disease were first described by the 
English apothecary surgeon James Parkinson in 1817 and named “maladie de 
Parkinson” or Parkinson's disease (PD) in 1861 by Jean-Martin Charcot, the founder of 
modern neurology. In today’s aging society, PD is the second most common 
neurodegenerative disease after Alzheimer disease and approximately 7-10 millions 
people worldwide are living with PD (Statistics from Parkinson's disease foundation, 
“PDF”).  
In section 1.1, I will open with an overview of the Parkinson's disease and 
synucleinopathies will be exerted following the order “from bedside to bench” and 
accordingly the motivations of the research undertaken in this dissertation will be 
addressed. The focus of this dissertation upon protein α-Synuclein (αS) as one major 
cause of PD will be introduced in section 1.1.1 and 1.1.2 in terms of its pathological, 
biophysical, and structural characteristics. In section 1.2, the category of intrinsically 
disordered proteins (IDPs) will be described particularly in terms of its general 
structural features and the propensity of protein misfolding. To conclude this chapter, 
within the scope of this dissertation, the challenges for current research of PD 
pathologies with respect to α-Synuclein will be listed in section 1.3.  
1.1 Parkinson’s Disease and Synucleinopathies  
1.1.1 Parkinson’s disease overview 
The occurrence of Parkinson’s disease is strongly age-dependent (Lees et al, 
2009). The average age of onset is about 65 years old and the incidence rises from 0.6% 
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at age 65–69 years old to 2.6–3.5% at age 85–89 years old (de Rijk et al, 2000). The 
onset of Parkinson's disease commonly presents with one or a few of the following 
motor-symptoms: impairment of dexterity, slight dragging of one foot, fatigue, stiffness, 
lugubrious stiff face, hangdog appearance, flexion of one arm with lack of swing, 
monotonous quality to speech, extreme slowing down (Hardy et al, 2009). These early 
symptoms are usually difficult to notice for patients and a delay of 2-3 years from first 
symptoms to diagnosis is common. Nonmotor symptoms (NMS) such as depress pain, 
hyposmia (loss of sense of smelling), disturbed sleep, and dysautonomia start to 
increase progressively in frequency and severity (Chaudhuri et al, 2006). In the late 
sages,  Parkinson’s disease is characterized by a masked and expressionless face, the 
monotonous, festinant, and slightly slurred speech, flexed simian posture with a severe 
pill rolling tremor of the hands (Hardy et al, 2009). Constipation, chewing and 
swallowing difficulties, drooling of saliva, and urge urinary incontinence are 
concomitant features.  
The primary pathology of Parkinson’s disease is progressive dopamingernic 
neuron loss in the substantial nigra of the midbrain. Several genes such as SNCA 
(PARK1), PARK2 (PARK2), PINK1 (PARK6), PARK7 (PARK7), LRRK-2(PARK8) 
have been implicated in this pathology, where the protein products of these genes are α-
Synulcein, PARKIN, Serine/threonine-protein kinase PINK1, DJ-1, and Leucine-rich 
repeat serine/threonine-protein kinase 2 (Pankratz et al, 2004). Since 2009, a large-scale 
GWAS genomic screen has been applied to PD and several novel putative PD-
associated genes have been identified as a marked progress in genome-wide studies of 
PD (Hardy, 2010; Nalls et al, 2011; Satake et al, 2009; Simon-Sanchez et al, 2009).  
The dominant mechanism associated with dopaminergic neuronal loss is the Lewy 
body pathology. The Lewy body (LB), the hallmark of PD, is one type of neuronal 
inclusion deposited in the disease-associated neurons and is viewed as the cause of 
neuron death. The major component of LB are the amyloid fibrils formed through the 
aggregation of protein α-Synulcein (αS) (Spillantini et al, 1997), the protein product of 
the SNCA gene (Polymeropoulos et al, 1997). Therefore, it is crucial to study the roles 
of αS in the pathological scenario of PD in terms of its biochemical and biophysical 
natures, aggregation pathway, toxic mechanisms, pathological regulation factors et al. 
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This is the original motivation of this dissertation. Moreover, αS is not only present in 
PD, rather it also gets deposited into oligodendroglial cytoplasmic inclusions in multiple 
system atrophy (MSA) and into large axonal spheroids in a number of rarer neuroaxonal 
dystrophies (Halliday et al, 2011; Spillantini & Goedert, 2000). Thus, these 3 diseases 
caused by the abnormal inclusion formed by αS are grouped under the single category 
of synucleinopathies.  
To date, PD is incurable, but oral drug administration improves the life quality and 
functional capacity of patients. The major PD treatment is dopamine replacement 
therapy which aims to increase the level of dompamines in the brain to compensate for 
the decreased levels caused by the neuronal loss. Levodopa (L-dopa) is one of most 
efficient and widely used drugs because it is the precursor of dopamine and able to pass 
through blood brain barrier (BBB) (Schapira et al, 2006). The catechol-O-
methyltransferase (COMT) inhibitors and monoamine oxidase (MAO) inhibitors are 
two main drugs that also reduce the metabolism of L-dopa (Huynh, 2011), whilst ergot 
dopamine agonists are in another class of PD drugs that delay early onset of motor 
complication with high efficiency (Schapira et al, 2006). However, the application of 
these agents can not stop the dopaminergic neuron loss and the neurdegerative disorder 
and current drugs in markets and in clinical trials targeting αS are rare (Huynh, 2011; 
Schapira et al, 2006). Recent studies indicate that the inhibitors of COMT, entacapone 
and tolcapone, are able to block the fibril formation of αS (Di Giovanni et al, 2010). In 
July 2012, it was reported that the first therapeutic antibody of PD designed to clear αS 
stocked in the membranes and spread between the cells has been under clinical trial 
(Dolgin, 2012). This antibody has been proved to reduce the neuronal loss and improve 
the cognition in the transgenic mouse models and trials on human have now begun.     
1.1.2 Research progress of α-Synuclein  
Primary sequence of α-Synuclein 
αS is an intrinsically disordered protein comprising of 140 amino acids 
(Polymeropoulos et al, 1997) that are mainly divided into 3 fundamental domains: N-
terminal (1-60), NAC (61-95) and C-terminal (96-140) (Bisaglia et al, 2009) [Figure 
1.1]. The N-terminal is amphipathic with high affinity to membrane. The middle NAC 
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region (non amyloid component) is a highly hydrophobic part of the protein and is 
located in the core region of amyloid fibrils, which is crucial in fibril formation. There 
are seven imperfect 11-mer repeats (XKTKEGVXXXX) spread through the N-terminal 
to NAC region.  The total number and the conserved motif “KTKEGV” of these 
imperfect repeats have been implicated in lipid-binding (Davidson et al, 1998)and 
regulating aggregation (Kessler et al, 2003). The C-terminal is acidic which is enriched 
in negatively charged residues with a highly disordered conformation. 3 familial 
pathological mutations A30P, E46K and A53T identified in the different kindred are 
located at the N-terminal and are highly involved in functional and pathological 
modification.  
Protein structures and biophysics of α-Synuclein aggregation  
Structural insights into αS monomers reveal that αS is intrinsically disordered but not 
fully denatured. High resolution NMR data indicates that αS monomer possesses the 
transient long range interactions between N-terminal and C-terminal of αS and thereby 
stabilizes tertiary structure of the protein (Bertoncini et al, 2005b; Dedmon et al, 2005c). 
The structural ensembles of αS mapped by the paramagnetic relaxation enhancement 
measured by solution NMR indicate that the long-range interactions close the protein 
conformation and lock the hydrophobic NAC region into a state less accessible for the 
NAC of neighboring αS, which is considered as the auto-inhibition mechanism of the 
aggregation (Bertoncini et al, 2005b). Later studies reveal that the electrostatic 
interactions between two termini of αS also contributed to the intermolecular 
interactions between the N-terminal of one αS and the C-terminal of another in a head-
to-tail manner (Wu & Baum), which is in concert with the in vivo observation by 
bimolecular fluorescence complementation(BiFC) (Outeiro et al, 2008). Recent studies 
have suggested that the endogenous αS directly isolated from the human living cells 
was mainly present as the helically folded tetramer (Bartels et al, 2011). The authors 
discussed that the protein recombination techniques and harsh conditions of sample 
purification for αS commonly adopted in the labs (Weinreb et al, 1996) might be 
harmful to to the retention of the native folded conformation of αS. However, a later 
study used the same conditions to generate the αS by isolating it from the living cells 
and found that the generated αS was still dominantly disordered in comparison to the 
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sample obtained through common recombination and purifications (Fauvet et al, 2012b). 
Thus the accumulated evidence confirms that the physiological conformation of αS 
should be disordered (Bertoncini et al, 2005b; Conway et al, 1998; Weinreb et al, 1996), 
but the α-helix propensity of αS N-terminus enables the protein to form the helix 
conformation under the certain conditions i.e. membrane binding.   
The intrinsic disorder and the presence of highly hydrophobic NAC region 
determine a strong aggregation propensity of αS. The aggregation of αS can be 
generally divided into 3 phases: oligomerization, fibril growth and saturation (Fink, 
2006). The aggregation pathway starting from αS monomers to the final fibrils 
deposited in the LB in plaques of PD patient brain is demonstrated in Figure 1.1.  
 
Figure 1.1 Aggregation pathway of α-Synuclein. The flowchart demonstrates the aggregation process 
of the oligomerization, fibrillization and deposition of LB (dark dots) observed at PD plaques. The figure 
is taken from (Lashuel & Lansbury, 2006). 
  The disordered αS monomers firstly associate with each other to form the 
oligomeric species. This process is kinetically defined as the nucleation period which is 
the rate determinating step for the whole aggregation process. The structural study of 
αS oligomers is of major interests and poses major challenges to understand αS 
neuronal toxicity. αS oligomers represent distinct shapes i.e. chain-like or annular 
observed by electron microscopy (EM) and atomic force microscopy (AFM) (Lashuel & 
Lansbury, 2006). The secondary structures of αS oligomers were indicated by CD as 
the β-sheet rich conformations. However, due to the nature of the aggregation 
intermediates i.e. structural heterogeneity and weak stability etc., αS oligomers until 
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now are still not characterized with high resolution. A recent study suggests that within 
the process of the oligomerization there is one conversion from the smaller sized 
oligomers to large sized oligomer and that the larger oligomers are toxic (Cremades et 
al, 2012). Moreover, SAXS data suggests that αS oligomers are finally assembled into 
fibrils with conserved size parameters, implying that mature αS oligomers act as the 
building blocks of αS fibrils (Giehm et al, 2011b).  
As shown in figure 1.2, after the oligomerization, αS is finally assembled into 
the fibrils with well-defined morphorlogys. The phase from the ending of 
oligomerization to the final plateau phase is fibril growth which is kinetically defined as 
elongation. In this phase, the oligomers of αS are assembled into the protofilaments 
along the fibril axis direction and the protofilaments are further associated with each 
other to form the morphologically straight bundle or the twisted fibril. Since the 
amyloid fibrils of αS are stable and insoluble in water, they are readily separated and 
purified for further structural analysis. Therefore, the structures of the amyloid core 
region of αS have been well studied by high resolution methods such as ssNMR, 
solution NMR based H/D exchange, Mass spectrum, EPR et al (Chen et al, 2007; Cho 
et al, 2011; Comellas et al, 2011; Del Mar et al, 2005; Heise et al, 2008; Heise et al, 
2005; Lemkau et al, 2012; Vilar et al, 2008). The boundaries of the fibril core region 
have been measured, where the core region has been extended from the NAC to ~ 37-97. 
However, there are discrepancies amongst the different reports regarding the locations 
and lengths of β-strands, involving factors such as sample preparation, the 
polymorphism of fibrils and different technique details of the experiments which should 
be taken into account to address the differences. Besides the fibril core, two termini of 
αS are mainly disordered. A recent report suggests that part of N-terminal residues are 
experiencing  contact with the core region and are likely to be participating in the fibril 
formation (Lemkau et al, 2012). The C-terminal of αS still remains in a highly 
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    Posttranslational modifications and phosphorylation 
There are several posttranslational modifications (PTMs) such as phosphorylation, 
truncation, ubiquitination, nitration, and acetylation associated with LB formation in PD 
patient brains and transgenic animal models (Oueslati et al, 2010a). The effects of these 
PTMs of αS on the protein structure, aggregation propensity, neuronal toxicity and 
disease progression have not been determined. Most of PTMs are located at the C-
terminus of αS.  Phosphorylation is one major PTM of αS. Multiple sites such as Ser87, 
T92, Y125, S129, Y133, Y136 have been reported to be phosphorylated by the known 
kinases like CKI, PLKs, GRKs, LRRK2 et al. Truncation is another major PTM of αS. 
In LBs, the major truncation sites at the C-terminus are D115, D119, N122, Y133 and 
D135 (Anderson et al, 2006). Accumulating evidence suggests that the C-terminal 
truncations of αS enhance aggregation propensity and initiate the aggregation process 
by seeding both in vivo and in vitro(Hoyer et al, 2002; Li et al, 2005; Liu et al, 2005). 
The co-localization of ubiquitin with αS has been extensively found in LBs and Lewy 
neutrites (Gomez-Tortosa et al, 2000). The K12, K21 and K23 of αS have been 
identified as major sites responsible for ubiquitination in LBs (Anderson et al, 2006). In 
addition, other lysine residues are also able to be ubiquitinated in vitro and in cell 
cultures, which most of them are located at the N-terminus of αS (Nonaka et al, 2005; 
Rott et al, 2008). But the relationship between ubiquitination and degradation of 
misfoled αS by ubiquitin-mediated proteasome pathway is still elusive (Tofaris et al, 
2001; Tofaris et al, 2003). A recent study indicates that ubiquitination by Nedd4 ligase 
promotes αS degradation by the endosomal–lysosomal pathway (Tofaris et al, 2011). 
Nitration is a potential mediator of PD and other neurodegenerative diseases (Souza et 
al, 2000). There are 4 tyrosine residues, Y39, Y125, Y133 and Y136, which can be 
nitrated in αS. The selectivity and specificity of different tyrosines is linked to the onset 
and progression of synucleinopathies (Giasson et al, 2000). N-terminal acetylation of 
αS has been less studied than other PTMs mentioned above and only recently has been 
focused on its effects on protein conformation, lipid-binding, aggregation propensity 
(Bartels et al, 2011; Fauvet et al, 2012a; Kang et al, 2012; Maltsev et al, 2012). 
Phosphorylation is the dominant PTM and the phosphorylation sites at C-
terminal are highly conserved through the different species [Figure 1.2] (Hejjaoui et al, 
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2012; Oueslati et al, 2010a). Of the Ser, Tyr and Thr phosphorylation, Ser 
phosphorylation has been extensively studied due to its prevalence in PD. 
Approximately 90% of αS has been identified as phosphorylated at Ser129 of αS. 
However, there are several key issues with respect to this phosphorylation which remain 
elusive: 1) which kinases are responsible for regulating this phosphorylation; 2) what is 
the consequence of this phosphorylation on αS structure in vivo; 3) whether this 
phosphorylation facilitates, inhibits or has no affect on αS aggregation; 4) dose 
phosphorylation occur before or after αS aggregation and LB formation; 5) how does 
this phosphorylation modulate the neuronal toxicity of αS.  Several kinases are involved 
in the Ser129 phosphorylation. Polo-like kinase (PLKs), G protein-coupled receptor 
kinases (GRKs), LRRK2, and Casein kinase II (CKII) are reported to specifically 
phosphorylate αS at Ser129 (Oueslati et al, 2010a). CKI is a kinase that is able to 
phosphorylate αS at both Ser87 and Ser129. NMR studies point out that 
phosphorylation of Ser87 and Ser129 together or individually can extend the 
conformation of αS in vitro (Paleologou et al, 2010; Paleologou et al, 2008). The 
phosphorylation of Ser87 and its mutation mimics exclusively inhibit the fibril 
formation of αS (Paleologou et al, 2010). But at Ser129, the major phosphorylation site, 
the effect of phosphorylation at this residue on αS aggregation still needs to be 
determined. Recent studies indicating that αS fibrils are able to be phosphorylated at 
Ser129 in vitro and that this phosphorylation is likely independent of aggregation, 
suggesting that this modification can occur after aggregation (Mbefo et al, 2010; 
Waxman & Giasson, 2011). One central issue is to investigate the effects of 
phosphorylation on aggregation behavior and toxicity of αS in vivo. However, the 
related results obtained from different animal models present large diversity, which due 
to the model difference and partially due to the mimics can not completely reproduce 
the effects of real phosphorylation (Braithwaite et al, 2012; Oueslati et al, 2010a).  
Interestingly, in the SH-SY5Y cell model, it’s suggested that Ser129 phosphorylation 
activates ER stress by inducing unfolded protein responses (UPRs) which is possibly 
caused by the disruption of ER-Golgi trafficking (Sugeno et al, 2008). On the other 
hand, Ser129 phosphorylation is suggested to suppress αS-induced vesicle trafficking 
deficit depending on genetic context in yeast model (Sancenon et al, 2012).  These two 
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findings together suggest that Ser129 phosphorylation possesses a potential role in 
regulating vesicle trafficking.  
 
Figure 1.2 Primary structure of αS. (A) Schematic depiction of αS sequence with its 3 domains. The 
positions of 3 familial mutations at the N-terminal are indicated by green lines. Identified and putative 
phosphorylation sites at C-terminal are indicated by black arrows. (B) Sequence analysis for the C-
terminal from 5 different species indicates that the phosphorylation sites are highly conserved. Figures are 
taken from (Hejjaoui et al, 2012). 
Alpha-Synuclein affects vesicle trafficking and its interplay with Rab-GTPases 
Several lines of evidence suggest that αS is involved in the vesicle trafficking in 
synaptic neurons. αS was reported to assist synaptic vesicle recycling and 
neurotransmitter release (Ben Gedalya et al, 2009; Liu et al, 2004).  αS ameliorated the 
neurodegeneration caused by the depletion of cysteine-string protein-alpha (CSPalpha), 
which suggests it has a positive role in co-operation with CSPalpha and SNAREs 
(Chandra et al, 2005). Moreover, it has been suggest that αS has a role in the 
maintenance of synaptic vesicle pools (Cabin et al, 2002; Murphy et al, 2000), activity-
dependent dopamine release (Abeliovich et al, 2000) and as a negative regulator of the 
vesicle priming (Larsen et al, 2006). However, more commonly, altering the expression 
levels and biophysical properties of αS and its familial mutants leads to the deficits of 
vesicle trafficking at multiple steps in animal models (Auluck et al, 2010).  
Rab-GTPases play a key role in coordinating both vesicle formation and 
trafficking (Stenmark, 2009). Serveral Rab proteins have been implicated in directly or 
indirectly interactions with αS in PD models. Immunoprecipitation suggests Rab3a 
binding to αS aggregates in LBs (Dalfo et al, 2004a). At same time, Rab3a, Rab5 and 
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Rab8 were reported to coimmunoprecipitate with αS in A30P αS transgenic mice 
(Dalfo et al, 2004b).  In PD models, αS overexpression disrupted vesicle trafficking 
between the ER and Golgi and overexpression of Rab1 attenuated αS toxicity (Cooper 
et al, 2006). Furthermore, Rab homeostasis was generally disturbed by αS in yeast and 
the overexpression of Rab1, Rab3a and Rab8a was protective against αS-induced 
toxicity in 3 different animal models (Gitler et al, 2008). αS was also reported to induce 
aggregation of many yeast Rab GTPases in the yeast model (Soper et al, 2011). In 
addition, Rab11a together with HSP90 displayed a regulatory role in the recycling of 
extracellular αS (Liu et al, 2009).  Moreover, overexpression of Rab3b, an isoform of 
Rab3, protected dopaminergic neurons in the PD model by improving dopamine 
handling and storage capacity at presynaptic terminals (Chung et al, 2009). These 
findings suggest extensive interactions between Rab proteins and αS and Rab proteins 
generally protect against vesicle trafficking deficits in neuronal models of 
synucleinopahy.  
Cellular toxicity  
Gain of toxic functions through protein misfolding/aggregation is one unifying feature 
of neurodegenerative diseases i.e. Alzheimer’s disease, PD etc. (Lansbury & Lashuel, 
2006; Stefani & Dobson, 2003). But which is the major toxic species of αS – monomers, 
oligomers or fibrils? This is a central question to be addressed in the research into the 
the synucleinopathy in PD. In the last ten years, a significant amount of evidence has 
developed which suggests that the most toxic species of αS and Aβ is the pre-fibrillar 
species (oligomers) rather than the insoluble neuronal deposition i.e. mature fibrils, LBs; 
whereas the well-formed amyloid fibrils are less harmful or even protective (Caughey & 
Lansbury, 2003; Cookson, 2009; Cookson & van der Brug, 2008; Lashuel et al, 2002a; 
Lashuel et al, 2002b; Volles & Lansbury, 2003; Winklhofer et al, 2008). One prevalent 
hypothesis attributes the basis of the oligomeric toxicity to the high membrane affinity 
of the soluble species of oligomers with respect to the membrane distortion and 
membrane leakage caused by the pore-forming capacity of the oligomers (Auluck et al; 
Bodner et al, 2009; Bodner et al, 2010; Butterfield & Lashuel; Lashuel & Lansbury, 
2006). In our lab, the pore-forming propensities have been well-characterized in vitro 
by generating the aggregation on-pathway oligomers from the cold-dissociation of 
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mature αS fibrils (Kim et al, 2009) and the oligomers of triple proline αS mutant 
designed on the basis of NMR structure (Karpinar et al, 2009). However, the oligomeric 
species normally presents continuum distribution in size and molecular weights, 
structural heterogeneity, instability and the mixture with αS monomers that make 
oligomers difficult to be separated. Therefore, we are still lacking the high resolution 
structural information of αS oligomers that determine its critical mechanism in the 
scenario of αS cellular toxicities.  
A concomitant question is whether we can exclude the cellular toxicities of αS 
fibrils with the dominant assumption that the oligomeric species are most toxic. 
However, a consensus upon the role of αS fibrils has still not achieved. Recent studies 
have reported that exogenous fibrils of αS were transmitted into cells and thus seeded 
intra-cellular aggregation and prompted LB formation (Li et al, 2008; Luk et al, 2009). 
This mechanism of fibril transmission can then lead to synaptic dysfunction and neuron 
death (Volpicelli-Daley et al). Furthermore, this transmission was also observed 
between the affected neurons and the grafted neurons in both clinical trials and animal 
models (Hansen et al; Li et al, 2008). Thus, the mechanisms of αS cellular toxicity still 
need to exact and systematic determination. Meanwhile, two relatively novel 
conceptions have been emerging: 1) the prion-like transmission of the pathological 
aggregates propagate the synucleinopathy between cells, different brain regions and 
organs, where the transmissions are realized by exo/endocytosis, membrane leakage, 
passive membrane translocation or alternatively by exosomal release or transport along 
tunnelling nanotubes (Angot et al, 2010; Braak et al, 2002; Brundin et al; Brundin et al, 
2010; Hawkes et al, 2007; Pan-Montojo et al, 2010; Steiner et al) [Figure 1.3]; 2) the 
aggregation process is toxic in comparison with the single species (monomers or 
oligomers, fibrils) (Taschenberger et al, 2012).  
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Figure 1.3 Putative mechanisms of α-synuclein prion-like propagation. (A) The different species of 
α-synuclein coexist in a highly dynamic equilibrium. (B) The prion-like transmission of αS follows an 
order that donor cell - the extracellular space -recipient cell. Figures are taken from (Angot et al, 2010)   
1.2   Intrinsically disordered proteins and protein misfolding 
Intrinsically disordered proteins (IDPs) are one category of proteins which are not 
folded in their functional form (Jensen et al, 2009). But differently from other 
unstructural proteins, IDPs possess the possibility of transient long-range and local 
order and the possibility of folding after binding to the partners (Jensen et al, 2009; 
Rezaei-Ghaleh et al, 2012). IDPs have been shown to participate in a broad range of 
cellular processes and the development of several human pathologies like 
neurodegenerative disease and cancer (Dyson & Wright, 2005).  
IDPs present high structural flexibility and thus the traditional structural 
methods established on precise determination of well-defined protein structures are not 
suitable for IDPs (Jensen et al, 2009). In addition, X-ray crystallography is not 
applicable to IDPs due to their disordered nature. Rather than the determination of a 
single set of atomic coordinates, therefore, the conformational behaviors of protein 
backbone or an explicit ensemble description of interconverting structures are more 
appropriate for the structural description of IDPs. For this, NMR spectroscopy is an 
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excellent for defining the transient long-range interactions and local conformations at 
atomic resolution on a wide timescale window (Dyson & Wright, 2004). The solution 
NMR terms such as PRE, RDCs, relaxation parameters, and chemical shift perturbation 
are powerful in describing the conformational ensemble and protein-protein/ligand 
interaction for IDPs. αS as paradigm in the structural studies of IDPs has been well 
characterized by these solution NMR methods (Bertoncini et al, 2005b; Cho et al, 2007; 
Mukrasch et al, 2007; Salmon et al, 2010; Skora et al, 2006). 
 In one subcategory of IDPs which includes αS, Tau et al., the proteins are able 
to fold and assemble into higher ultramolecular structures and are thus highly involved 
in the neurodegenerative diseases (Uversky, 2009; Uversky et al, 2008). According to 
the prevaling theory, the folding of the nascent polypeptide chain passes through the 
folding intermediates or partially folded states, to the native state that is located at the 
lower bottom positions in the funnel-shaped folding energy landscape [Figure 1.5] 
(Hartl et al, 2011; Hartl & Hayer-Hartl, 2009). Due to the ruggedness of the free-energy 
landscape, several kinetically trapped conformations during the folding need to 
overcome the energy barrier to reach an energy-favored downhill path. Protein 
chaperones play an important role in facilitating this energy conversion and controlling 
the conformational correctness of folding.      
 
Figure 14. Schematic representation of funnel-shaped folding energy landscape. The kinetically 
trapped conformations as the folding intermediates present in the folding or aggregation pathway. The 
figure is adapted from (Hartl et al, 2011).  
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The aggregation normally occurs as a consequence of the energy surface of 
intramolecular folding overlaping with the surface of intermolecular aggregation in the 
energy funnel. As described in Figure 1.4, this is the reason that proteins might through 
partially folded states adopt the aggregation pathway to misfold to the amorphous or the 
ordered aggregates. For αS, Tau, and Aβ, due to their hydrophobic regions highly 
exposing to outer environment, they are readily able to achieve the intermolecular 
association with neigbouring proteins in cellular (Fink, 2006). Therefore, they 
preferentially fold though the downhill routine of intermolecular aggregation in the 
energy funnel to form well-ordered amyloid fibrils. This fibrillar aggregation typically 
occurs in a nucleation-dependent manner for the oligomerization. As protein chaperones 
are able to inhibit the misfolding, the study of interactions of the chaperones (i.e. HSPs) 
with αS and their role in modulating αS cellular toxicities is an active field in the 
research of Synucleinpathies (Dedmon et al, 2005a; Falsone et al, 2009; Huang et al, 
2006; Liu et al, 2009; Lo Bianco et al, 2008; Putcha et al, 2010; Roodveldt et al, 2009). 
At the same time, the aggregation of αS has been developed as the promising 
therapeutic target for PD  treatments (Brundin & Olsson, 2011; Madine & Middleton, 
2009).    
1.3 Major challenges  
The major research interests and challenges are summarized in the following section.  
(1) Assess structures of the αS oligomers at atomic resolution and characterize the 
interaction of proteins/ligands with αS intermediates.  
(2) Clarify the toxic species in the scenario of αS aggregation, monomers, oligomers, 
fibrils or establish alternative hypothesis.  
(3) Define the functional relevance of posttranslational modification, particularly the 
dominant phosphorylation at Ser129 of αS. 
(4) Identify the protein-protein interactions involved in αS pathologies. 
(5) Investigate the structural basis for the cell-to-cell prion-like transmission. 
(6) Detect the origin and functional relevance of polymorphism of αS aggregates   
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(7) Search for the interplay between different PD genes.  




2  Materials and Methods 
2.1 Materials 
2.1.1 Facility  
Table 2.1 Facility used in sample reparation, NMR measurements and biophysical studies 
Facility Specifications 





















UV-Vis  Photometer  
Asylum Research MFP-3D™ Stand Alone Atomic Force Microscope 
Sartorius B 3100 S & AC 210 S 
Eppendorf Centrifuge 5415D 
Eppendorf Centrifuge 5804 
Beckman TL-100 with TLA-100.3 rotor 
Amicon Microcon, Centricon, Centriplus/ Amicon Ultra, Ultracel 
Thermo Scientific Slide-A-Lyzer Dialysis Cassettes 
Wyatt DynaPro Titan 
Philips CM12 
Varian Cary Eclipse Spectrophotometer 
Millipore 0.2 μm syringe filter 
BioRad Power Pac 300 
Thermo Scientific, Heraeus, B6 and B20 
Braun Biotech Christ Alpha 2-4 
Bruker Avance 400 MHz, TXI probe,  
Bruker AvanceIII 600 MHz, QXI probe 
Bruker Avance 600 MHz, cryoprobe 
Oxford Avance 700 III MHz, TXI probe 
Bruker Avance 700 MHz, cryoprobe 
Bruker Avance III 800 MHz, 1.7mm and 5.0mmcryoprobe,                            
Bruker Avance 900 MHz, cryoprobe 
Hewlett-Packard 8453 
2.1.2 Chemicals  
Table 2.2 Chemicals used in experiments. 
Application Chemicals 




Other chemicals  
Pf1, Asla, Riga, Latvia 
GuSCN, Sigma-Aldrich, Deisenhofen, Germany 
PLK1-3, Cell Signaling Technologies and Invitrogen, USA 
CKI, New England Biolabs, USA,  
Thioflavin T, Sigma, Steinheim, Germany 
DTT, Gerbu, Gaiberg, Germany 
Bench Mark protein ladder, Invitrogen, Karlsruhe, Germany 
SDS, Serva, Heidelberg, German 
Acetonitrile, APS, ATP, HEPES, TEMED, Roth, Karlsruhe, Germany 
Formic acid, Glycine, Hydrochloric acid, Manganese chloride 
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dihydrate, Sodium chloride, Sodium dihydrogen phosphate, Sodium 
hydroxide, TFA, Tris, Merck, Darmstadt, Germany 
2.1.3 Software 













Bruker Biospin, Karlsruhe, Germany 
spin.niddk.nih.gov/NMRPipe (Delaglio et al. 1995) 
www.cgl.ucsf.edu/home/sparky (Goddard and Kneller) 
http://www3.mpibpc.mpg.de/groups/zweckstetter/_links/software_mars.htm (Jung 
2004, Narayanan 2010) 
http://www3.mpibpc.mpg.de/groups/zweckstetter/_links/software_pales.htm 
(Zweckstetter and Bax 2000, Zweckstetter 2008) 
DeLano Scientific LLC, Palo Alto, CA, USA 
Wolfram Research, Champaign, IL, USA 
OriginLab Corporation, Northampton, MA, USA 
Microsoft, USA 
2.2 Sample preparation  
2.2.1 Protein expression and purification 
Sample expression and purification of wt-αS, 15N wt -αS, 15N-E46K αS, 15N-A53T αS, 
P128E/S129E αS, M127E/P128E/S129E αS were performed by Dr. Stefan Becker, 
Karin Giller, Sebastian Wolff in Dept. NMR-based Structural Biology, Max Planck 
Institute for Biophysical Chemistry in Göttingen. Wild-type αS and its mutants were 
expressed in E. coli in M9 medium and purified as described (Bertoncini et al, 2005b; 
Hoyer et al, 2002).  The samples of 15N-A30P αS, 15N-E46K αS, 15N-A53T αS for real-
time NMR assays were prepared by Prof. Dr. Hialal Lashuel’s group.   
Rab1b-GDP, Rab1b-GppNHp, Rab3a-GDP, Rab3a-GppNHp, Rab8a-GDP,    
Rab8a-GppNHp, Rab8a(6-176)-GDP, Rab8a(6-176)-GppNHp, 15N-Rab1b-GDP, 15N-
Rab8a-GDP, 15N-Rab1b(1-175)-GDP, 13C,15N-Rab1b(1-175)-GDP, 13C, 15N-Rab8a-
GDP were prepared by the group of Dr. Amyelt Itzen, Dept. Physical Biochemistry, 
Max Planck Institute of Molecular Physiology in Dortmund.  
2.2.2 Synthesis of Rab8a C-terminal peptide  
The C-terminal Rab-peptide of Rab8a comprising residues Asp176-Arg205 was 
synthesized by Kerstin Overkamp (Dept. NMR-based Structural Biology, Max Planck 
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Institute for Biophysical Chemistry in Göttingen) by using standard solid-phase 
fluorenylmethoxycarbonyl chemistry. The peptide was purified by semipreparative 
reverse-phase HPLC, and the purity (>95%) was analyzed by MS. 
2.2.3 Preparation of the phosphorylated Ser129 α-Synuclein 
α-Synuclein was dissolved in the phosphorylation buffer containing Mg2+, ATP and the 
phosphorylation was stated by the addition of Polo-like Kinase 3 (PLK3). The solution 
was incubated at 30 °C for 2.5 hours to reach full phosphorylation at the Ser129. Trace 
amount of the phosphorylation product was loaded into MS to identify the single 
phosphorylation which was indicated by the mass change of 80 Da compared with wt-
αS [Figure 2.1 (A) and (B)]. The phosphorylated αS was purified by semipreparative 
reverse-phase HPLC coupled with the online monitors of UV-Vis and MS. The purified 
protein was lyophilized and dissolved into the aggregation buffer. The single 
phosphorylation was further confirmed by 1D NMR spectrum [Figure 2.1 (C)].  The 
steps of HPLC/MS were implemented by Gerhard Wolf (Dept. NMR-based Structural 
Biology, Max Planck Institute for Biophysical Chemistry in Göttingen). 
 
Figure 2.1 Characterization of Ser129-phosphorylation of αS. Mass spectrum of the phosphorylated 
αS (14540.8 kDa) (A) and wt-αS (B) as a reference (14460.8 kDa). (C) 1D 1H NMR spectra comparison 
demonstrates the single peak of the phosphorylated Ser129 occured after PLK3 phosphorylation.  
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2.3 Methods 
2.3.1 Phosphorylation assays 
PLKs phosphorylation 
For real-time NMR to measure the enzymatic kinetics, samples contained ∼ 0.1 
mm 15N-labeled αS in 20 mm HEPES, 10 mm MgCl2, 2 mm dithiothreitol, and 1.09 
mm ATP, pH 6.9. The real-time assay was started by the addition of kinase into the 
sample, with a protein/kinase ratio of 100:0.5. The temperature was set to 303 K to 
allow for efficient phosphorylation. To reduce the impact of signal broadening due to 
amide proton exchange, the temperature was lowered to 288 K during the measurement 
of 1H,15N heteronuclear single quantum coherence (HSQC) spectra. In the case of PLK3, 
the phosphorylation reaction proceeded very rapidly at 303 K. Therefore, we also 
followed the kinetics of phosphorylation of αS by PLK3 at 293 and 288 K using ∼
0.075 mm αS (protein/kinase = 100:0.5 μg). 
 
CKI 
The kinase was incubated at 37°C for 5 minutes before mixing it with the protein (225 
μM) in CK1 Reaction Buffer (New England Biolabs), pH 7.4. The reaction was carried 
out in the presence of 1.09 mm ATP and 1200 units of CK1/145 μg of αS. Afterwards, 
the phosphorylation was started and monitored by the real-time NMR method at 15 °C.  
2.3.2 Aggregation assays 
Aggregation assays for αS performed in this thesis follow the steps: 1) concentration 
calibration (UV-Vis, NMR); 2) solution processing: filtering with 0.22 μm membrane to 
remove of large particles and ultracentrifuge with 60K rpm to remove the oligomeric 
species; 3) aggregation with constant stirring at specified temperature. Thioflavin-T 
(ThT) as specific dye was used to monitor the fibril-formation kinetics. Dynamic light 
scattering (DLS) was used to monitor the oligomerization process. Electron microscopy 
(EM) and Atomic force microscopy (AFM) were selectively used to morphologically 
characterize the αS aggregates.  
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Three buffer systems are used in this thesis. (1) HEPES buffer: HEPES 50mM, 
NaCl 100mM, pH 7.4, used in the assays: aggregation in the presence of the Rab 
proteins, aggregation of the phosphorylated αS and the phosphorylation mimics. (2) 
Phosphate buffer:  Phosphate 50mM, NaCl 100mM, pH 7.4, used in the generation of 
the compounds-stablized oligomers. (3) Tris buffer: Tris 20mM, NaCl 100mM, pH 7.4, 
used in the producing the fibrils of the pathological αS mutants. 0.1% NaNa3 is 
normally included in the buffer for sterilization.  
Standard temperature for αS aggregation is at 37oC. For the aggregation assays 
in the presence of Rab proteins, the temperature was set at 21oC taking into account the 
stability issue of Rab proteins. And the co-aggregating factors i.e. ligands, proteins 
should be added before the filtering step.  
2.3.3 NMR spectroscopy 
2.3.3.1 Backbone assignment 
Backbone assignment methods 
Backbone assignment, determing the nucleus that the resonance originates from, is the 
primary work to analyze the structure of macromolecules like proteins and nuclear acids 
by NMR spectroscopy (Wüthrich, 1986), particularly after the advent of 
multidimensional spectroscopy (Bax & Grzesiek, 1993; Oschkinat et al, 1988). Protein 
backbone assignment is achieved by transferring of coherence along the network of 
scalar coupled spins 1HN, 15N, 13Cα (13Cβ), and 13CO of the 13C, 15N isotropic labeling 
protein in 3D NMR experiments [Figure 2.2] (Sattler et al, 1999). INEPT (Insensitive 
Nuclei Enhanced by Polarization Transfer) is a fundamental block responsible for the 
coherence transfer based on the scalar coupling (J) specific to the different coupled 
spins. INEPT is designated to transfer nuclear spin polarization from spins with large 
Boltzmann population differences to nuclear spins of interest with low Boltzmann 
population differences (Morris & Freeman, 1979). To obtain maximal sensitivity, the 
proton with largest gyromagnetic ratio (γ) is firstly polarized by the excitation of pulse 
in most of the cases and then the polarization was transferred by INEPT to the 
heteronuclei that this proton attaches to i.e. 15NH, 13Cα, 13Cβ. The following phase is 
performing the mixing and evolution, by which the coherence is transferred along the 
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pathway targeting the specified sequential connectivity and chemical shifts of the 
indirection dimensions were labeled by encoding the modulation of Larmor frequencies 
of each nuclear in spin system to the magnetization strength. The final phase is 
transferring the magnetization back to the proton which would be detected by recording 
the FID.    
 
Figure 2.2 Network of the scalar coupling along protein backbone. Spin system of the peptide 
backbone and the size of the 1J and 2J coupling constants that are used for magnetization transfer in 13C-, 
15N-labelled proteins. Figure is adapted from (Sattler et al, 1999). 
There are two manners, “out and back” and “one way”, commonly used for the 
INEPT transfer pathway for constructing 3D experiments. The “out and back” 
experiments such as HNCO, HNCA, HNCACB are in one category experiments that 
magnetization transfer was started and ended at same protons. The “one way” is that the 
transfer is started from one proton and ended at another proton, for instance the 
CBCAcoNH is started from Hα/Hβ and ended at amide HN. The time set for the INEPT 
delay is taken into account the compromise between sufficient coherence transfer based 
on J coupling and the diphase caused by transverse relaxation (R2) during the longer 








Δ = i i , 
where J is the coupling constant and T2 is the transverse relaxation time. 
Therefore, the relaxation features should be estimated prior to start recording of 3D 
experiments. One-one echo experiment designed based on the rotation frame is a 
straightforward and ready way to estimate the T2, global rotational correlation time (τc) 
and thereby the molecular weight of the protein that assessing situation of the 
oligomerization (Sklenar & Bax, 1987). At the same time, 1D NMR spectrum can also 
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be used as an evidence to judge if protein is folded after sample preparation procedure. 
However, the proteins with larger molecular weights (≥20kDa) exhibit worse the 
spectra qualities with respect to the sensitivity and resolution, which are the results of 
strong nuclear relaxation and singal overlap because of the large number of residues. A 
major trend in the development of NMR spectroscopy applied in structural biology is 
extending the detection limits posed by the large molecular weight of proteins. 
Transverse relaxation optimized spectroscopy (TROSY) is one approach that improves 
the spectra qualities by select the component with the mutual cancellation of dipole-
dipole couplings (DD) and chemical shift anisotropy (CSA), where the transverse 
relaxation of the large proteins are dominated by these two mechanisms (Pervushin et al, 
1997). TROSY as the alternative to heteronuclear correlation spectroscopy (HSQC) can 
be incorporated into the well-established 3D or higher dimension experiments 
(Salzmann et al, 1998) and thus successfully enables NMR assignment and the 
following structural analysis for the large proteins.  
Following the acquisition of 3D experiments required for establishing the 
sequential connectivity [Table 2.3.1], the backbone assignments will be implemented by 
the steps of spin system recognition and sequential connectivity searching. Herein, the 
assignments were performed by MARS, a robust automatic backbone assignment 
program  (Jung & Zweckstetter, 2004a; Jung & Zweckstetter, 2004b). The manual peak-
picking and prediction of secondary chemical shifts based on the primary sequence are 
required prior to running MARS. The specified assignments, the residual dipolar 
couplings (RDCs), dihedral angles and existed crystal structure can be optionally 
contained in the input data. The sequential connectivity of the local fragment and 
globular backbone is established by linking the inter- and intra-residue signals and 
mapped onto the protein sequence, which the secondary structure propensity is taken 
into account. The assignment is finally output by combining the local and globular 
assignment. 
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Table 2.3.1 3D experiments used for backbone assignments of the Rab proteins 
Experiments Bruker pulse code Parameters ⊥ 
HNCA trhncagp3d2 50×24×1024 pts; ns=16; 600MHz 
*50×25×1024 pts; ns=24; 800MHz 
HNCACB trhncacbgp3d 68×21×1024 pts; ns=32; 700MHz 
*61×26×1024 pts; ns=48; 800MHz 
CBCA(CO)NH trcbcaconhgp3d 64×20×1024 pts; ns=36; 700MHz 
*64×23×1024 pts; ns=32; 800MHz 
HNCO trhncogp3d 50×33×1024 pts; ns=32; 700MHz 
HN(CA)CO trhncacogp3d 65×21×1024 pts; ns=32; 700MHz 
*Recorded for Rab8a-GDP with 1.7mm cryoprobe 
⊥Specification for spectrometer parameters: number of complex points (pts) in t1, t2 and t3 time domain; 
number of scanes (ns); field strength for 1H 
Structural analysis based on chemical shifts 
After the backbone assignment is obtained, we are able to perform the structural 
analysis for protein based on the chemical shifts. Firstly, the secondary chemical shifts 
of carbon (Cα, Cβ, CO) are highly indicative of the structural propensity of secondary 
structure.  The secondary chemical shifts were determined by the difference between the 
experimental chemical shifts (δexp) and the random coil chemical shifts (δcoil) of the 
residue (Schwarzinger et al, 2001; Schwarzinger et al, 2000):  
exp coilδ δ δΔ = −  
To correct the referencing errors, the difference between the secondary chemical shifts 
of Cα and Cβ has been applied (Wang et al, 2005): 
α βδ δΔ − Δ  
Secondly, residual dipolar couplings (RDCs) can be measured by adapting the 
protein into the weak alignment mediums i.e. the liquid crystal and bacterial phage 
where the dipolar coupling between two nuclear dipoles is partially retained due to the 
motion of molecule is restricted in the medium (Prestegard et al, 2004). For instance, 
the RDCs of NH vector can be measured by comparing the difference of scalar coupling 
of NH between the aligned sample and isotropic sample (in free solution). To this aim, 
the IPAP-HSQC (Ottiger et al, 1998) and interleaved TROSY/HSQC (Kontaxis et al, 
2000) are two common approaches to measure the J-couplings.   
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Herein, the RDCs for 15N-Rab1b-GDP were obtained from the interleaved 
TROSY/HSQC spectra: 
1 2 ( )HSQC TROSYNH N ND ν ν= −i  
At the same time, the RDC values were back-calculated from the crystal structure of 
Rab1b (PDB code: 3NKV) using singular value decomposition (SVD) by the program 
PALES (Zweckstetter, 2008). A comparison of the experimental and the calculated 
RDCs was used to evaluate the difference between solution conformation and crystal 
structure. The solution conformation matches the crystal structure well if the Q-factor of 
fitting is below 0.2.    
2.3.3.2 HSQC-based study of protein-protein/ligand interactions 
NMR signals of backbone amides provide excellent information to probe protein-
protein/ligand interaction with the description of interaction interface and binding 
affinity according to perturbation of chemical shift and line-width analysis (Craik & 
Wilce, 1997; Gao et al, 2004). In practice, 1H,15N-HSQC spectra have been recorded for 
the 15N-labeled protein in the absence and presence of the interaction partners that are 
normally unlabeled proteins or ligands. The chemical shifts perturbations are calculated 
as: 
2 2( / 5) ( )HN N Hδ δ δ=Δ Δ + Δ  
The HSQC spectra of 15N-labeled sample are recorded in the presence of the 
binding partners at different molar ratios to the sample. In this case, the chemical shift 
perturbations are increased as a function of concentration of the binding partners, which 
the dissociation constant Kd can be estimated by fitting to a single-site binding model 
(Cavanagh et al, 2007):    
{ }( )1/22max [ ] [ ] ([ ] [ ] ) 4[ ] [ ] / (2[ ] )T T d T T d T T TL P K L P K L P Pδ δΔ = Δ + + − + + −i i  
where the  Δδmax is the maximal chemical shift perturbation value at saturation, [P]T and 
[L]T are the total concentration of protein and ligand. This approach is particularly 
advantageous to determine the Kd for weak binding system (Kd >10-6M). The 
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crystallization for such system is difficult or impossible (Cavanagh et al, 2007) and ITC 
used for measuring such weak binding might bear bigger uncertainty.   
2.3.3.3 Real-time NMR method used in the investigation of phosphorylation kinetics 
Real-time NMR methods used in studies of the enzymatic kinetics possess predominant 
advantages than other common methods like MS spectrometry and immunodetection 
(Landrieu et al, 2006). Firstly, 2D NMR HSQC spectrum is able to unambiguously 
identify the residues undergoing phosphorylations and the resonances of the 
phosphorylated residues are located at the downfield region of the spectrum which is 
well-resolved with the unphosphorylated resonance. Secondly, the enzymatic resolution 
can be monitored at atomic resolution, which the onset time and reaction rate can be 
assessed for different phosphorylation sites simultaneously.  
For our phosphorylation kinetics studies, 15N-labelled αS and the assignment for 
1H,15N-HSQC of αS are required. The real-time assay was started immediately after the 
sample was mixed with the kinases and ATP. A series of HSQC spectra were recorded 
and quantitative analysis of the phosphorylation kinetics was implemented based on the 
measurement of resonance intensity. For better time resolution, the fast acquisition 
pulse SOFAST-HMQC was applied to investigate the fast kinetics instead of common 
HSQC (Schanda & Brutscher, 2005; Schanda et al, 2005). SOFAST, “band-Selective 
Optimized-Flip-Angle Short-Transient”, is a technique to design the pulse sequence 
based on the Ernst-angle excitation: 
1cos exp( / )opt rect Tα = −  
where αopt  is the optimized flip angle of the excitation or so-called “Ernst angle”, trec is 
the time of recover delay and T1 is the longitudinal relaxation constant. Here, the 
SOFAST is combining this technique with the selective 1H pulses which are aiming to 
optimize the longitudinal relaxation.  
2.3.3.4  NMR approach to study H/D exchange rate of protein backbone 
Hydrogen/Deuterium exchange method has been widely applied to characterize the 
structures of amyloid fibrils (Carulla et al, 2010).  In this dissertation, this method based 
on solution NMR has been used for structural analysis of αS fibrils and Oligomers. For 
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αS fibrils, as demonstrated in Figure 2.3, the collected fibrils were adapted into 99.9% 
D2O solution containing 200mM NaCl and 0.1% formic acid (pD 4.0) for two weeks. 
During this period, the hydrophobic core buried inside fibrils should be protected 
against the solvent but other fraction of protein not in the core would exposose to the 
solvent and thus was exchanged by deuterium. After this exchange period, the fibrils 
were collected again and dissolved by GuSCN into NMR observable monomers which 
encode the protection information. This dissolving solution contains 50% D2O only and 
at pH 2.4. Thus the residue previously expososed to the solvent would experience a 
back-exchange from 99.9% deuteration to 50%. The sample was transferred into NMR 
spectrometer immediately after the dissolving in order to start the acquisition of the 
HSQC spectra with the average dead time of 15 minutes and acquisition time of 25 
minutes. The HSQC spectra were recorded at 5oC to restrict the proton exchange rate. 
The residue from protected or exposed regions could be distinguished by mapping the 
change of resonance intensity against the time course. The increasing pattern of 
intensity denotes this residue was in an exposure region before, whereas the previously 
protected region would have the flat or decreasing patterns.  
The working principle of H/D exchange for αS oligomers is similar. However, 
the distinct nature of the oligomers requires the modifications for most of steps. Firstly, 
for the exchange, D2O has been directly added to the solution containing the oligomers 
and the time for the exchange was within 10 minutes since the hydrophobic protection 
in oligomers is expected to be wearker than in the fibril core. Secondly, the GuSCN was 
then directly added into the solution and adjust the pH down to 2.4, which the solution 
volume was thus expanded.   
In addition, to shorten the acquisition time for better time resolution, we used 
HSQC with band-selective excitation Short-Transient (BEST-HSQC) (Lescop et al, 
2010). The BEST-HSQC replaces all proton hard pulses by band selective excitation 
pulses to only excite the amide protons of protein and remain the other type protons and 
water signals not to be directly excited. The spin-lattice relaxation of a 1H spin depends 
on the initial spin-state of the surrounding 1H spins. The excited amide protons can 
exchange polarization with surrounding non-excited aliphatic protons and water protons 
though NOE or spin diffusion effects, by which the T1 relaxation of the amide protons 
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can be shortened. By this way, the recover delay can be shortened, which both repetition 
rate and sensitivity can be improved.  
 
 
Figure 2.3 Schematic flowchart of H/D exchange. αS aggregates (fibrils/oligomers) (A) are adapted 
into the D2O buffer (B) for a specified period. The hydrophobic core region of the aggregates should be 
protected against the solvent exchange. After the exchange period, the aggregates are dissolved by 
GuSCN into the monomers encoding the protection information (C) and quickly transferred to the NMR 
spectrometer to start recording a series of HSQC spectra. Finally, the change of residue-specific peak 
intensity reflects the extent of protection/exposure.  
2.3.3.5 Diffusion coefficient 
NMR diffusion experiments detect the translational diffusion of molecules in solution 
by using pulsed field gradients (Johnson, 1999). The spatial enconding for the 
molecules is firstly implemented by the pair of pulsed field gradients (bipolar gradients) 
coupled with one spin-echo pulse. Then there will be a diffusion period that allows the 
molecules to move away from the original encoding position.During this period, the 
motional rate of the molecules depends on the diffusion coefficient. After this diffusion 
time, the position of the molecule can be decoded by the second pair of pulsed field 
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gradients with same net strength but opposite direction. The gradient strength applied in 
the spectrum is normally varied from 25% to 95%. The diffusion coefficient of the 
molecule is estimated by fitting the signal intensities as the function of varying gradient 
strength according to: 
2 2 2 ( /3)
0
D gI I e γ δ δ− Δ−=  
where I is the observed intensity, I0 the reference intensity, D the diffusion coefficient, γ 
the gyromagnetic ratio of the observed nucleus, g the gradient strength, δ the length of 
gradient and Δ the diffusion time. For αS, the peaks located with the range of 0.5-2.0 






where K is the Boltzman constant, T the temperature, η the viscosity of the solution and 
Rh hydrodynamic radius of the molecules. Thus, we can measure the hydrodynamic 
radius of the protein by referring to the internal reference molecule, dioxane, with 
known Rh (2.12 Å). In our measurements, we used the pulsed field gradient spin-echo 
(PGSE) sequence with the incorporation of WATERGATE (W5) element which 
significantly suppresses the water signal (Zheng et al, 2008).  
2.3.4 Biophysical methods 
2.3.4.1 Fluorescence spectroscopy  
Fluorescence measurements with specified excitation and emission wavelength enable 
us to detect specific information. Thioflavin-T (ThT) is a dye specific to the structure of 
crossing β-sheets and thus widely used to characterize kinetics of the fibril formation 
process (LeVine, 1999). The excitation wavelength is 446nm and the emission 
wavelength is 460 to 600nm, where the maximum emission is at 482 nm for amyloid 
fibrils. For the fluorescence measurement, 5μL in-time aggregation solution is mixed 
into 5μM×2mL ThT solution. 
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2.3.4.2 UV-Vis Spectroscopy 
UV absorption at 280 nm is used to determine protein concentration according to Beer-
Lambert law: 
280 280εA c d= ⋅ ⋅  
A280: the absorption at 280 nm 
 ε280: The molar extinction parameters at 280nm calculated by the TRP, TYR amino 
acid content in the protein sequence.  
c: protein concentration (M) 
d: path length of light (cm) 
2.3.4.3 Dynamic light scattering   
Dynamic light scattering (DLS) is an approach to measure the particle size, namely 
hydrodynamic radius, in solution based on the evaluation of their translational diffusion 
constants of Brownian motion, which is also known as Photon Correlation Spectroscopy. 
DLS was performed by Wyatt Dynamo Titan with temperature control. Sample that 
would be used for DLS measurement should be filtered by 0.22 μM membrane at 
beginning. If solution conains large fibrils, it should be centrifuged at 10k rpm for at 
least 15 mins and only supernatant can be used for DLS measurement. Then, the sample 
is transferred into DLS cuvette and 18 μL as a minimal volume are required. The DLS 
measurement was implemented at 25oC. The laser power is set at 15% and can be 
adjusted according to the size of oligomeric species formed during aggregation. 
Acquisition time for each scan is 20 seconds and each measurement contains 20 scans. 
The measurement is normally repeated for 3~5 times. 
The hydrodynamic radius calculated based on the light scattering data are 
containing the contribution of hydration. To keep control, the diffusion measurements 
(DOSY) performed by NMR spectroscopy are an alternation and the gyrations 
measured by small angle X-ray scattering are a complementary approach to further 
investigate the configuration of particles.  
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2.3.4.4  Electron microscopy  
Transmission electron microscopy (TEM) for characterization of αS aggregates, the 
oligomers and fibrils, were performed by Dr. Dietmar Riedel and Gudrun Heim in Max 
Planck Institute for Biophysical Chemistry. Aggregated protein samples were deposited 
on Formvar-coated 200 mesh copper grids (Electron Microscopy Sciences) at a 
concentration of 25 μM. For more concentrated sample, the dilution by buffer is 
required for better resolution. Grids were washed with two drops of water and stained 
with two drops of freshly prepared 0.75 % (w/v) uranyl acetate (Electron microscopy 
sciences). Specimens were inspected on a Philip CIME 12 electron microscope, 
operated at 80 kV. Digitized photographs were recorded with a slow scan CCD camera. 
 
2.3.4.5 Atomic force microscopy 
Atomic force microscopy (AFM) is an alternation approach to TEM for characterizing 
the αS aggregates. The set-up is installed in Dept. NanoBiophotonics, Max Planck 
Institute for Biophysical Chemistry.  
The aliquots of 3~5 μL from aggregation system were deposited on freshly 
cleaved mica. After drying in air for 1 hr, unbound sample and buffer were removed by 
3 times washing with 30 μL distilled water. The samples were imaged using an Asylum 
MFP3D AFM machine, with a resonant frequency of about 100 kHz, a scan frequency 


















3.1 Phosphorylation of alpha-Synuclein 
Phosphorylation at Ser129 of αS is one of major posttranslational modifications. 
Approximately 90% of αS is phosphorylated at this site in pathological inclusion-Lewy 
body, a hallmark of PD (Fujiwara et al, 2002). Ser87 at NAC region of αS can also be 
phosphorylated by kinases, inhibiting the fibrillization of αS (Paleologou et al). 
However, the functional role of αS phosphorylation has still not been defined. 
Therefore, based on atomic resolution provided by NMR spectroscopy, we investigated 
the residue-specific kinetics of phosphorylation at both Ser87 and Ser129 of αS as 
mediated by different kinases.  
We first investigated the effects of 3 disease mutations of αS, A30P, E46K and 
A53T on phosphorylation kinetics of Ser87 and Ser129. Two kinases, CKI and PLK2 
were respectively used in this assay to phosphorylate αS mutants. Furthermore, PLKs 
phosphorylate αS selectively at Ser129 but not Ser87 in CNS as well in vitro (Inglis et 
al, 2009; Mbefo et al). This offers us an opportunity to study the phosphorylation 
specifically at Ser129. Thus, the kinetics of αS phosphorylation mediated by PLK1, 2, 
and 3 were investigated. Finally, we studied whether phosphorylation at Ser129 of αS 
can affect its aggregation. We generated Ser129-phosphorylation (pS129) αS and two 
phosphorylation mimics, P128E/S129E αS and M127E/P128E/S129E αS. Aggregation 
assays for pS129 αS and its two mimics were implemented in vitro. These results 
extended our understanding the structural mechanism and aggregation behaviors 
involved in αS phosphorylation.  
3.1.1 Phosphorylation of disease-associated α-Synuclein mutations 
Three familial mutations in gene coding of αS (SNCA) were linked to the autosomal 
dominant inherited form of PD: A53T (Golbe et al, 1990; Polymeropoulos et al, 1997; 
Puschmann et al, 2009), A30P (Kruger et al, 1998) and E46K (Zarranz et al, 2004). 
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Increasing evidence suggests that these point mutations can alter the monomeric 
conformation, fibril formation, and membrane binding and thereby inducing differently 
physiological and pathological behaviors (Bisaglia et al, 2009; Bodner et al, 2010; 
Bussell & Eliezer, 2001). Therefore, our study of the effects of these three mutations on 
the phosphorylation enables us to depict the interplay between the familial mutations 
and the major posttranslational modifications.  
3.1.1.1 Kinetics of α-Synuclein phosphorylation by PLK2 
Heteronuclear NMR spectroscopy on 15N-labeled protein modified by a kinase allows 
the identification of the phosphorylation sites, measures the level of integration, and 
yields kinetic data for the enzymatic modification of the individual sites (Landrieu et al, 
2006). Although the reaction mixture contains enzyme, ATP and αS, filtering through 
the 15N label allows monitoring of the kinase activity in the NMR tube without any 
further sample purification. To obtain single-residue resolution and identify all potential 
phosphorylation sites, the enzymatic reaction was followed by two-dimensional 1H-15N 
heteronuclear correlation spectra. For wt-αS and its 3 familial mutants, the resonances 
were sharp and showed a limited dispersion of chemical shifts, reflecting a high degree 
of backbone mobility [Fig. 3.1.1 A]. Phosphorylated serine residue was readily detected 
because phosphorylation shifts their amide proton resonance downfield of 8.8 ppm, to 
an empty region of the 1H-15N HSQC spectrum.  
With increasing incubation time, the intensity of the NMR signal of 
phosphorylated Ser129 increased with the concomitant decrease of unphosphorylated 
Ser129. In agreement with data from cell assays (Mbefo et al, 2010), only Ser129 was 
phosphorylated, highlighting the specificity of PLK2 for Ser129 phosphorylation. 
Quantitative analysis of the phosphorylation kinetics of wt-αS and the 3 mutants was 
implemented based on the measurement of resonance intensity. After one day, 40-50% 
of the wt protein, and the three αS mutants were phosphorylated at Ser129, and the 
reaction reached saturation in the following 10 hours [Fig.3.1.1 B]. A comparison of the 
kinetics of phosphorylation revealed that wt-αS was phosphorylated faster than all three 
genetic variants under controlled in vitro conditions using the same kinase and protein 
concentrations. Although the saturation levels are only slightly different, after four 
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hours of incubation the degree of Ser129 phosphorylation of wt αS was larger by a 
factor of 1.5 when compared to the genetic mutants. 
 
Figure 3.1.1. Kinetics of mutant αS phosphorylation by PLK2. (A) Comparison of two-dimensional 
1H-15N HSQC spectra of unphosphorylated wt (green) and PLK2-phosphorylated WT αS (red). A dashed 
rectangle marks glutamine and asparagine side chain resonances. Note that PLK2 phosphorylates αS only 
at Ser129. (B) Kinetics of in vitro phosphorylation of Ser129 by PLK2 in wt (black), A30P (red), E46K 
(green) and A53T (blue) αS. The reactions were monitored by real-time NMR spectroscopy. Error bars 
are based on the signal/noise ratio observed in the NMR spectra.  
3.1.1.2 Kinetics of α-Synuclein phosphorylation by CK1 
Real-time NMR spectroscopy was also used to follow the kinetics of phosphorylation of 
wt-αS and its 3 familial mutants by CK1. The NMR signals appearing in the downfield 
region of the HSQC spectrum were assigned to phosphorylated Ser87 and 
phosphorylated Ser129. These two downfield signals were seen in the spectra of wt-αS 
and the 3 mutants, indicating that CK1 is capable of phosphorylating wt-αS as well as 
the three genetic variants at both sites.  
During the phosphorylation reaction, the resonance intensities of phosphorylated 
Ser87 and Ser129 increased, and their unphosphorylated counterparts decreased 
[Fig.3.1.2 A]. The rate of phosphorylation at Ser87 was identical for all three genetic 
mutants and wt α-syn [Fig.3.1.2 B]. At the same time, a comparison of the kinetic 
profiles of phosphorylation at Ser129 α-syn revealed a slightly higher rate of 
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phosphorylation in the case of wt-αS [Fig.3.1.2 C]. It should be noted that the highly 
similar phosphorylation kinetics of all four proteins at Ser87 served as a ruler and 
proved that the conditions of the phosphorylation reaction were identical. 
 
Fig. 3.1.2. Kinetics of phosphorylation of mutant αS by CK1. (A) Comparison of two-dimensional 1H-
15N HSQC spectra of unphosphorylated wt (green) and CKI-phosphorylated αS (red). Both Ser129 and 
Ser87 are phosphorylated. Kinetics of in vitro phosphorylation of Ser87 (B)  and Ser129 (C)  by CKI in 
wt (black), A30P (red), E46K (green) and A53T (blue) αS. The reactions were monitored by real-time 
NMR spectroscopy. 
3.1.2 Phosphorylation of α-Synuclein at Ser129 
he study of the postmortem human brain shows that a significantly increased level of 
phosphorylation occurs at Ser129 of αS, from less than 5% of the population in healthy 
human brains to 89% in the brains of PD patients (Visanji et al; Waxman & Giasson, 
2011). Recently, extensive research has been devoted to several issues regarding Ser129 
phosphorylation, such as its impact on aggregation (Fujiwara et al, 2002), relevance to 
neuronal toxicity (Gorbatyuk et al, 2008; Sancenon et al, 2012), membrane binding 
(Kuwahara et al, 2012; Visanji et al, 2011) et al. In term of αS primary structure, Ser129 
is located at the highly flexible and acidic C-terminal which plays an important role in 
ligand binding, enzymatic recognition, the maintainence of protein conformation and 
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modulating aggregation. Previous studies have indicated that the transient long range 
interactions existing between C-terminus and N-terminus were modified by the Ser129 
phosphorylation and thereby the aggregation profile of αS was potentially affected 
(Paleologou et al, 2008). 
As described in last section 3.1.1, PLK2 is suggested as a major kinase 
responsible for specific phosphorylation of Ser129 in neurons (Inglis et al, 2009). 
Together with the in vivo methods, we investigated three closely related members of the 
human Polo-like kinases (PLKs) family (PLK1, PLK2, and PLK3), to observe their 
enzymatic performances on phosphorylating αS in different cell cultures and catalysis 
kinetics in vitro  (Mbefo et al, 2010). Furthermore, to assess impacts of the Ser129 
phosphorylation on αS aggregation, we generated phosphorylated Ser129 of αS (pS129) 
for aggregation assay. Finally, two mimics of Ser129 phosphorylation of αS, 
P128E/S129E and M127E/P128E/S129E, were studied in terms of their aggregation 
propensities.   
3.1.2.1 Kinetics comparison of different kinases (PLK1, PLK2, PLK3) 
In collaboration with Dr. Hialal Lashuel, we identified that PLK1-3 phosphorylated 
both αS monomers and fibrils at Ser129 in the in-vitro assays, but PLK4 didn’t 
phosphorylate both forms of αS (Mbefo et al, 2010). Lashuel’s lab also observed that 
PLK2 and PLK3 phosphorylated αS efficiently in both HEK293T cells and HeLa cells 
and these two kinases partially co-localized with pS129 in primary hippocampal 
neurons and cortical brain areas of αS transgenic mice (Mbefo et al, 2010). These 
results suggest that PLKs play important role in the phosphorylation of αS Ser129.  
Therefore, we investigated the enzymatic performance of PLKs on the Ser129 
phosphorylation of αS  
The real-time NMR assay was applied to monitor the PLK1-3-catalyzed 
phosphorylation reaction by measuring yield kinetics and identifying all potential 
phosphorylation sites in the cases of PLK1 and PLK3. Taking advantages of the single-
residue resolution realized by the real-time NMR method, amide proton resonance of 
pS129 was unambiguously shown in 15N-αS HSQC spectrum in the case of PLK3-
catalyzed reaction. Importantly, no additional NMR signals of phosphorylated residues 
appeared, indicating that PLK3 exclusively phosphorylated αS at Ser129. 
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 Figure 3.1.3. Phosphorylation of synucleins by PLK1-3.  (A) Comparison of two-dimensional 1H-15N 
HSQC spectra of unphosphorylated WT (green) and αS phosphorylated by PLK3 (red). A dashed 
rectanglemarks glutamine and asparagine side chain resonances. (B) Kinetics of in vitro phosphorylation 
of Ser129 in αS by PLK3 (black), PLK2 (red), and PLK1 (blue) as monitored by real-time NMR 
spectroscopy. NMR samples contained ∼0.1 mm 15N-labeled αS in 200 mm HEPES, 10 mm MgCl2, 2 
mm dithiothreitol, and 1.09 mm ATP, pH 6.9. The real-time assay was started by the addition of kinase 
into the NMR sample using a protein/kinase ratio of 100:0.5 mg. The error bars were determined based 
on the signal/noise ratio observed in the NMR spectra. 
In the case of PLK3, the peak of phosphorylated Ser129 was already clearly 
observed already after 45 minutes [Figure 3.1.3 A]. With increasing incubation time, the 
intensity of the NMR signal of phosphorylated Ser129 increased. Quantitative analysis 
of the increase of the NMR signal of phosphorylated Ser-129 indicated that PLK3 fully 
phosphorylates αS within 2.5 hours under the conditions of the assay [Figure 3.1.3 B]. 
In the case of PLK1, no phosphorylation of αS could be detected during the time course 
of the experiment. The significantly reduced PLK1 phosphorylation of αS in the NMR 
experiments in comparison to the in vitro kinase assay, is most likely due to the fact 
that the NMR phosphorylation experiments were performed at a lower temperature (15 
°C versus 30 °C for in vitro kinase assays) to reduce the impact of signal broadening 
due to amide proton exchange. As previously described, real-time spectroscopy of αS 
phosphorylation by PLK2 showed that PLK2 also showed phosphorylates αS at Ser129 
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only. However, the kinetics of the enzymatic reaction is significantly slower for PLK2 
than for PLK3, and αS was not fully phosphorylated at the end of the assay. 
In contrast to PLK1 and PLK2, our real-time assay showed that PLK3 possessed 
a remarkable efficiency in phosphorylating αS. However, the fast kinetics of PLK3-
catalyzed phosphorylation largely limited the detailed information that can be accessed 
by a standard HSQC experiment at the initial stage. Consequently, we employed band-
Selective Optimized-Flip-Angle Short-Transient (SOFAST) HMQC to circumvent this 
time restriction by shortening the time required for recording one spectrum.  
The SOFAST-HMQC experiment generates the resonance signal of amide 
proton correlation with shorter time intervals of recovery delay between each scan than 
the standard HSQC spectrum. In particular, T1 relaxation optimization and Ernst angle 
are collectively integrated into the pulse scheme of this experiment to achieve a 
markedly reduction in inter-scan delay. Sensitivity and resolution are key factors for 
practical considerations when handling NMR experiments. To reach maximal time-
shortening whilst retaining the necessary sensitivity and resolution for measurement of 
phosphorylation kinetics, we further narrowed spectra width in indirect dimension to 
reduce the time spent on a large number of incrementing points. The recycle delay was 
finally set at 0.3 seconds. Extraordinarily, the peak of phosphorylated Ser129 is well-
resolved in the spectrum [Figure 3.1.3.A], and thereby favored all the strategies adopted 
above. Moreover, according to theory of enzymatic reaction, temperature is an 
important factor that affects reaction kinetics. By lowering the experimental temperature, 
we were able to slow down the reaction rate and capture more kinetic information under 
the given spectroscopic conditions. 
Finally, we measured the kinetics of PLK3-mediated Ser129 phosphorylation by 
optimized SOFAST-HMQC with time resolution of 17 mins at temperature of 288K and 
293K. Kinetic profiles of Ser129 phosphorylation by PLK3 were mapped by measuring 
resonance intensity of pS129 within beginning 200 mins. Under both experimental 
temperatures, a distinguishable peak of the phosphorylated Ser129 already appeared 
after 20 min which contained the dead time and time for recording first spectrum. The 
peak intensity increased rapidly with increasing reaction time and approximately 90% 
phosphorylation was reached at 70 mins under both temperatures. After ~ 2 hours, the 
56 3  Results 
kinetics under both temperatures had already achieved saturation, suggesting that the 
reaction finished and αS was fully phosphorylated at the Ser129 by PLK3. 
Quantitative comparison between 288K and 293K shows that the kinetic 
difference is indistinguishable, indicating a temperature-independence for kinetics 
within this temperature range. Moreover, the kinetic curves measured by SOFAST-
HMQC spectra under these two temperatures are highly similar to the kinetics measured 
by standard HSQC spectra under temperature of 303K [Figure 3.1.3 B], at which 70% 
αS has been phosphorylated at 50mins and a complete phosphorylation was reached 
within  2.5 hours. 
 
Figure 3.1.4. Phosphorylation of αS by PLK3 at the lower temperatures by SOFAST-HMQC. 
Kinetics of  phosphorylation of Ser-129 of αS by PLK3 under temperature of 293K (black) and 288K (red) 
were monitored by real-time NMR spectroscopy. NMR samples contained ∼0.1 mm 15N-labeled αS in 
the phosphorylation buffer for PLKs described before. The real-time assays were started by the addition 
of kinase into the NMR sample using a protein/kinase ratio of 100:0.5 mg. The error bars were 
determined based on the signal/noise ratio observed in the NMR spectra. 
In summary, real-time NMR spectroscopy revealed that PLK2 and PLK3 
exclusively phosphorylated αS at Ser129, consistent with other in-vitro and in-vivo 
assays (Mbefo et al, 2010). Moreover, PLK3 phosphorylated αS with significant 
efficiency that full phosphorylation could be achieved within 2.5 hours under the assay 
condition. Based on the fast acquisition technique, we further demonstrated that PLK3 
phosphorylated nearly 50% αS within 25 mins and its enzymatic kinetics were not 
strongly altered by changing reaction temperature.  
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3.1.2.2 Aggregations assays of phosphorylated Ser129 α-Synuclein 
One major focus on αS phosphorylation is to address the relationship between 
phosphorylation and aggregation. Hitherto, the role of phosphorylation, particularly at 
Ser129, in modulating aggregation and the chronological order of these two events in 
pathological cascades of PD have still not been clearly defined.  Fujiwara et al. firstly 
reported that αS was phosphorylated at Ser129 by their Mass Spectrometry assays and 
that this modification could promote αS aggregation in vitro (Fujiwara et al, 2002). 
However, by using phosphorylation-mimicking (Ser to Asp/Glu) and –retarding (Ser to 
Ala) mutants to simulate the effects of phosphorylation or to block other 
phosphorylation sites (i.e. Ser87), Paleologou et al. investigated the interplay between 
Ser129 phosphorylation of αS and its aggregation and suggested that the S129 
phosphorylation blocked fibril formation (Paleologou et al, 2008). Similarly to in vitro 
studies, accumulating in vivo findings from different cell cultures and animal models 
presented diversified indications regarding the role of Ser129 phosphorylation in 
modulating αS aggregation and neuronal toxicity (Azeredo da Silveira et al, 2009; Chen 
& Feany, 2005; Chen et al, 2009; McFarland et al, 2009; Smith et al, 2005).   
Most of studies mentioned above were performed by using the specified mutants 
to resemble the effects of phosphorylation. However, it should be noted that 
phosphorylation mimics by point mutation can not completely and accurately reproduce 
all aspects of native phosphorylation and the mutations at other sites are likely to 
introduce nonspecific side-effects. Thus, to produce accurate phosphorylation at an 
expected site without applying additional mutations is of critical importants in our 
experiment.  
Our previous real-time NMR assay identified the exclusive selectivity and 
significant efficiency of PLK3 on phosphorylation of αS Ser129. Therefore, we chose 
PLK3 as the kinase to specifically phosphorylate Ser129 in vitro. To investigate 
whether the phosphorylation of Ser129 modulates its aggregation, the aggregation assay 
has been performed based on the PLK3-mediated phosphorylation is described in Figure 
3.1.5.(A).  
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Figure3.1.5. Preparation for aggregation assay of phosphorylated-Ser129 αS. (A)Flow chart of the 
aggregation assay for pS129-αS. The consecutive steps include phosphorylation by PLK3, 
characterization and purification of phosphorylated sample. (B) Characterizing phosphorylation by 1D 
NMR spectrum. The spectrum of wt-αS (blue) and pS129-αS (red) are compared. In spectrum of pS129-
αS, single peak at 8.8 ppm denotes the single phosphorylation at Ser129.  
In the first stage, wt-αS was adapted into the phosphorylation buffer containing 
Mg2+ and ATP. Then phosphorylation was started by the addition of PLK3 and 
incubated under 30°C for 2.5 hours to achieve complete phosphorylation. Secondly, 
trace amount of the reaction product has been checked by Mass spectrometry to identify 
whether there was a mass difference of 80-Dolton in comparison to the wt-αS sample. 
At the same time, the purity of the phosphorylation product was examined. Accordingly, 
the confirmed sample was loaded into RP-HPLC coupled with UV and MS detection to 
collect pS129-αS. The purified material of pS129-αS was lyophilized to remove the 
solvent used in HPLC and further dialyzed against the aggregation buffer together with 
wt-αS to assure that both samples dissolved in identical solution for the aggregation 
assay. At the end, PULCON method (Wider & Dreier, 2006) based on NMR 
spectroscopy was employed to calibrate the protein concentration of pS129 αS and wt-
αS aiming to produce identical concentrations for both proteins in the aggregation assay 
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for both proteins. A comparison between 1D NMR spectrum of pS129 αS and wt-αS 
clearly shows one single peak at 8.8 ppm [Fig. 3.1.5(B)] which was identified as the 
phosphorylation of Ser129 by HSQC spectrum in the previous real-time assay.   
Following the purification and concentration-calibration, the samples of pS129-
αS and wt-αS were further processed by getting rid of small particles and small 
oligomeric species and were consequently adapted to start the aggregation assay with a 
monomeric concentration of 50μM. Kinetics of the fibril formation were monitored by 
Thioflavin T (ThT) fluorescence. Unexpectedly, within the time course of 150 hours, 
general kinetic trend and fibril yield reflected by ThT did not show a significant 
difference between pS129-αS and wt-αS under the assay condition [Figure 3.1.6 A]. 
After 40 hours of the time course, the growth rates of fibrils for both samples became 
much slower and no distinguishable difference between two samples was observed. 
This revealed that the aggregation kinetics were close to saturation and the fibril yields 
for these two samples were similar. In line with kinetic data, EM images revealed that 
fibrils of pS129-αS [Figure3.1.6 D] and wt-αS [Figure3.1.6 E] presented similar 
morphology.  
Interestingly, a significant difference was observed at 24hours. Including the 
consideration of experimental uncertainty, the sample of pS129 αS shows relatively 
stronger ThT intensity than that of wt αS at 24 hours. This observation agrees with the 
structural findings that phosphorylation at Ser129 of αS potentially modifies protein 
conformation by partially releasing the long-range interactions within the polypeptide 
chain (Paleologou et al, 2008). As an intrinsically disordered protein (IDP), the transient 
long range interactions between N-terminal and C-terminal of αS importantly 
contributes to maintaining the protein conformation and inhibiting aggregation 
propensity(Bertoncini et al, 2005b; Dedmon et al, 2005c). Furthermore, this 
phenomenon was reproduced in the aggregation assay at a lower αS concentration 
(10μM) shown in Figure3.1.6 (B).  
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Figure 3.1.6. Aggregation assay of pS-129 αS and wt-αS. Fibril formation of pS129 (red) and wt-αS 
(black) were followed by ThT fluorescence under the different aggregation conditions. (A) pS129-αS and 
wt-αS started aggregation at a monomeric concentration of 50μM. EM images of the final aggregation 
products of pS129 and wt-αS are shown in (D) and (E) respectively. (B) Reproducing aggregation for 
both proteins at the lower concentration (10μM). (C) Agregation assay was performed with the presence 
of AMppNp(500μM), a hydrolysis-resistant analogue of ATP. All error bars were estimated based on 
statistics of triplicate trials for each sample.  
In addition, we checked whether ATP can have impact on αS aggregation. ATP 
is the necessary compound for phosphorylation and is likely present during the 
aggregation of phosphorylation in vivo. Therefore, AMppNp, one hydrolysis-resistant 
analogue of ATP, has been included in the aggregation system with the amount of 10-
fold in excess of the proteins (AMppNp: 500μM and proteins: 50μM). The aggregation 
profile in the presence of AMppNp is similar to the aggregation profile counterpart 
observed in the case of its absence. A slight increase of fibril amount during the 
saturation phase compared to the assay without the addition of the compound was 
observed in Figure 3.1.6 (C). Also, ThT intensities for the two samples at 24 hours were 
also similar. Hence, modifications of aggregation kinetics and fibril yield induced by 
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AMppNp were not drastic, suggesting that these minute effects were non-specifically 
caused by this ATP analogue, but were not critical.        
3.1.2.3 Aggregation assays of Ser129 phosphorylation mimics of α-Synuclein 
Although the effects of phosphorylation can not be completely reproduced by the 
mimics, genetic mutation of Ser to Glu or Asp still provides us opportunity and freedom 
to artificially modify the side-chain of the residue and simulate the steric and 
electrostatic properties of phosphorylation not only in vitro but also in vivo 
(Figure3.1.7).  
 
Figure3.1.7 The atomic structures of the side chains of Glu and phospho-Ser demonstrate the 
structural and electrostatic similarities between the two moieties. The figure is taken from the 
publication (Paleologou et al, 2008). 
To further determine the potential roles of Ser129 phosphorylation on protein 
aggregation, we produced two Glutamine mutants to mimic the phosphorylation. 
Double mutant P128E/S129E αS and triple mutant M127E/P128E/S129E αS were 
designed aiming at multiplying the effects of phosphorylation at the neighboring region 
of Ser129 and hence further clarifying the issues regarding how these mutations impact 
on αS aggregation.  
The aggregation assay for the two mutants and wt-αS indicated that these two 
mutations did not affect aggregation kinetics [Figure3.1.8]. Three samples displayed 
similar scales of lag phase and fibril growth rate. The final yields of fibrils were also 
very similar. This was also consistent with corresponding EM images, which the fibrils 
of the three proteins were in similar size and morphology. 
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Figure3.1.8 Aggregation assay for the αS phosphorylation mimics. The aggregation kinetics of wt αS 
(black), double mutant P128E/S129E (red) and triple mutant M127E/P128E/S129E (blue) are shown. 
In conclusion, we examined the aggregation propensity of αS with Ser129 
phosphorylation. Both αS with phosphorylation at the Ser129 by kinase PLK3 in vitro 
and the phosphorylation mimics displayed similar aggregation kinetics of fibril 
formation and morphology of fibril products, suggesting that phosphorylation at this site 
does not significantly change the aggregation. This finding agrees with the observations 
that phosphorylation of Ser129 of αS is independent of αS aggregates formation, where 
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3.2  Interplay between alpha-Synuclein and Rab proteins 
The family of Rab GTPases belongs to Ras superfamily of small G proteins. The human 
Rab family consists of 70 members and most of them exert important functions in 
regulating vesicular trafficking and the exocytosis of living cells (Hutagalung & Novick, 
2011). In neurons, vesicle trafficking is a pivotal process responsible for 
neurotransmitter transport and release. The specified Rab proteins are involved in all 
steps of the trafficking process from the vesicle budding to final diffusion to plasmid 
membrane. Meanwhile, the deficit of vesicle trafficking is characterized as one 
phenotype of αS neuronal toxicity (Auluck et al, 2010). In well-established yeast assay 
for αS (Outeiro & Lindquist, 2003) , the overexpression of Rab1, Rab3a, and Rab8a 
respectively were found to rescue the αS-induced deficits occurring at multiple stages of 
vesicle trafficking (Cooper et al, 2006; Gitler et al, 2008).  
What are the structural mechanisms underlying this rescuing effect of the Rabs? To 
answer this question, we performed NMR based structural analysis and correlated 
biophysical assays to study the interactions between αS and Rabs. Analysis of amino 
acid sequences of Rab1b, Rab3a and Rab8a revealed diversity at their C-termini. 
Following this, we used NMR titration to study potential interactions that might exist 
between αS and these Rabs at atomic resolution and found that Rab8a was capable of 
binding to αS. Using the peptide synthesis technique and the expression of the truncated 
protein, this interaction has been dissected with respect to different parts of Rab8a. To 
further characterize the interaction in details, we implemented the NMR assignment for 
Rab1b and Rab8a. Accordingly, we were able to map interaction sites on Rab8a exactly. 
Moreover, we also found that the binding affinity of Rab8a to αS depending upon the 
different nucleotide-bound states of Rab8a.  
In parallel to the studies of the interactions based on NMR structures, we also 
performed an aggregation assay for αS in the presence of different Rabs. Our scope was 
thus extended to search for potential interactions between the Rabs and αS aggregates 
and to evaluated the influence of Rab proteins on the oligomerization and fibrillization 
of αS. Taken together, the studies reveal the interplay between the different Rab 
proteins andαS of different states. 
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3.2.1 Sequence alignment of Rab1b, Rab3a and Rab8a 
The in vivo investigation demonstrates that the overexpression of Rab1, Rab3a and 
Rab8a can suppress dopaminergic neuron loss caused by overexpression of human αS in 
C. elegans and primary rat midbrain cultures (Gitler et al, 2008). Interestingly, in the 
model of C. elegans, Rab8a reduced the neurodegeneration of affected worms from 
85% to 60%, whereas Rab1 reduced the neurodegeneration to 80% and Rab3a reduced 
to 75%. Thus, this suggests that 3 Rab proteins might differentiate mechanistically in 
their interactions with αS. 
 
Figure 3.2.1 Sequence alignment for Rab1a, Rab1b Rab3a and Rab8a. Multiple sequence alignment 
has been implemented for the four protein sequences (homo sapiens) by T-coffee method on the server 
(Notredame et al, 2000; Poirot et al, 2003). “*”: Identical, “:”:conserved substitution, “.”: semi-conserved 
substitution. The color scale indicates the scoring of alignment from blue (score=0) to red (score=100), 
where the intermediate score is indicated by range of yellow.  
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Sequence alignment provides us a preliminary insight into the difference between 
the primary structures of 3 Rab proteins. As shown in Figure 3.2.1, Rab1a and Rab1b 
share very high degrees of similarity and identity of sequence in which only 14 residues 
differ, most of them are restricted to the range 180-199 (Touchot et al, 1989). Rab8a as 
the closet paralog to Rab1, also displays a high degree of similarity to Rab1a (75% 
similarity and 55% identity) and it mainly differs from Rab1 at at its C-terminal tail 
regarding its distinct physiological function on post-Golgi vesicles. Of these four Rab 
proteins, Rab3a shows the least similarity to the other three, particularly that its N-
terminal possesses additional 11 residues that are not present in the other three proteins, 
accounting for the neuron-specific expression of Rab3a (Hutagalung & Novick, 2011). 
Apart from the amino and carbonyl termini of these four proteins, the majority of the 
sequences corresponding to the folded parts of Rab proteins are highly similar. This is a 
common feature conserved in members of the Ras-GTPases family as this part is 
responsible for GTP hydrolysis (Itzen & Goody, 2011).  
3.2.2 Unique binding of Rab8a to α-Synuclein 
NMR signals of backbone amides provide excellent information to probe protein-
protein/ligand interactions with description of the interaction interface and binding 
affinity according to perturbation of chemical shift and line-width analysis (Craik & 
Wilce, 1997; Gao et al, 2004). Thus, based on NMR spectroscopy, we studied 
interactions of αS with different Rabs and identified the corresponding binding sites at 
αS. 
3.2.2.1 Rab8a, but not Rab1b and Rab3a binds α-Synuclein 
The 1H–15N HSQC spectra of αS in the presence of Rab1b, Rab3a, and Rab8a 
respectively for molar ratios up to 1:10 of αS to the Rab were recorded at 15°C and pH 
7.4. The resonances of the spectra for αS were well resolved and sharp. Both GDP- and 
GppNHp-(a hydrolysis-resistant structural analogue to GTP) bound Rabs were titrated 
into αS.   
As reflected in Figure 3.2.2(A), titration of unlabeled Rab8a (GDP- and 
GppNHp-) into isotropic 15N-labeling αS resulted in the shifting of the C-terminal 
resonances of αS. However, there were no significant bindings found in the cases of 
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Rab1b and Rab3a. In the presence of Rab1b and Rab3a, the C-terminal and rest parts of 
αS did not show a clear trend of chemical shift perturbation. In the presence of Rab8a, 
the affected residues of αS with chemical shift perturbation beyond 0.06ppm were 
mainly located at the acidic C-terminal region from G111 to A140. The rest parts of the 
N-terminus and NAC region of αS remain unperturbed by the presence of Rab8a. 
Displacement of αS peak positions was demonstrated as the function of stepwise 
addition of Rab8a(GDP) and Rab8a(GppNHp) [Figure3.2.2 (B), (C)]. Neighboring 
regions of residue Y125 and D134 of αS were mostly influenced by an increasing molar 
ratio of Rab8a to αS. Both GDP- and GppNHp-bound Rab8a displayed similar binding 
pattern to αS but different affinities.  
Based on the chemical shift perturbation of αS at different amounts of Rab8a, 
the Kd values for Rab8a(GDP) and Rab8a(GppNHp) binding to αS were estimated as 
0.186902 ± 0.008463mM and 0.45089 ± 0.045431mM respectively. Indeed, quantitative 
comparison represented by Kd demonstrated that GDP-bound Rab8a possessed stronger 
binding affinity to αS than the GppNHp-bound Rab8a, consistent with the observation 
of titration [Figure3.2.2 (B), (C)]. The Kd difference in these two states would have 
importantly functional implication regarding to the interplay between αS and Rab8a. 
Hence, in the following analysis, we mechanistically dissected this interaction to 
identify the binding sites at both proteins in detail.  
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Figure 3.2.2 NMR titration of Rab1b, Rab3a and Rab8a into 15N-αS. (A)Chemical shift perturbation 
for studying protein interaction was shown by defining resonance shifting in NMR HSQC spectra of αS, 
which were in the presence of Rab GTPases at the concentration ratio 1 to 5 (black bar: Rab8a, green line: 
Rab1b and purple dash line: Rab3a). Replacement of the affected peaks of αS was increased as the 
function of added concentrations of Rab8a at GDP-bound state (B) and GppNHp-bound state (C). (The 
HSQC spectra were recorded by María L. Orcellet.)  
3.2.2.2 Anatomy of the interaction between α-Synuclein and Rab8a 
αS consists of three functional domains, namely the N-terminus, the NAC region and 
the C-terminus. Each of these three domains has been well-characterized with distinct 
features with respect to monomeric structure, fibril formation, molecular modification, 
membrane affinity, ligand binding etc (Bisaglia et al, 2009). It’s therefore necessary to 
determine the structural reason why Rab8a specifically binds to C-terminal part of αS 
(residue110-140).  
Compared with other two domains, negatively charged residues (Glu and Asp) 
are enriched in the C-terminal part of αS. Such significant number of negative charges 
contributes to the long-range interactions and stabilizes the tertiary conformation of αS 
(Bertoncini et al, 2005b; Dedmon et al, 2005c). Meanwhile, the abundant negative 
68 3  Results 
charges offer the opportunity for positively charged binding partners to interact with the 
C-terminal of αS, which was found in the case of polyamines binding (Fernandez et al, 
2004). It’s has also been noticed that the members of the Rab family differs mainly at 
their C-termini. Based on this fact, we firstly analyzed the sequence of αS and the 3 Rab 
proteins [Figure 3.2.3]. Unsurprisingly, a significant number of negative charges “-13” 
are distributed at C-terminal part (100-140) of αS and Rab8a is the only one possessing 
positive net-charge “+3” at its C-terminus. However, Rab1b and Rab3a possess rather 
neutral or even negative charges at their C-termini respectively. Therefore, the observed 
binding of Rab8a to αS by NMR titration occurs probably as a result of charge-driven 
electrostatic interaction between C-termini of the two proteins.  
 
Figure3.2.3. Charge distribution of C-terminal residues of Rab1b, Rab3a, Rab8a and αS. The 
charge distribution has been demonstrated by labeling the charged residue by specified color (red: 
positive charge, cyan: negative charge). The significant positive net-charge of Rab8a and negative net-
charge of αS were unambiguously indicated.  
According to the analysis of the charge distribution, we synthesized the C-
terminal peptide of Rab8a comprising of 30 residues (Asp176-Arg205) and titrated it 
into αS. The six positively charged residues Lys177, Lys178, Lys192, Lys199, Arg200, 
Arg205 and three negatively charged residues Asp176, Glu180, Asp196 were included 
in this peptide and together were characterized as “+3” net charges. The peptide-
induced perturbations of chemical shifts to αS resembled well the effect of full-length 
Rab8a on the C-terminal of αS [Figure3.2.4]. The black bars in the figure represent the 
chemical perturbation at the molar ratio of Rab8a-GDP to αS as 5:1, shown as a 
reference in this figure. The red line indicates the chemical perturbation of αS at 10:1 
ratio of peptide:αS. The pattern and the magnitude of perturbation of the peptide is 
similar to full-length Rab8a. But, the amount of peptide used is twice the amount of the 
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full-length protein, suggesting that full-length protein maintain a stronger affinity to αS 
than its C-terminal fraction. 
 
Figure 3.2.4. Interaction between C-termini of αS and Rab8a. Chemical shift perturbations show 
the binding between the C-termini of Rab8a and αS. αS (Black bar) and phosphorylated-Ser129 αS 
(cyan dash line) were titrated by Rab8a at αS:Rab8a ratio of 1:5. Meanwhile, αS was titrated by Rab8a 
C-terminal peptide at αS to peptide ratio of 1:10 (red line) and the inlet represents the corresponding 
chemical shift perturbation plot of the peptide titration. 
Phosphorylated Ser129 αS was generated by using Polo-Like Kinase 3 (PLK3) 
and the interaction between phosphorylated αS and Rab8a was then assessed. 
Phosphorylated-Ser129 αS displayed a similar binding model to wt-αS but the degree of 
perturbation was enhanced by approximately a factor of approximately 2 due to the 
phosphorylation [Figure 3.2.4]. The phosphorylation at Ser129 introduced one more 
negative charge to C-terminus of αS, which can be reflected by the increased 
perturbation around pSer129. Therefore, the opposite charges existing at the carboxyl 
termini of αS and Rab8a play an important role in adjusting their interaction.   
70 3  Results 
Table 3.1 Statistics of charged residues for C-terminally truncated Rab1b, Rab3a and Rab8a 




Sum of charges (Net-
charge) 
Rab1b(1-175) 21 24 -3 
Rab3a(1-187) 23 27 -4 
Rab8a(1-173) 27 24 +3 
 
 
Figure 3.2.5. Surface mapping of electrostatic potential for C-terminally truncated Rab1b, Rab3a and 
Rab8a. Electrostatic potential based on the coulomb interactions was calculated by Swiss-PdbViewer 
(Guex & Peitsch, 1997). The structures of Rab1b (PDB code: 3NKV), Rab3a (PDB code:3RAB) and 
Rab8a (PDB code: 3QBT) were chosen for the surface mapping (Dumas et al, 1999; Hou et al, 2011; 
Muller et al, 2010). Each structure with the surface mapping was displayed with the view of both facing 
and back. The blue color stands for positive potential, whereas red color and white color stand for 
negative potential and neutral potential.  
The positively charged C-terminal peptide can resemble the effect of full-length 
Rab8a binding to αS, but has a relatively weaker affinity of this peptide to αS than the 
full-length protein has been recognized. This suggests that except for the C-terminal tail, 
other parts of Rab8a are capable of binding to C-terminus of αS as well. Therefore, we 
investigated the charge states of the folded parts of these 3 Rab proteins. The statistic of 
charge states for the C-terminally truncated parts of 3 Rabs has been performed by the 
ExPASy Protparam Tool (Artimo et al, 2012) [Table 3.1]. By counting the number of 
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positively and negatively charged residues in the N-terminal folded part, the total charge 
of Rab8a is positive 3, contrary to the -3 for Rab1b and the -4 for Rab3a. This suggests 
that the folded part of Rab8a also has potential to bind to the C-terminal of αS.  
Furthermore, surface mapping by electrostatic potential was performed for the 
published crystal structures of these three Rab proteins [Figure 3.2.5]. In line with the 
charge statistics described in Table3.1, the surface of Rab8a largely presents positively 
electrostatic potential which indicates that the outer surface of Rab8a is dominantly 
occupied by positively charged residues. Whereas, Rab3a shows relatively neutral 
surface and Rab1b presents more negative potential on its surface. In conclusions, 
charge statistics and surface potential mapping suggests that N-terminally folded part of 
Rab8a possesses a strong propensity to bind to the highly negative C-terminus of αS. 
3.2.2.3 C-terminally truncated Rab8a binds to α-Synuclein 
Rab8a(6-176) with the truncation of the C-terminal tail (Rab8a-δC) has been 
used to study its potential to interacting with αS. Both Rab8a-δC(GDP) and Rab8a-
δC(GppNHp) were titrated into 15N-αS and changes of αS were reflected by cross-
peaks of backbone 1H-15N resonance of αS in two dimensional HSQC spectra 
[Figure3.2.6]. Both Rab8a-δC(GDP) and Rab8a-δC(GppNHp) reproduced the binding 
effects to the acidic C-terminus(G111-A140) of αS similarly to the full-length protein 
and the C-terminal peptide described before. Interestingly, the change of resonance 
positions illustrates that the Rab8a-δC(GDP) binds to αS with a stronger affinity than 
Rab8a-δC(GppNHp) at the same molar ratio to αS.  
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Figure 3.2.6. Analysis of Rab8a(6-176) binding to αS by NMR spectroscopy. Changes in individual 
cross-peak positions of backbone 1H-15N resonance of αS in two dimensional HSQC spectra in the 
presence of Rab8a(6-176)-GDP(A) and Rab8a(6-176)-GppNHp(B) for the molar ratios up to 1:10 of 
αS/Rab.  
To clearly represent the different affinities, the changes of the peak positions in 
HSQC spectra of αS in presence of molar ratio 1:1, 1:5, 1:10 αS/ Rab8a-δC(GDP) and 
Rab8a-δC(GppNHp) have been selectively displayed and compared in Figure3.2.7. At 
molar ratio 1:1, the presence of both Rab8a-δC(GDP) [Figure3.2.7(A)] and the Rab8a-
δC(GppNHp) [Figure3.2.7(B)] did not induce obvious changes in αS. At the ratio of 1:5, 
both samples shows the binding to the C-terminal of αS. But, the GDP-bound form 
[Figure3.2.7(C)] already shows ~3-fold larger magnitidue of resonance shifts as the 
GppNHp-bound form [Figure3.2.7(D)] and this trend remains until the molar ratio of 
Rab8a-δC to αS reached 10:1 for the GDP-bound form [Figure3.2.7(E)] and GppNHp-
bound form [Figure3.2.7(F)]. The higher affinity of Rab8a-δC(GDP) than Rab8a-
δC(GppNHp) for binding to αS was also demonstrated by the intensity plot at the 




3.2  Interplay between alpha-Synuclein and Rab proteins 73 
  
Figure3.2.7 Analytic comparison for Rab8a(6-176)-GDP and Rab8a(6-176)-GppNHp binding to αS. 
Change in chemical shifts of individual HSQC peaks of αS in the presence of Rab8a(6-176)-GDP (A, C, 
E) and Rab8a(6-176)-GppNHp(B, D, F) at molar ratio of 1:1, 1:5, 1:10 of αS to Rab8a(6-176). The 
dashline in chemical shift perturbation plots indicates average noise level as estimated by comparing 
repeating experiments. The intensities of cross peaks of αS at 1:10 molar ratio to Rab8a(6-176) have been 
shown in (G) and (H) for GDP and GppNHp bound Rab8a(6-176). Error bars were calculated based on 
signal to noise.  
In summary, we found that the electrostatic interactions existing between αS and 
Rab8a were important for the binding of Rab8a to αS. This was further confirmed by 
the fact that Ser129 phosphorylation of αS enhances the binding remarkably and that 
the C-terminus peptide of Rab8a can reproduce the binding to αS. Furthermore, not 
only the C-terminus but also the N-terminally folded part of Rab8a possesses capacity 
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to bind to αS, indicated by surface mapping of its crystal structure. NMR titration of 
Rab8a-δC into αS proved that this truncated Rab8a could bind to αS. We also observed 
a different affinity of GDP- and GppNHp- bound Rab8a-δC to αS, consistent with the 
results of full-length Rab8a.   
3.2.3 Aggregation assays of α-Synuclein with Rab8a and it’s C-terminus 
Following the identification of Rab8a/αS interaction by NMR, we investigated the role 
of Rab8a in mediating αS aggregation by ThT fluorescence. Linking with the NMR 
interaction assays, αS was incubated with full-length Rab8a(GDP) and the C-terminus 
peptide of Rab8a respectively under the aggregation conditions. Firstly, Rab8a 
displayed a distinctive efficiency in modulating αS aggregation [Figure 3.2.9. (A)]. For 
the applied molar ratio of Rab8a to αS, all 1:0.3, 1:1, 1:3 ratios revealed that substantial 
enhancement of fibril formation was achieved by shortening the lag phase time and 
reaching the saturated stage more rapidly than in the absence of Rab8a. Interestingly, 
however, when the molar ratio was raised up to 5:1 of Rab8a to αS, the profile of 
aggregation kinetics was different to the cases with lower amount of Rab8a. At this ratio, 
no kinetic improvement was observed and the fibril growth displayed similar trend to 
the αS control without the addition of Rab8a.  
Following the aggregation, EM was used to distinguish between the different 
fibrillar species generated under the different molar ratios of Rab8a to αS [Figure 3.2.9. 
(B)-(D)]. Referring to the characteristic morphology displayed by the fibrils of αS 
control, EM images addressed the increased protein backgrounds accumulated on the 
surface of fibrils as a consequence of increased amounts of Rab8a. With the increased 
amount of Rab8a, morphological diversity and the content of fibril association were also 
enlarged, particularly for the circumstances where the amount of Rab8a exceeded αS. 
This protein background is likely as a result of the Rab8a attaching to the fibril surface 
by binding to the αS C-terminus. The C-terminus of αS retains its disordered 
conformation outside the fibril core and thus is readily recognized by binding partners, 
i.e. Rab8a. We also observed the precipitates in all trials in the presence of Rab8a. The 
amount of precipitates was well correlated with the amount of Rab8a added at the 
starting of aggregation as depicted in Figure 3.2.9 (B) – (D). This observation indicates 
3.2  Interplay between alpha-Synuclein and Rab proteins 75 
that the observed precipitates were from the amorphous aggregates formed by Rab8a 
during the time course of αS aggregation. Rab8a was reported to possess low stability 
and solubility under some expression conditions (Bleimling et al, 2009; Lim et al, 2011).  
Additionally, recent study shows that αS can cause the aggregation of many different 
Rab GTPases in yeast and additionally the aggregation of αS can also be enhanced (Lim 
et al, 2011). 
 
Figure 3.2.9. Aggregation assays of αS in the presence of Rab8a. (A) αS aggregations were influenced 
by Rab8a reflected by ThT fluorescence at αS:Rab8a ratio of 1:0.3, 1:1, 1:3, 1:5. The corresponding EM 
images for the αS control, 1:1 and 1:3 molar ratios are shown in figure (B) - (D), which illustrate both the 
amorphous background associated with Rab8a aggregates increased and the αS fibrils with distinct 
morphology decreased as the function of present amounts of Rab8a. 
In line with the observation that the C-terminus of Rab8a simulated the binding 
of full-length Rab8a to αS, this segment can also contribute to the mediating effects of 
Rab8a on αS aggregation. The synthesized peptide containing 30 residues (174-205) of 
Rab8a C-terminal used in binding study was adapted in the aggregation assay by using 
3 different molar ratios to αS (1:1, 3:1, 6:1). This peptide showed a does-independent 
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manner of enhancement to αS aggregation [Figure 3.2.10]. The comparison of kinetics 
of αS aggregations in the presence of Rab8a and its C-terminal fraction reflects that the 
peptide shortened lag phase to a similar extent to the whole protein, but prompted the 
fibril elongation by a relatively weaker efficiency than the full-length protein. Threfore, 
we found that the carboxyl terminus participates in the functions played by intact Rab8a 
on binding to αS and improving αS aggregation.   
 
Figure 3.2.10. The C-terminal peptide of Rab8a simulated the effects of full-length protein on αS 
aggregation by enhancing the kinetics. The molar ratios of αS:peptide were set as 1:1, 1:3 and 1:6.  
In conclusions, both Rab8a and its C-terminal peptide improve the aggregation 
of αS by significantly shortening the lag phase and enhancing the elongation rate. In 
concert with the interaction studies by NMR, Rab8a adjusts αS aggregation by binding 
to its C-terminus.  
3.2.4 Aggregation assays of α-Synuclein with Rab1b and Rab3a 
Rab1 and Rab3a were suggested to suppress the neuronal toxicity induced by αS in 
animal models (Gitler et al, 2008). However, we did not observe the interactions of 
Rab1b or Rab3a with monomeric αS in our NMR titrations. It’s likely that these two 
Rab proteins selectively interact with αS aggregates, i.e. oligomers and fibrils, rather 
than monomers. To address this question, we implemented aggregation assays for αS in 
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the presence of Rab1b and Rab3a to identify effects of these two Rabs on αS 
aggregation.  
3.2.4.1  Aggregation with Rab1b 
 
Figure 3.2.11. Aggregation assay of αS in the presence of Rab 1b. Aggregation kinetics of αS was 
catalyzed by the presence of Rab1b. αS was incubated with Rab1b(GDP) and Rab1b(GppNHp) at molar 
ratio of 0.5:1, 1:1, 3:1 to αS under aggregation conditions. The control here is including Rab buffer to 
examine its effects on αS aggregation. Fibril formation of αS followed by Thioflavin T fluorescence. The 
starting concentration of αS is 50μM, and the temperature for aggregation was 21°C.  
As shown in Figure 3.2.11, the characteristic lag time of αS aggregation was 
slightly reduced due to the addition of Rab1b. Moreover, the elongation rate as an index 
highly correlated with the fibril growth rate was increased remarkably and thereby the 
time spanning for reaching saturation of fibril assembly was reduced by one half 
compared with αS alone. Interestingly, not only the modification of kinetics was 
observed, but the yields of fibril product mirrored by ThT intensity during the saturation 
stage were also amplified by a factor of 2 in the presence of Rab1b, which illustrated 
that the fibrillization was substantially improved by Rab1b. Additionally, EM images 
showed the fibrils generated with additions of Rab1b(GDP) and Rab1b(GppNHp) 
represent more twisted or bundled assemblies of protofilaments, which is different from 
the canonical morphology of αS fibrils as more single and extended forms.  
Furthermore, the kinetic data highlighted that the fact that the presence of varied 
molar ratios of Rab1b to αS however did not lead to pronounced kinetic variance, 
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indicating that Rab1b mediated the aggregation by a dose-independent manner. The 
potential physiologically relevant differences between the active and inactive state of 
Rab is of major interests in our research. To this end, both Rab1b(GDP) and 
Rab1b(GppNHp) were adapted in the aggregation assays. However, there was no 
discrepancy in aggregation behaviors between the samples that modulated by the two 
forms of Rab1b. For Rab proteins, as members of GTPase family, the buffer used to 
dissolve Rabs contains nucleotide (GDP, GTP or its analogue) and ion Mg2+. The 
aggregation of αS with only Rab1b buffer but without the protein was exerted as a 
control to examine the effects of these co-existing small molecules on aggregation. The 
kinetic of the Rab-buffer control kept same pattern as the αS alone, suggesting that the 
nucleotides and Mg2+ at the concentration used this assay did not interfere with αS 
aggregation.  
3.2.4.2 Co-aggregation control with BSA 
Besides Rab1b, globular proteins, such as protein chaperon HSP70 and HSP90, have 
been reported to effect on αS aggregation (Dedmon et al, 2005b; Falsone et al, 2009; 
Roodveldt et al, 2009). For the case of HSP70 in particular there were no direct 
interactions observed between this chaperon and monomeric αS either, but it did 
modify αS aggregation in an ATP-dependent manner. Therefore, does coexistence of 
globular proteins have generic impact on αS aggregation? To clarify this point, we 
placed protein BSA (Bovine Serum Albumin) as a globular protein control into αS 
aggregation.  
Under the aggregation conditions, only the presence of Rab1b-GDP distinctively 
improves aggregation of αS [Figure3.2.12]. The presence of BSA slightly shortened the 
lag phase but it did not simulate the function of Rab1b in promoting fibril growth. Pure 
BSA and Rab1b did not generate the ThT-active fluorescence throughout 90 hours of 
aggregation time. Thus, in comparing with BSA, Rab1b significantly enhances αS 
aggregation with respect to fibril growth. We can thereby conclude that the aggregation 
improvement we observed in the previous assays was specifically as the result of Rab1b. 
 
3.2  Interplay between alpha-Synuclein and Rab proteins 79 
 
Figure 3.2.12. Co-aggregation control of αS with Bovine serum albumin (BSA). αS was aggregated 
with BSA and Rab1b(GDP) respectively at equal molar ratio. BSA and Rab1b-GDP were also incubated 
alone under the aggregation condition. The starting concentration of αS was 40μM, the concentrations of 
BSA and Rab1b(GDP) were 4μM. The temperature for aggregation was 21°C.      
3.2.4.3 Aggregation with Rab3a 
Rab3a has highly neuron-specific expression and it can suppress the neuronal 
toxicity of αS in the animal models (Gitler et al, 2008). At the same time, similar to 
Rab3a, Rab1b doesn’t bind to monomeric αS but it does significantly enhance αS 
aggregation. Therefore, we investigated whether Rab3a has a similar effects on αS 
aggregation.     
 
Figure 3.2.13. αS aggregation in the presence of Rab3a. αS: Rab3a ratios of 1:0.5, 1:1, 1:3 were 
adopted and compared to the control of αS alone. As Rab1b and Rab8a, Rab3a could effectively enhance 
αS aggregation at all 3 ratios and when it reached the ratio of 3:1 of Rab8a to αS, the aggregation kinetics 
was significantly modified.  
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Under the aggregation condition, the αS control displayed a typical lag phase 
more than 20 hours and reached the saturation phase at 40 hours of experimental time. 
In contrast, the aggregation kinetics was significantly accelerated by the presence of 
Rab3a-GDP at all 3 molar ratios. At the time point of 18 hours, all the trials with Rab3a 
already ended the lag phase and started the elongation. Similar to the control, the 
kinetics of αS aggregation with Rab3a achieved saturation around 40 hours, but the 
fibril yields of the all 3 ratios characterized by ThT fluorescence were shown as twice as 
great as the control. Moreover, there is no dose-dependence observed between the molar 
ratio αS to Rab of 1:0.5 and 1:1. For the molar ratio of 1:3, the lage phase was 
significantly shortened. And the elongation rate of αS showed an even faster rate than 
the other ratios, but finally remains at a similar level of fibril yield as the other two 
molar ratios. Therefore, Rab3a enhances αS aggregation in a manner similarly to Rab1b. 
Furthermore, unlike Rab8a, both Rab1b and Rab3a don’t bind to monomeric αS but 
they rather modulate aggregation of αS, suggesting that these two Rabs interact with αS 
aggregates.   
3.2.5 NMR assignment of Rab1b and Rab8a 
In our studies described above, Rab1b, Rab3a and Rab8a have been shown to modulate 
αS aggregation in a similar manner. However, according to the NMR titrations, only 
Rab8a binds to monomeric αS whilst Rab1b and Rab3a do not. Hence, there two 
questions that arise following these observations: 1) How dose αS bind to Rab8a and 
are there additional binding sites on Rab8a other than its C-terminal tail?; 2) Even if no 
bindings are observed, Rab1b and Rab3a still impacts on αS aggregation. Does this 
implicate that they selectively interact with αS aggregates.  
Bearing these two questions, we performed NMR assignment for Rab1b and 
Rab8a. Rab1b(1-175)-GDP (Rab1b-δC) and full-length Rab8a-GDP with uniformly 13C 
and 15N labeling were prepared based on the optimized conditions achieved by Dr. 
Amyelt Itzen’s group. Based on the assignment we obtained, the solution structures of 
these two proteins have been analyzed and the interaction studies related to αS have 
been further implemented for these two Rab proteins.    
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3.2.5.1 Assignment and structural analysis of Rab1b  
Uniformly 13C, 15N-enriched Rab1b-GDP was prepared with a concentration of 1.5mM 
and used in the backbone NMR assignment of Rab1b. The assignment was achieved by 
defining protein backbone sequential connectivity through the Cα/Cβ moiety and CO 
moiety based on corresponding NMR spectra (Sattler et al, 1999). For assignment, triple 
resonance NMR experiments were applied based on transferring of coherence along the 
network of scalar coupled spins1H, 13C and 15N. 3D HNCACB and HNCA spectrums 
generated the resonances of both intra-residue and inter-residue Cα/Cβ. With aid of 3D 
CBCAcoNH that selectively presents the inter-residue resonance, the intra- and inter- 
peaks were distinguished in the spectra and their chemical shifts were labeled for 
construction of sequential connectivity through Cα/Cβ. Similarly, NHCO and HNcaCO 
together provided the distinguished peaks of both intra- and inter- CO. Thereby, the 
sequential connectivity through CO was further established. For better resolution, all 3D 
spectra were recorded with TROSY-based fashions (Salzmann et al, 1998).  The 
chemical shifts of distinguished Cα/Cβ and CO were input into the automatic 
assignment program MARS (Jung & Zweckstetter, 2004a; Jung & Zweckstetter, 2004b). 
MARS achieved assignment by establishing sequential connectivity and propensity of 
secondary structure which was reflected by carbon chemical shifts. Finally, 80% 
backbone assignment for Rab1b-δC(GDP) was reliably obtained.  
As shown in Figure 3.2.14(A), the resonances are well dispersed and 
characteristic of folded proteins in 1H-15N TROSY. Most of the resonances that 
appeared in the spectrum have been unambiguously assigned apart from the signals 
introduced by side chains. Meanwhile, the selected strips representing the resonances in 
the HNCACB spectrum are shown in Figure 3.2.14(B), where the sequential 
connectivity has been demonstrated by linking the intra and inter Cα and Cβ resonances 
of the fraction R49 to K56 of Rab1b-δC. All the chemical shifts of assigned residues 
were shown in the appendix I.  
Interestingly, one part of protein consisting of residue Thr65-Thr75 could not be 
assigned. Inspecting into the spectra, these residues were likely disappearing. Mapping 
this sequence onto published crystal structure, we found this part corresponding to the 
Switch II region. This region is highly dynamical and strongly affected by the 
82 3  Results 
nucleotides binding as a common feature of Ras-GTPases family (Lee et al, 2009). The 
Switch II region consists of one short α-helix (α2) and one long disordered loop (G3). 
The crystal structure with B-factor mapping [Figure 3.2.15(D)] indicates that this region 
possesses the highest B-factors in the whole protein (Muller et al, 2010). Therefore, the 
failure of assignment for this part might be as a result of the strong chemical exchange 
caused by its highly dynamic nature. To circumvent this, a series of 1H-15N HSQC 
spectra were recorded at different temperatures (283 K, 293 K, 298 K, 303 K and 308 K) 
to test the potential temperature dependence of chemical exchange. 
We also employed the sensitivity-improved HSQC sequence that uses a CPMG 
pulse train during the INEPT stage to reduce the loss of dephasing of spin coherence 
due to chemical exchange (Mulder et al, 1996). However, despite applying both two 
approaches above, the state of the spectra was not improved and few newly appeared 
peaks were found.  
 
A 
3.2  Interplay between alpha-Synuclein and Rab proteins 83 
 
 
Figure 3.2.14. NMR assignments for Rab1b (1-175). (A) Resonance assignments are indicated with 
amino acid types and residue numbers in 1H-15N TROSY. (B) Strips of the HNCACB spectrum 
demonstrate the sequential connectivity represented by Cα/Cβ within the fraction of R49-K56.   
To correlate the solution conformation and crystal structure, structural analysis 
for Rab1b was implemented based on the assignment we obtained. Secondary chemical 
shifts of Cα [Figure 3.2.15(A)] agree with the elements of secondary structure (on the 
top of the figure) determined by X-ray crystallography (Muller et al, 2010). This 
indicates that solution conformation measured by NMR is highly consistent with the 
crystal structure. Furthermore, residual dipolar couplings (RDCs) measured in pf1 
bacterial phage shows basic agreement between the crystal structure and secondary 
chemical shifts [Figure 3.2.15(B), (C)]. However some parts, particularly the 
conjunction areas between structured and disordered regions, show inconsistence with 
the other types of structural data, suggesting that these locations adopt different 
orientations in solution than in crystals. Moreover, the crystal structure of Rab1b-
δC(GppNHp) (PDB: 3NKV) is represented with b-factor mapping [Figure 3.2.15(D)]. 
B 
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As the core part of the Switch II region, helix α2 displayed in the X-ray structure is 
relatively short, looser and more distorted than other structured regions. B-factor 
mapping also points out that this region experiences more intensive thermal fluctuation 
than other parts, especially when compared with the core region of the fold denoted by 
the color blue. Hence, the Switch II region is highly dynamic in the protein. This region 
also provides the structural motif for tight binding of the regulator and effector proteins, 
i.e. GEF, GAP, GDI, and its conformation is highly sensitive to nucleotides binding 
(Lee et al, 2009). These features can largely contribute to chemical exchange that 
induced peak broadening and loss of sensitivity in the NMR spectroscopy. Hence, as 
described above, this feature accounts for the fact that corresponding resonances of α2 
and G3 disappeared in the NMR spectra.  
 
Figure 3.2.15 Structural characterization of Rab1b-δC. The secondary chemical shift of Cα (A) and 
residual dipolar couplings (RDCs) of NH of Rab1b(1-175) (B) are compared with the secondary 
structural elements determined by X-ray crystallography(The bar on the top: blue arrows indicate β-strand, 
red rectangles indicate α-Helix and black solid lines indicate the loop). (C) Correlation of experimental 
RDCs and SVD back-calculated RDCs based on crystal structure. (D) Crystal structure of Rab1b-
δC(GppNHp) (PDB code: 3NKV, resolution 1.7 A) is represented with B-factor mapping (green: high, 
blue: low). The typical Switch II region consisting of α2 helix and G3 loop is denoted. 
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Previously, the interaction between monomeric αS and Rab1b was not observed 
by NMR titration. The titration experiments were implemented by titrating Rab1b 
material into 15N-αS and observing changes in 1H-15N resonances of αS. To further 
confirm this finding, we repeated the titration assay by adding isotopically natural 
abundance αS into 15N- Rab1b-δC and monitoring possible resonance-changes of the 
Rab1b. Moreover, we also titrated the fibrillar αS into 15N Rab1b-δC to detect potential 
interactions between RAb1b and αS aggregates since Rab1b can modulate the 
aggregation of αS.  
Figure 3.2.16 shows that there are no significant bindings of Rab1b to αS 
monomers and fibrils. For the case of monomeric αS, the region of Rab1b from residue 
40 to 60 displays the trend that the chemical shifts were slightly affected by the addition 
of αS. But in comparison to the rest of the protein, the αS-induced perturbation is not 
pronounced. This might be due to some nonspecific interactions that partially perturbed 
this region. Both chemical shift perturbation and intensity plot indicated that no 
significant interaction took place between Rab1b and αS fibrils.  
 
Figure 3.2.16. NMR binding assay for Rab1b and αS. Monomeric and fibrillar αS were titrated into 
15N-enriched Rab1b (1-175) by monitoring the variation of chemical shift (A) and signal intensity (B) of 
the peaks in the 1H-15N HSQC spectrum of Rab1b. The applied Rab1b: αS ratios were 1:7 for monomeric 
αS to Rab1b and 1:5 for fibrillar αS (molar equivalents of monomeric protein). 
Additionally, the 15N- Rab1b-δC used for the titration is C-terminally truncated. Thus, 
the titration did not reflect whether αS could interact with the C-terminus of Rab1b. 
Howevert, the Rab1b previously used for titrating into 15N-αS is the full-length protein 
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and no binding was reflected by the resonances of αS [Figure 3.2.2 (A)]. Analyzing the 
sequence of amino acids for 3 Rab proteins also suggests that except Rab8a, the termini 
of Rab1b and Rab3a do not strongly bind to αS according to the charge distribution 
[Figure 3.2.3].      
In conclusions, the solution conformation of Rab1b-δC(GDP) is consistent with 
the crystal structure. Moreover, we did not observe significant interactions between 
Rab1b-δC(GDP) and αS monomers and fibrils. However, based on our aggregation 
assay, Rab1b modulated the aggregation of αS. This suggests that Rab1b likely interacts 
with aggregation intermediates.  
3.2.5.2 Assignment and structural analysis of Rab8a 
Rab8a shares highly sequential similarity and identity with Rab1. In parallel to this, the 
folded parts of these two Rabs also possess high similarity, except their C-terminal 
loops, which is a conserved feature in Ras GTPases superfamily. Therefore, these 
factors enable us to apply NMR assignment to Rab8a based on the assignment of Rab1b. 
However, in comparison to Rab1b, Rab8a is more difficult for sample preparation. First 
of all, it requires protein chaperones to assist its folding, which is not common in the 
Rab family. Secondly, Rab8a is insoluble in E. coli expression system and its 
purification is restricted to C-terminally truncated Rab8a(1-183) due to the structural 
flexibility of the C-terminus. Through codon-optimization and co-expression with 
protein the chaperone GroEL/GroES in E. coli, Dr. Amyelt Itzen’s lab produced full-
length Rab8a with an improved yield as well as the a reduced insolubility and 
heterogeneity (Bleimling et al, 2009). However, the expression of the isotopic labeling 
sample suffered even more difficulties and thereby substantially hampered NMR 
assignment and assessment for Rab8a. Finally, 100μM 15N-Rab8a-GDP in volume of 
200μL and 300μM 13C,15N-Rab8a-GDP in volume of 70μL were prepared. The paucity 
of the sample largely restricted our NMR studies. However, it still provided us with the 
opportunity to approach the structural analysis of Rab8a and the mechanistic study on 
the binding of αS to Rab8a.   
Not surprisingly, in reference to Rab1b-δC(GDP), 1H-15N HSQC of Rab8a(GDP) 
exhibits certain similarity in resonance distribution compared with Rab1b due to their 
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structural similarity [Figure 3.2.17]. Superposition of the spectra of the two Rabs 
indicates a few peaks of Rab8a were highly overlapped to the peaks of Rab1b.. Based 
on the sequence alignment of these two Rab proteins and the assignment of Rab1b, 
these paired peaks should correspond to the conserved residues between the 2 proteins, 
such as G56 and A154 of Rab8a. These specific residues were helpful for the 
assignment of Rab8a.    
 
Figure 3.2.17. 1H-15N HSQC spectrum of Rab8a. HSQC of Rab8a (red) was shown with Rab1b(1-175) 
(green) as a reference. Both spectra were acquired at 298K. The conserved residues based on sequence 
alignment of Rab1b and Rab8a i.e. G56, A154 were labeled. 
To correlate with full-length Rab8a, we also acquired natural abundance 1H-15N 
HSQC for the C-terminal peptide of Rab8a which previously identified that it could 
bind to αS C-terminus and affect the aggregation of αS. The HSQC of peptide was 
overlaid with the spectrum of full-length Rab8a, which showed that part of the 
resonances of the peptide were well overlaid with full-length protein, i.e. I193 and T194, 
but the rest of resonance were not. This is probably due to peptide adopts different 
conformation when it remains alone. It is necessary to obtain the assignment of Rab8a 
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and implement structural analysis of both the folded part and the C-terminal loop within 
Rab8a. 
Since the sample amount of 13C,15N-Rab8a was fairly limited, to record the 
NMR spectra required for assignment of Rab8a, a 1.7 mm cryogenical probehead was 
installed on the Bruker 800M spectrometer. 3D TROSY-based HNCA, HNCACB and 
CBCAcoNH were recorded for assignment. Sample instability caused substantial loss of 
the sample as the precipitation appeared after long time acquisition and this disabled 
further spectra aquistion.  
Spectra overlaying and sequence alignment identified 3 peaks that belonged to 3 
conserved residues between Rab8a and Rab1b, which are Gly20, Gly56, Ala154. The 
resonance positions of these 3 residues were well-resolved in the HSQC spectrum of 
Rab8a and were specified in MARS program to enhance the assignment. The cutoffs 
were optimized as 0.15ppm for Cα and 0.5ppm for Cβ in order to maximally and reliably 
establish sequential connectivity by MARS.  
Finally, 112 out of 209 residues of Rab8a were assigned reliably (appendix II). 
Secondary chemical shifts of Cα for assigned residues of Rab8a were consistent with 
secondary structural elements determined by X-ray crystallography for Rab8a-δC 
[Figure 3.2.19]. The missed assignments were mainly at the Switch II region, C-
terminal tail and the short turn between β2 and β3. The Switch II region comprised of 
G3 loop and α2 helix (Asp65-Thr77) was also unassigned in Rab1b(1-175) due to its 
dynamics. Major fragments of the C-terminal loop starting from Asn182 to Lue209 
were also largely unassigned. This is because the long loop region of 28 residues leads 
to the substantial degeneracy of the resonances due to it disordered state. The two 
proline residues Pro184 and Pro195 also interrupted the establishment of sequential 
connectivity for this loop region. A few repeats such as Gln197Gln198, Ser201Ser202, 
Phe203Phe204 and Leu208Leu209 were not readily distinguished very well under the 
conditions of spectra. Furthermore, the general limitations of the sample such as lower 
concentration, small amount and high instability also largely retarded the sensitivity and 
resolution of the NMR spectra. However, based on the half of Rab8a assignment, we 
still have an opportunity to examine potential bindings of Rab8a to αS. 
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Figure3.2.18. 1H-15NHSQC spectrum of the C-terminus peptide of Rab8a. (A) 1H-15N HSQC for the 
C-terminus peptide was recorded at natural abundance (red) at 298K and the HSQC for full-length Rab8a 
recorded at same temperature was shown using the color blue as reference. The region containing most of 
the peptide resonances is enlarged and displayed in (B) indicating that the fingerprint of two spectrums is 
partially overlaying. 
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Figure 3.2.19 Secondary chemical shift mapping for Rab8a-GDP. Secondary chemical shifts of Cα 
were mapped aginst residue. The secondary structural elements of Rab8a determined by X-ray 
crystallography(PDB code: 3QBT) were described on the top of figure (Hou et al, 2011). 
3.2.6 Mapping interaction sites on Rab8a 
As described in the previous sections, both Rab8a-δC and the C-terminal tail of Rab8a 
can bind to the C-terminus of αS. Therefore, in order to map the interfaces of Rab8a 
that enable Rab8a to bind to αS, a series of HSQC spectra of 15N-Rab8a(GDP) were 
recorded with the addition of different amounts of αS and analyzed based on the 
attained assignment.  
In Figure 3.2.20, three segments of Rab8a(GDP) are distinguished by increasing 
the added concentration of αS. The first motif is I43G44I45D46 identified by the change of 
both resonance positions and intensities. The changes of chemical shift were increased 
as a result of the increased concentration of αS. Interestingly, the resonance intensities 
of these 4 residues also increased with the continuous addition of αS and this effect was 
significantly shown at the molar ratio Rab8a/αS of 1:8 referencing to the neighbor 
regions. This suggests that chemical exchange in this region was restricted due to the 
binding of αS and thereby the previous broadening of the resonances of these residues 
was alleviated. Mapping this motif onto the crystal structure of Rab8a(1-178) (Hou et al, 
2011), we found that it corresponds to the end of the G2 loop [Figure3.2.20], typically 
defined as the Switch I region that experiencing drastically structural change during the 
process of GTP hydrolysis. Switch I region consists of the G2 loop and the beginning of 
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the following β2 strand, where there are positively charged residues such as K48, R50 
that might provide binding potential. 
According to the intensity plot [Figure3.2.20. B], the region D55-I59 displayed 
propensity for increased intensities upon the addition of αS. This fraction is located at 
the β3 strand which is encompassed in the Interswitch region that typically represents 
the region between the Switch I and Switch II. This Interswitch region normally 
undergoes allosteric effects caused by the structural regulations of the two Switch 
regions. Another region from residues A112 to I120 also shows changes in the chemical 
shifts but not in resonance intensities. This part contains one loop region between the 
α3 helix and β5 strand and the starting fraction of β5, which is labeled in pink color in 
Figure 3.2.21. The composition of amino acids in this region contains D115, E117 and 
K118 which does not display strongly positive potential and suggests the changes of 
chemical shifts are likely to be secondary effects of αS binding.  
The C-terminus of Rab8a as a loop region enriched by positively charged 
residues displayed strong propensity for binding to αS reflected by both chemical shifts 
and resonance intensity in Figure 3.2.20 as expected. Missed assignment for the 
majority of the C-terminus led to substantial loss of binding details at this region. 
However, M119I120 in the C-terminal loop shows significant chemical shift 
perturbation since at the ratio of 1:3. These two residues are directly after K117K118 
that very likely acts as a binding motif for αS. Moreover, the intensity plot indicates a 
clear trend of intensity increase starting from A173 until Gly181. In addition, the short 
fraction K192I193T194 showed intensity increase as well. The increase of intensities 
observed for these assigned C-terminal residues also indicates that the backbone 
dynamics were affected by the binding of αS.  Thus, in agreement with our previous 
result from the Rab8a C-terminal peptide, the C-terminus of Rab8a provides a another 
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Figure3.2.20 αS binds to Rab8a-GDP revealed by NMR titration. Changes in chemical shift and 
intensity of resonances of 1H-15N HSQC spectra of Rab8a-GDP were resulted from the addition of αS 
with 1:1, 1:3 and 1:8 molar ratio of Rab8a:αS. The changes of chemical shifts and intensity are reflected 
in (A) and (B) for the ratio of 1:8, (C) and (D) for the ratio of 1:3, (E) and (F) for 1:1. Error bars for 
intensity plots were estimated based on signal to noise.   
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Figure 3.2.21. Mapping interactions between Rab8a-GDP and αS. The binding of αS to Rab8a was 
recognized by the NMR titration assay and mappedonto the crystal structure of Rab8a (9-178)-GppNHp 
(PDB: 3QBT). Both “top” (left) and “down” (right) views are displayed. The binding motif of 
I43G44I45D46 which is part of G2 loop is labeled in magenta. Another motif of residues A112 to I120 is 
labeled in pink color. The unassigned Switch II region is labeled in light blue and the starting of C-
terminal loop is labeled in red. According the nomenclature for secondary structure elements of Ras-
GTPases, loops (G2, G3), helixes (α2, α3), β-strands (β3, β5) are selectively noticed.   
In conclusion, by using NMR titrations assays, we defined the interactions 
between Rab8a and monomeric αS. The binding is reflected in the NMR spectra of both 
Rab8a and αS. For αS, the binding of Rab8a occurs at its highly negatively charged C-
terminus. Rab8a is a protein that is enriched by positively charged residues at its C-
terminus and N-terminally folded parts as well. This feature of charge distribution 
enables Rab8a to offer multiple sites for αS binding.  
Both GDP- and GppNHp-bound Rab8a can bind to αS but Rab8a(GDP) displays 
stronger binding affinity to αS than Rab8a(GppNHp). Moreover, the structural data of 
αS binding to Rab8a indicates that the binding likely reduces the chemical exchange 
around the major binding sites of Rab8a, i.e. the Switch I region and the C-terminal 
loop. Unlike Rab8a, Rab1b and Rab3a do not bind to monomeric αS, but they enhance 
the aggregation of αS in a very similar manner, indicating that they potentially interact 
with αS aggregates and facilitate fibrillization.  
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3.3 Structural characterization of alpha-Synuclein aggregates 
The structural study of αS aggregates is important to understand the pathological 
consequences of αS. Fibrils of αS are recognized as a major component of Lewy bodies, 
the neuronal inclusion viewed as the hallmark of Parkinson’s disease(PD) (Spillantini et 
al, 1997). And αS oligomers, the aggregation intermediates, were proposed as major 
toxic species responsible for neuronal degeneration of PD. Until now, fibril structure of 
wt-αS has been well-characterized by EPR (Chen et al, 2007), mass spectrometry (Del 
Mar et al, 2005), solid-state NMR (ssNMR) (Comellas et al, 2011; Heise et al, 2008), 
and combination of solution NMR and ssNMR (Vilar et al, 2008). On the other hand, 
oligomeric species as the intermediates of αS aggregation are rarely characterized by 
structural methods at atomic resolution due to their instability and heterogeneity.  
As described in sections 1.2, αS fibrils still play an important role in PD 
pathology; and three disease-related mutants present different cellular physiologies and 
structural features. However, previous structural studies on fibrils of E46K and A53T 
αS by ssNMR still didn’t achieve consensus regarding structural perturbation of the 
mutations to β-sheets enriched fibril core, particularly for E46K (Comellas et al, 2011; 
Heise et al, 2008). Moreover, a conserved solvent-protected core in amyloid fibrils 
of wt and A30P aS has been observed (Cho et al, 2011). It is also unknown whether a 
conserved core also exists in amyloid fibrils of E46K and A53T αS? To address these 
questions, we performed H/D exchange by solution NMR on the fibrils of these two 
mutants. 
Most of low resolution data suggest that oligomers of αS mainly adopt β-sheet 
conformation similar to the fibrils. Thus, with the aid of the compounds that specifically 
maintain αS at oligomeric stage with certain size, we performed the optimized NMR 
H/D exchange method to tentatively detect the potential hydrophobic protections inside 
the oligomers.     
3.3.1 H/D exchange for fibrils of E46K and A53T α-Synuclein mutants 
Mutations of A30P, E46K and A53T are associated with familial forms of PD. 
Structurally, these 3 mutants were reported to perturb intra-molecular long-range 
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interactions between N- and C termini of αS and thereby alter its aggregation behavior 
(Bertoncini et al, 2005a). The A30P mutation slows αS fibrillization and produces more 
soluble oligomeric intermediates. However, it does not change the arrangement of β-
sheets in core region of the fibrils (Lemkau et al, 2012). Compared with A30P, the 
E46K and A53T mutations are closer to the NAC region centrally for fibril formation. 
Both E46K and A53T promote the fibril formation and display faster kinetics than wt-
αS (Fredenburg et al, 2007; Greenbaum et al, 2005). Moreover, by morphological 
comparison, ultrastructural diversity of amyloid fibrils was observed amongst the 
mature fibrils of wt-αS and its 3 mutants (van Raaij et al, 2006). These findings together 
suggest that the familial mutations of αS modify both fibrillization kinetics and 
assembly of protofilaments. It’s thus intriguing to investigate whether the fibrils of 
E46K and A53T adopt a similar conformation at their fibril core region respecting to the 
fibrils of wt and A30P αS. Furthermore, it is interesting to assess how modifications of 
micro-environment of amino acids impact on fibrillization kinetics and ultrastructural 
assembling of fibrils.  
The monomers of E46K and A53T αS were incubated respectively under the 
aggregation condition at 37oC with constant stirring. Fibrils were harvested after 2 
weeks. The formation of fibrils was characterized by ThT fluorescence and electron 
microscopy. ThT fluorescence of E46K αS aggregation after 2 weeks was 3 fold higher 
than A53T αS. Comparison of EM images illustrated that the fibrils of A53T αS 
adopted a typical morphology of αS fibrils, but the fibrils of E46K αS were relatively 
shorter, more branched and heterogeneous [Figure 3.3.1]. Therefore, the aggregation 
kinetics and morphological analysis indicates that these two αS mutants differ in 
manner of fibrillization and particularly in assembly of the protofilaments.     
After two weeks of aggregation, the fibrils of E46K and A53T αS were collected 
by ultracentrifugation with 60k rmp for 2 hours at 4oC. The pellet of fibrils was then re-
suspend into distilled H2O and ultracentrifuged again for removal of soluble 
components attached to the fibrils. At the end, the pellets of fibrils were suspended into 
the exchange buffer containing 99.9% D2O, 200mM NaCl and 0.1% formic acid (pD 
4.0). The system was set on a rotator for 1 week in the cold room where the temperature 
was maintained at 4oC. 
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Figure 3.3.1. Electronic microscopy for fibrils of E46K and A53T αS. The fibrils were collected after 
2 weeks under the aggregation condition and used for the following H/D exchange.  
The fibrils after 1 week of H/D exchange were collected and washed 2 times by 
ultracentrifugation. The prepared fibrils were dissolved to monomers in 50% D2O 
solution with 2M GuSCN, 0.4% formic acid (pD 2.4). Since the fibril pellets were 
dissolved, the monomers encoding the structural information of fibrils in solution were 
quickly transferred into the NMR spectrometer to start recording spectra. All the NMR 
parameters of acquisition were calibrated prior to fibril dissolution using a reference 
sample prepared in identical solution conditions. After a 12 minutes deadtime for 
sample tuning in spectrometer, a series of 1H-15N HSQC spectra with band-selective 
excitation (BEST-HSQC) were recorded with interval of 25 minutes for each spectrum. 
Comparing with the solution used for forward-exchange described previously, 
the concentration of D2O was reduced from 100% to 50% in the dissolving solution of 
GuSCN. This possesses the advantages that the region previously protected or exposed 
in the 100% D2O environment can be distinguished by observing the decreasing or 
increasing trends of intensity in 50% D2O, as a process of back-exchange. In addition, 
the pH was set at 2.4 and the spectra were acquired under 5oC, which maintained the 
proton/deuterium exchange rate at a minimum level and enabled us to follow the 
kinetics of back-exchange with a better time resolution under given spectroscopic 
conditions.  
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Figure 3.3.2. Intensity plots of HSQC spectra for back-exchange. The residue-specific resonance 
intensities were mapped as a function of dissolution time starteing from the time that fibrils were 
suspended into the GuSCN/D2O solution (black:E46K, red:A53T). Each back-exchange profile was fit 
with a single exponential function curve.  
In Figure 3.3.2, residues from different regions of αS respond differently during 
the back-exchange process and a few residues of the two mutants experience different 
kinetics. Most of the selected residues at the N-terminus display an exponential increase, 
such as V3, V16, E20, E28, E35, suggesting that these residues are exposed to D2O 
during the forward exchange. Distinctively, residues from 37 to 97 majorly adopt a 
relatively flat or decreasing pattern in the intensity plot, denoting that the residues from 
this segment were buried inside the structured elements of mature fibrils and the amide 
protons were protected against exogenous deuterium by forming hydrogen bonds inside 
the fibrils. A few exceptions, like G68 and E82, implicates they might locate at the loop 
region between β-sheets. For the C-terminal residues starting from 98, both mutants 
showed an obvious increasing pattern in their intensity due to the less protection of the 
C-terminus than that of fibril core during forward exchange.  
To quantitatively map the extent of protection and depict structure of fibril core, 
according to the back-exchange curve, we back-calculated the initial hydrogen content 
and the corresponding level of deuterium incorporation as two alternative 
representations for residue-specific protection extent of the fibrils against H/D exchange 
during forward-exchange [Figure3.3.3 (A) and (B)]. The patterns of both figures 
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consistently and clearly define the boundaries of fibril core at residue 37/38 and 97/98. 
According to the protection pattern, this core region is conserved in fibrils of both E46K, 
A53T αS. Out of the core region, C-terminal residues 98-140 were most strongly 
affected by the exchange and obtained averagely highest extent of deuterium 
incorporation. N-terminal domain also possessed significantly less protection than fibril 
core but relatively less pronounced than the C-terminus, indicating that there were likely 
residual structures presenting in N-terminal (Gath et al, 2012).  
Based on the protection patterns inside fibril core, the putative β-sheets 1, 2, 3, 4, 
5a and 5b were depicted on the top of the figures by identifying the putative loops 
between two consecutive β-sheets by recognizing the residues with less protection. This 
structural arrangement is in agreement with the previously defined fibril structures of 
wt-αS and A30P αS by H/D exchange coupled with HR-MARS (Cho et al, 2011), 
where the loop residues could be recognized by HR-MARS due to their flexibility. 
Interestingly, the basic arrangement of fibril core remains conserved in both 
mutants. Slight difference is shown that the boundary residues were shifted from 
V37/K97 for E46K αS to L38/K96 for A53T αS. Accordingly, the first and last two 
putative β-sheets were shifted by one residue for the fibrils of A53T αS compared with 
the fibrils of E46K αS. But, generally, the structural patterns of the fibrils of these two 
αS mutants demonstrate that the mutations didn’t drastically alter the conformation of 
fibrils core. The difference shown in EM pictures for these two mutants might account 
for that polymorphism of amyloid fibrils and association fashion of protofilaments was 
modified by mutation. At position 46, the mutation from Glu to Lys can reverse the 
charge state of side chain and potently affect the local structure and ambient regions. 
However, by protection pattern we notice that this position locates likely at the loop 
region between first and second β-sheets of fibril core and thus this mutation should not 
strongly change the arrangement of core. Moreover, no significant changes appeared at 
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Figure 3.3.3. Characterization of protection extent against H/D exchange for fibrils of E46K, A53T 
αS. The mutation positions in protein sequence were labeled by red lines. The back-exchange profile was 
fit with single exponential function and extrapolated the initial intensity representing the hydrogen 
content at the starting point of back-exchange (A). Correspondingly, in (B), the original level that 
deuterium incorporated into fibrils after 2 weeks H/D exchange was back-calculated from back-exchange 
profile and taken into account that after completion of the back-exchange the protonation level was 47% 
(with calibration due to extra protons introduced by GuSCN). Error bars were calculated on the basis of 
the signal-to-noise ratio in the last and first HSQC spectrum. At the top of figure, the secondary structural 
elements of αS fibrils determined previously are described as arrows for β-sheets and as a curve for linker. 
(EPR(Chen et al, 2007); solid state NMR (ssNMR-1) (Heise et al, 2005); solid state NMR (ssNMR-2) 
(Comellas et al, 2011); H/D exchange and solid state NMR(Vilar et al, 2008); H/D exchange and HR-
MAS (Cho et al, 2011), filled circle represents the flexible regions observed by HR-MAS.) 
. 
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In summary, the mutations of E46K and A53T don’t induce dramatical change 
of the solvent protection pattern of fibril core, suggesting a conserved core region in 
fibrils of these two mutants. And this conserved core is highly similar to fibrils of wt-αS 
and A30P αS. Therefore, our results suggest that a highly conserved structure 
embedding in fibril core of wt-αS and its 3 familial mutants.  
3.3.2 Probing conformation of the compounds-stabilized oligomers of                   
α-Synuclein 
Several lines of evidences attribute neuron toxicity of αS to its oligomeric states 
(Caughey & Lansbury, 2003; Cookson, 2009; Cookson & van der Brug, 2008; Lashuel 
et al, 2002a; Lashuel et al, 2002b; Volles & Lansbury, 2003; Winklhofer et al, 2008). 
Thus it’s of central interests to study physiological and biophysical features of αS 
oligomers. However, as aggregation intermediates, continuum distribution of molecular 
weight, highly structural heterogeneity and weak stability of the oligomers pose 
hindrances for us to acquire structural information of αS oligomers with high resolution 
and accuracy, which largely hampers us to understand in-depth mechanism of its 
neuronal toxicity.  
A series of organic compounds have been successfully screened for developing 
potential therapeutic agents of PD by Sergey Ryazanov and Andrei Leonov in our 
department. These compounds can block fibrillization of αS by stabilizing the 
oligomers within a certain size range (hydrodynamic radii of ~100 nm) and significantly 
reduce cellular toxicity of αS in serveral animal models. Biophysical characterizations 
demonstrate that these compounds effectively convert the αS oligomers from on-
pathway to off-pathway, from larger size to the smaller size with pronounced stability. 
Solution NMR investigation points out that these compounds do not bind to αS 
monomers, but preferentially interact with αS oligomers. Furthermore, recent research 
defined that there was one conversion from smaller oligomers of αS to the larger 
oligomers, which the αS oligomers with larger size were putatively more toxical than 
the smaller ones in cell tests (Cremades et al, 2012). 
Therefore, the better stability and promising clinical application stimulates us to 
access high resolution structural information for these compounds-stabilized αS 
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oligomers. The H/D exchange method was adopted. Based on experience applied for αS 
fibrils, we specifically optimized the method for studying conformation of the 
compounds-stabilized oligomers.  
The oligomer sample for H/D exchange was prepared by the standard 
aggregation procedures with the addition of compounds before aggregation started with 
ratio that 100μM αS/100 μM sery166a or 70μM αS/100 μM anle138c. Both sery166a 
and anle138c are names of the compounds that stabilize αS oligomers [Patent No.: WO 
2010/000372 A2]. The aggregation of αS was maintained 3~4 days that maximal 
amount of oligomers was expected. At the end, sample was monitored by Atomic force 
microscopy (AFM), Dynamic light scattering (DLS) and Thiol-flavinT fluorescence 
(ThT) [Figure 3.3.4]. Fluorescence shows that no ThT-positive fibrils were formed 
under the aggregation condition up to 3 days. DLS measurement identified that the sizes 
of these oliomgers mainly distributed around 100 nm (hydrodynamic radii) and AFM 
characterized the oligomers with annular shapes distinct to the classical morphology of 
αS fibrils. To remove filaments probably existing in the solution, the samples were 
centrifuged with 5K rpm for 15 minutes prior to H/D exchange.   
 
Figure 3.3.4. Biophysical characterization for the compounds-stabilized αS oligomers. Molecular 
structures of anle138c and sery166a are shown (A). ThT fluorescence (triplicate measurements) indicates 
that no fibrils formation after 3 days aggregation with anle138c (A). The oligomers were characterized by 
DLS with hydrodynamic radii around 100nm (B) and Atomic force microscopy with annular shape (C).    
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A primary consideration differing to the case of αS fibrils is that the oligomeric 
species of αS are soluble and hard to be separated from mostly populated αS monomers 
by the means like ultracentrifuge. Thus, for the process of forward H/D exchange, we 
directly added D2O into the oligomer solution to reach the D2O ratio not less than 50%. 
Then the whole system was kept in cold room of 4oC for forward exchange of 10 
minutes. The following procedure including oligomer dissociation by GuSCN, quick 
transfer and tuning of spectrometer was mostly same as the H/D exchange for fibrils.  
Two factors we took into account were: 1) unlike fibril sample, the deuterated 
oligomers were difficult to be further isolated from monomers; 2) the central part of 
oligomers was assumed to be solvent exchange-resistant due to hydrogen bonds and 
hydrophobicity. Therefore, after the forward exchange GuSCN was directly added into 
the oligomer solution to dissociate oligomers. After the dissociation by GuSCN, there 
should be different responses for the fraction inside central part of the oligomers and for 
the fraction that is out of hydrophobic center and highly exposural to solvent. Moreover, 
the original αS concentration used for aggregation was 100 μM and reduced to less than 
50μM after the addition of D2O and GuSCN. Thus longer experimental time for each 
HSQC spectrum was used to compensate signal to noise.  
Under the condition described above, the H/D exchange profile after the addition 
of GuSCN is shown in Figure 3.3.5. Unlike profile of the fibril exchange, 6 selected 
residues from different parts of αS didn’t display region-specific kinetics. In the case of 
fibril samples, the residues like A53, I88 were highly associated with the hydrophobic 
core of αS fibrils. But their H/D exchange profile of the oligomer sample reflected by 
peak intensities didn’t tend to drop as expected. Moreover, most of residues showed a 
relatively plateau profile, suggesting that they have been saturated by solvents during 
the exchange process before starting dissociation. Only a few residues like Y133 tended 
to decrease, but this might be a result of bulkily side chain of residue which retarded 
solvent accessibility. Additionally, we observed strong average uncertainty represented 
by error bars. This was due to low concentration of αS as the solution was diluted by 
the addition of large extra amount of D2O.  
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Figure 3.3.5. H/D exchange profile of the compound-stabilized (anle138c) αS oligomers. The curves 
represent the residue-specific change of peak intensities after the GusSCN dissociation. 6 residues from 
N-terminal, NAC and C-terminal are shown. The unit of Y axis is arbitrary.   
Since exchange profiles of most residues were nearly plateau, it implicated that 
probably both the fractions outside and inside of the presumably hydrophobic center of 
oligomers already was saturated by solvent during the first exchange period. We 
considered that hydrophobic interactions and compactness of the oligomers should not 
be as strong as inside fibril core and the possibility to form hydrogen bonds should also 
be less than the fibrils. Therefore, it’s necessary to improve the exchange conditions to 
circumvent these drawbacks. \ 
Firstly, we raised the D2O ratio from 50% to 70% gradually for amplifying the 
potential difference of exchange behaviors between the central part and the outer part of 
the oligomers during the first period of the exchange. Secondly, considering that the 
oligomers might adopt a relatively loose conformation and thus the solvent could 
approach the assumed core region more easily than the case of fibrils, the exchange time 
was shorten from 10 minutes to 5 minutes. Under such condition, more solvent-exposed 
residues were expected to finish the deuterium to proton exchange within 5 minutes but 
the central part was not. Furthermoe, to improve sensitivity of NMR spectra, we used 
the membrane with specific molecular weight cut-off filter (i.e. 10 kDa) to concentrate 
the sample prior to the exchange condition.  
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Figure 3.3.6. Optimized H/D exchange for the compound(anle138c)-stabilized oligomers. The peak 
residue-specific intensities were drawn as the function of exchange time after adding GuSCN. The unit of 
Y-axis is arbitrary.  
Compared with the previous trials, under this improved condition, overall 
sensitivity reflected by the error bars was enhanced and the exchange curves of residues 
display slightly distinguishable patterns [Figure3.3.6]. Most of residues from N-terminal 
part like K10 and V26 tended to adopt plateau trend during 13 hours exchange time. 
Residue Y39, at the boundary region of αS fibrils defined by previous fibril exchange, 
showed slightly decreasing trend in the αS oligomeric sample. The residues like A53, 
V63, Q68, A69, I88 also exhibited the decreasing trend during the exchange. These 
residues were previously identified in β-sheets inside of fibril core. Other residues 
previously in the fibril core region like Q62, V66, Q67 showed fairly weak decrease or 
even slight increase. Interestingly, these residues located in the loops between two β-
sheets of fibril core found by previous fibril exchange experiment. K97 should be the 
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residue at another boundary of the fibril core. The oligomeric sample showed that this 
residue display slight decrease pattern contrary to its following residues D98 and Q99 
which were experiencing increase and plateau respectively but no decrease. Thus, these 
observations implicate that potential correlation of protection pattern against the 
solvents between the compound(anle138c)-stabilized αS oligomers and αS fibrils, 
suggesting that potential structural homology might be shared by these two types of αS 
aggregates. 
We also found that some residues like D119 and E139 at C-terminus showed the 
decreasing pattern. Ser129 also experienced a clear decrease of peak intensities along 
the exchange time. The behavior of these C-terminal residues suggested that they might 
experience protection during the first exchange period, which was also indicated by the 
peak intensities of first HSQC spectrum of the oligomer sample compared with the 
monomer reference [Figure 3.36. A]. But, like Ser129, the same situation was also 
observed for Ser9 at N-terminus, which could be due to the effect of residue side chain. 
This can also indicate that under current conditions, the differentiation between residues 
from different parts of αS oligomers were still not significant and far from the precise 
required for quantitative analysis. Especially, the side effects from individual side-chain 
and their neighbor residues still largely affected the exchange process and might be 
more pronounced than the structural effects that we expected to observe.        
Comparing to the results of H/D exchange for fibrils of E46K and A53T αS 
fibrils, the compounds-stabilized oligomers displayed much weaker protection against 
solvent exchange. Even under exchange condition i.e. 70% D2O and 5 minutes forward 
exchange time, we still didn’t observe the expected difference of protection at different 
regions of αS. In αS fibrils, hydrogen bond is a major factor that protect amide proton 
against solvent exchange. Thus, the weaker protection of the oligomers suggests that the 
compounds-stabilized oligomers don’t contain the regions that are enriched in hydrogen 
bonds.  
Another factor we need to take into account was that after 3 days aggregation 
with compounds under the given condition, maximally 30% αS monomers would be 
converted into NMR-invisible oligomers measured by the 1D NMR monomer-
consumption assay. Due to the heterogeneity and continuum distribution of oligomeric 
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species, the effective population of oligomers that finally contributed to our observation 
during the exchange could be far less than 30% of total amount of αS. Thus the 
corresponding signals from oligomers were not enough to be distinguished from 
dominating monomer signals.      
In summary, we optimized H/D exchange methods for probing conformation of 
the compounds-stabilized αS oligomers. After the stepwise improvement for each 
experimental condition, we observed that the residues from NAC region displayed 
slight solvent protection. But the general protection of the compounds-stabilized 
oligomers was much weaker than that of fibrils, suggesting that the compounds-








4.1 Functional relevance of alpha-Synuclein phosphorylation  
4.1.1 The effect of PD-associated mutations on the phosphorylation of α-
Synuclein 
Although αS phosphorylation has been implicated in the pathogenesis of PD, little is 
known about effects of PD-associated mutations (A30P, A53T and E46K) on the 
phosphorylation of αS, or vice-versa. The aim of this section was to address this gap in 
knowledge and to provide insights into the impact of the PD-associated mutations on 
phosphorylation of αS at S87 and S129 in vitro. This was achieved by real-time NMR 
method and by employing kinases that are known to specifically and efficiently 
phosphorylate αS at these residues, namely PLK2 (S129) and CK1 (S87 and S129).  
Our quantitative analysis of phosphorylation kinetics revealed that wt-αS was 
phosphorylated at S129 faster and slightly higher levels than all three genetic variants 
by using the same kinase and protein concentrations (Figures 3.1.1 and 3.1.2). 
Analogous findings regarding the in vitro phosphorylation of the pathogenic A30P and 
A53T αS by CK2 were reported previously (Ishii et al, 2007). Both A30P and A53T 
were reported to be phosphorylated in vitro at a slower rate compared to wt-αS. It is 
noteworthy that the extent of CK2-mediated phosphorylation of αS does not exceed 5-
10%.  However, we observed that none of the PD mutants seemed to influence the 
kinetics or extent of phosphorylation at S87 (Fig. 2B).  
The above observations raise questions about why the disease-related mutants 
affect the levels of phosphorylation of S129 but not S87.  The answer to this question 
may lie in differences in the structural consequences of the S87 and S129 
phosphorylation. The previous studies indicated that αS phosphorylation at S87, but not 
S129, interferes with αS binding to membranes (Paleologou et al, 2010). It is also likely 
that the conformational changes resulting from the amino acid substitution in the 
108 4  Discussion 
disease mutants affect their interaction with kinases and/or phosphatases. It has 
previously been shown that the A30P mutation disrupts a region of residual helical 
structure that exists in the wt protein, whereas the A53T mutation results in a slight 
enhancement of a small region around the site of mutation with a preference for 
extended conformations (Bussell & Eliezer, 2001). Furthermore, the A30P and A53T 
mutations slightly weaken transient interactions between the acidic C-terminal tail of 
αS and its N-terminal region (Bertoncini et al, 2005b). In contrast, the E46K mutation 
enhances such contacts (Rospigliosi et al, 2009).  
4.1.2 Functional relevance of the Ser129 phosphorylation of α-Synuclein 
Several posttranslational modifications of αS have been described, including 
phosphorylation, nitration, ubiquitination, and truncations, but the role of these 
modifications in modulating the physiologic and/or pathological properties of α-syn 
remains poorly understood. One can speculate that many αS properties and functions 
are regulated by its interactions with other proteins and its subcellular 
localization/targeting, which in turn might be regulated by posttranslational 
modifications. Therefore, identifying the key molecules responsible for regulating αS 
post-translational modifications and elucidating their mechanism of action are essential 
for unraveling the molecular basis of αS function(s) in health and disease.  
Of the posttranslational modifications, phosphorylation at the Ser129 is the 
major modification of αS, which nearly 90% αS in Lewy body was phosphorylated at 
the Ser129 (Anderson et al, 2006; Fujiwara et al, 2002; Okochi et al, 2000). Therefore, 
we investigated the selectivity and efficiency of PLKs-mediated phosphorylation of αS. 
Our kinetics data indicated that both PLK2 and PLK3 could phosphorylate αS with high 
efficiency and selectivity at the Ser129, especially PLK3 could achieve 100% 
phosphorylation of the Ser129 within 2.5 hours.  
 
At the same time, the different phosphorylation kinetics of Ser129 by PLK1-3 
suggest that “the propensity of PLKs to phosphorylate α-syn is determined by their 
substrate specificity and sequence complementarities between the catalytic site of each 
kinase and the amino acid sequence flanking the phosphorylated serine residue as well 
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as the conformation of the protein. Sequence analysis and three-dimensional homology 
modeling studies revealed that PLK2 and PLK3 show the highest pairwise identity of 
the catalytic domain and ATP binding site. The sequence identity between PLK2 and 
PLK3 at the catalytic domain and ATP binding site is 68 and 97%, and that of PLK2 
and PLK3 to PLK1 is %53 and 86–90%, respectively (Johnson et al, 2007). 
Furthermore, the consensus sequences of PLK2 and PLK3 are very similar and 
characterized by the presence of acidic residues within the 3–4 residues flanking the 
phosphorylation site ((D/E)X(S/T)θ(D/E), where θ denotes a hydrophobic amino acid. 
PLK1 to 3 have a preference for substrates in which at least one of the three residues 
flanking the serine residue is negatively charged. Both αS and βS fulfill this criterion. 
This charge distribution on the substrates complements the electropositive distribution 
on the substrate binding sites of PLK1 to 3” ((Mbefo et al, 2010), p.2818, co-authored).  
As it’s already proved that PLK2 and PLK3 were responsible to phosphorylate 
αS with high specificity and efficiency at Ser129, the next question is whether 
phosphorylation of Ser129 could affect αS aggregation. This is of crucial aspects to 
evaluate functional relevance of the Ser129 phosphorylation. Thus, we generated 
pS129-αS by PLK3 and the mimics of the Ser129 phosphorylation P128E/S129E and 
M127E/P128E/S129E by genetic mutations. Both the phosphorylated αS and its two 
mimicking mutants showed very close aggregation kinetics and morphology to wt αS, 
strongly suggesting that the phosphorylation at Ser129 of αS didn’t affect the 
aggregation. Similar finding has also been reported that phosphorylation of Ser129 
didn’t change the aggregation propensity of αS (Waxman & Giasson, 2011). A 
structural reason that Ser129 phosphorylation of αS would not affect its aggregation is 
that Ser129 is located at αS C-terminus. C-terminal (residue 100-140) is well known for 
its highly disordered state in both monomeric and fibrillar states. Thus, even embedded 
into the fibrils, C-terminal of αS still retains its disordered conformation outside the 
fibril core and thereby spatially offers chance for kinase recognition. This feature is 
drastic to the Ser87, which is located in central part of NAC and deeply buried inside of 
the rigid fibril core. Because of this special location, Ser87 is very hard to be accessed 
by the kinase at its fibrillar state. Vice versa, if monomeric αS was phosphorylated at 
Ser87, then the fibrillization could be blocked due to one strong polar group was 
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introduced into the core region responsible for the fibril formation (Paleologou et al, 
2010).  
Moreover,  several line of evidence have already pointed out that αS fibrils could 
be phosphoryalted by PLK1-3 in vitro (Mbefo et al) and in vivo (Waxman & Giasson, 
2011). These findings indicate that αS could also be phosphorylated after they 
aggregated into fibrils in Lewy body. Therefore, we speculate that the aggregation and 
the phosphorylation of Ser129 are two independent events in physiological scenario of 
αS. This indicates that pathological effects of the Ser129 phosphorylation of αS might 
not rely on modifying pathway of its aggregation. The question that why 90% αS 
deposited in Lewy Body were phosphorylated at the Ser129 still needs to be further 
addressed in future research.   
 
4.2 Rab proteins bind to alpha-Synuclein and modulate its 
aggregation 
Lindquist group found: (1) Rab1, Rab3a and Rab8a could suppress the disruption of 
vesicle trafficking at multiple steps caused by αS; (2) The cellular Rab homeostasis was 
disturbed by αS (Cooper et al, 2006; Gitler et al, 2008). To unearth the molecular 
mechanisms underlying these findings, we implemented the protein interaction studies 
for αS and the different Rab proteins by NMR spectroscopy and the aggregation assays 
for αS in the presence of Rab proteins. 
4.2.1 Rab8a binds to monomeric αS 
4.2.1.1 Rab8a binds to C-terminus of αS 
NMR titration identified that only Rab8a binds to monomeric αS in solution, however 
Rab1b and Rab3a lack binding. At the same time, our investigations revealed that both 
GDP- and GppNHp-bound Rab8a could bind to C-terminal of αS, but interestingly 
Rab8a(GDP) binds to αS with a stronger affinity than Rab8a(GppNHp). By sequence 
analysis for Rab8a, we found that Rab8a was relatively positive-charged and predicted 
that both C-terminal loop and N-terminally folded part of Rab8a were capable of 
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binding to αS independently. This has been proved by our NMR titration of C-
terminally truncated Rab8a-δC and the Rab8a C-terminal peptide into 15N-αS. As 
addressed in the literature of Lindquist, they found that only Rab3a and Rab8a similar to 
Rab1 could protect against cellular toxicity induced by αS in primary rat midbrain 
cultures and C. elegans. (Gitler et al, 2008). In C. elegans., Rab8a uniquely displayed 
the strongest rescuing effect characterized by extending lifespan of the worms. 
Correlating our NMR titration data, it therefore suggests that the molecular interaction 
between αS and Rab8a might play an important role in the rescuing mechanism of 
Rab8a against αS toxicity in the animal models.  
Even the weaker amelioration to the αS toxicity displayed by Rab1 and Rab3a in 
C. elegans., it’s noteworthy that these two Rab proteins can also suppress the αS 
toxicity in rat midbrain culture as similar extent as Rab8a. This suggests that these 3 
Rabs are capable of protecting the αS-induced toxicities with close extent but probably 
with different mechanisms. One speculation could be that αS indirectly interacts with 
effector or regulator proteins of Rab1 and Rab3a rather than the direct binding. Recent 
study demonstrated that vesicle trafficking was modulated by the interaction between 
αS and prenylated Rab acceptor protein 1(PRA1) (Lee et al, 2011). This protein 
interaction was proposed to inhibit the recycling between GDP and GTP bound Rab and 
thereby interfered the related vesicle trafficking. PRA1 is a protein comprising both 
transmembrane and cytosol domains and located at ER and Golgi. It interacts with 
prenylated Rab-GTPases and facilitates Rabs anchored at the membrane at active GTP-
bound state to play its function on regulating vesicle trafficking (Figueroa et al, 2001; 
Hutt et al, 2000). Particularly, it’s shown that PRA1 binds to Rab1, Rab3 and Rab5 
(Bucci et al, 1999; Martincic et al, 1997).  
Another speculation is that Rab1 and Rab3a modified the αS toxicities by 
modulating αS aggregation rather than direct interactions with αS monomers. This issue 
will be discussed in section 4.2.2.   
4.2.1.2 αS binds to the Switch I region of Rab8a  
The interaction mechanism of Rab8a and αS was further coherently shown by titrating 
αS into 15N-Rab8a and we thereby mapped the binding sites on Rab8a. There were two 
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regions of Rab8a, Switch I region and C-terminus, mainly involved in the binding to αS. 
For Switch I region, we observed increased chemical shift perturbation and enhanced 
intensity as the response to the addition of αS [Figure 3.2.20], indicating that αS binds 
and restricts the chemical exchange of this region. Switch I is an important region 
responsible for interactions of Rab8a with guanine nucleotide exchange factors (GEFs) 
and effector proteins (Itzen & Goody, 2011). As a common feature, the GEFs and 
effectors interacts with specific sites of Switch I and Switch II region and hence induce 
the significant structural changes to these two regions and the interswitch region. 
Therefore, the switch regions were enriched in potent binding sites for different binding 
partners and they are structurally sensitive to external bindings. Kd measured for 
Rab8a(GDP) binding to αS quantitatively depicted the binding strength for this protein-
protein interaction. As the Kd for Rab8a binding to αS is at the order of ~100μM, this is 
normally in the range of weak binding and much weaker than the common binding 
partners like GEFs and effectors in the Kd range of nM. Therefore, in real systems like 
neurons, αS likely needs to compete with these stronger binding partners of Rab8a. 
However, αS is much more abundant than GTPases in cells. The large excess of αS 
could favor the binding to Rab8a. Especially, under the pathological conditions, αS 
would progressively accumulate at the vesicles.  
According to the definition of the Switch regions, Switch I and Switch II regions 
experience significant structural changes between GDP and GTP states as a common 
feature conserved in Ras family and thus these two regions were named with “Switch” 
(Lee et al, 2009; Milburn et al, 1990; Schlichting et al, 1990). Our titration data show 
that Switch I region of Rab-GDP was significantly affected by the binding of αS and 
the following interswitch region also display slight increase in peak intensities [Figure 
3.2.20]. This observation suggests that a major binding site was located in Switch I 
region and the interswitch region was also allosterically modified by the structural 
change in Switch I. Notably, the conformational nucleotide-dependence of the switch 
regions describes that for GTP state, Switch regions usually adopts more structured 
conformation and expose the hydrophobic patch to favor the binding of effectors. 
Contrarily, Switch regions present as more disordered conformation at GDP state (Itzen 
& Goody, 2011). Thus, this conformational nucleotide-dependence can provide the 
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structural basis to understand the preference for αS binding to Rab8a as we identified 
that Switch I region of Rab8a serves as major binding site for αS.  
As described in section 3.2.2.1, the Kd for Rab8a(GppNHp) binding to αS is 
approximately 2.5 fold higher than the binding of Rab8a(GDP) to αS, suggesting that 
Rab8a(GDP) possesses a stronger binding affinity to αS than Rab8a(GppNHp). And, 
this difference was also unambiguously shown in the NMR titration of C-terminally 
truncated Rab8a(6-176) into 15N-αS as shown in section 3.2.2.3 [Figure 3.2.6]. For all 
the molar ratios that we used for titrating Rab8a(6-176) into 15N-αS, Rab8a-δC(GDP) 
induced larger chemical shift perturbation to αS than Rab8a-δC(-GppNHp). Taken 
together, these observations indicate that there is a structural preference for αS binding 
to folded part of Rab8a. Importantly, as we identified that Switch I region of Rab8a was 
a major site for αS binding, this structural preference can attribute to the significant 
nucleotide-dependence of conformation of the Switch regions and the interswitch region.  
Moreover, more disordered conformations are commonly present to Switch 
regions at GDP state might be more favorable for binding of αS C-terminal, whereas 
more structured conformation of Switch regions at GTP state is usually favorable for 
effector protein binding (Itzen & Goody, 2011). There are two functional relevance of 
this structural preference of Rab8a binding to αS can be taken into account. αS 
preferentially binds to Rab8a(GDP), which leads the active Rab8a, namely 
Rab8a(GppNHp), to be less affected by the presence of αS. This serves as a protection 
mechanism to effects of αS on normal function of Rab8a, which supports the existing 
results that over-expression of Rab8a can suppress the cellular toxicity of αS.  However, 
there should be a well-balanced equilibrium existing between the GDP- and GTP-bound 
Rab8a. If large excess of αS is present in the cytosol it could bind to Rab8a-GDP and 
disturb the equilibrium of Rab8a between the GDP and GTP states and. Thus the 
reduced pool of Rab8a(GTP) can cause the trafficking deficits which could be viewed 
as one phenotype of αS-induced cellular toxicity.  
4.2.1.3 αS binds to the C-terminus of Rab8a  
Another major binding site is C-terminus of Rab8a (Asp176-Arg205). We considered 
this region due to its positive net charge, which is capable of compensating the negative 
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charges enriched in the C-terminal region of αS. We further identify this charge-driven 
interaction mechanism by our NMR titration assays. Titration of the synthesized C-
terminus peptide of Rab8a into 15N-αS could reproduce the effects of full-length Rab8a 
binding to αS [Figure3.2.4]. Correspondingly, this interaction has also been observed at 
C-terminus of Rab8a when we titrate αS into the full-length 15N-Rab8a [Figure3.2.20]. 
Especially, the binding of αS restricted the chemical exchange of Rab8a C-terminal 
reflected by the intensity plot at 8:1 molar ratio of αS to Rab8a(GDP), which was 
similar to the response of Switch I region of Rab8a-GDP. The C-terminus of Rab8a is 
structurally disordered and functionally responsible for the membrane-anchoring 
through prenylation of the cysteine in the CVLL motif. The 1H-15N HSQC spectra of the 
peptide and full-length Rab8a were not fully overlapped, suggesting that this terminal 
region possesses contacts with other parts of protein. But, in comparison to the binding 
of αS to Switch I region in the N-terminally folded part, the C-terminus of Rab8a is 
highly disordered loop and less affected by the different nucleotide binding. Hence, 
even at GTP state this C-terminal region can still largely contribute to the interaction 
between Rab8a and αS, although the conformation of Switch I region is unfavorable for 
the binding of αS. Taken together, the C-terminus of Rab8a play an important role in 
the interaction of Rab8a and αS due to its positive net-charge and relatively 
conformational independence of the nucleotide-binding. The characters of this C-
terminus enable Rab8a to bind to αS at both GDP and GTP states. Furthermore, due to 
the binding of αS, the structural contacts between disordered C-terminal and the 
structured part of Rab8a might be affected and the thereby the external perturbation 
could be partially introduced to the tertiary structure of Rab8a.   
Additionally, we found that both Rab8a-δC and the C-terminal peptide of Rab8a 
can bind to αS. But, we also observed that the binding strengths of these two fractions 
to αS were weaker than the full-length protein according to the chemical shift 
perturbation. Therefore, these observations suggest that the Switch I region and C-
terminus of Rab8a are simultaneously contributing to the binding of full-length Rab8a 
to αS.   
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4.2.1.4 The Ser129 phosphorylation enhances the binding of αS to Rab8a 
Phosphorylation of αS at Ser129 is one of most common posttranslational modifications 
to αS. As we discussed in section 3.1 and 4.1, the functional role of this 
phosphorylation is still less defined. Within the scope of this dissertation, two major 
questions for the Ser129 phosphorylation of αS remain to us: 1) what are the 
physiological functions of this phosphorylation; 2) what is the pathological relevance of 
this phosphorylation in synucleinopathies.  
Herein, base on the NMR titration, we found that the Ser129 phosphorylation 
enhanced the binding of αS to Rab8a in comparison to wt-αS [Figure 3.2.4]. The 
phosphorylation modified the side chain of Ser129 by introducing one negative charge. 
The length of  side chain of Ser129 was increased and the phosphate group attached on 
the end of Ser129 side chain possesses stronger electronegativity than side chains of 
normal amino acids. These factors can be the reasons for the binding enhancement.  
To date, most of studies on the Ser129 phosphorylation of αS were mainly 
addressing the questions based on the level of cell culture and other animal models. 
These assays can study the Ser129 phosphorylation in more physiological environments. 
But, they are less efficient to identify and determine the specific mechanism at 
molecular level (Braithwaite et al). Recently, V. Sancenon et al. reported that 
phosphorylation of αS at Ser129 could reduce vesicle trafficking defects caused by αS 
(Sancenon et al, 2012). In this paper, the authors also reported that the level of Rab5 
was increased as a marker of the endosome abnormality occurred in this pathological 
process. This implicate that there might be a pathological connection between Rab-
GTPases and αS in the scenario of vesicle trafficking deficits induced by αS. However, 
the kinases used in this paper were CK family kinases. CKs normally phosphorylate αS 
not only at Ser129 but also Ser87 as we described in section 3.1.1. Thus, it should not 
be excluded that the effects observed in the paper might also be result from the Ser87 
phosphorylation. Moreover, the impacts of the Ser129 phosphorylation on the vesicle 
trafficking deficits were defined based on genetic background and the specific 
interactions involved in the observations were not recognized in the paper. 
Compensating to these two points, our in vitro investigation was based on αS with the 
phosphorylation specifically at Ser129 by PLK3. At the same time, our investigation 
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identified the enhancement effects of Ser129 phosphorylation on αS-Rab8a interaction 
unambiguously by NMR spectroscopy at atomic resolution. Hence, this enhancement 
mechanism observed by us suggests that the Ser129 phsophorylation of αS likely plays 
an important role in the interaction with Rab8a and thereby further mediates αS toxicity 
in the context of vesicle trafficking disrupted by the large accumulation of αS. 
Additionally, this is also the first specific indication based on protein-protein interaction 
to demonstrate that how phosphorylation at Ser129 of αS mechanistically mediates the 
functions of αS.  
4.2.1.5 Overview for the molecular interaction of αS and Rab8a  
In section 4.2.1.1 – 4.2.1.4, we in-depth discussed the mechanism of the interaction 
between αS and Rab8a. Rab8a binds to αS C-terminal through its C-terminus and 
Switch I region and the electrostatic interaction is a major driven force for the binding. 
This binding has been well characterized from both αS and Rab8a sides. At the same 
time, this binding displays nucleotide-dependence mechanism that Rab8a-GDP binds to 
αS stronger than Rab8a-GppNHp. As the Switch I region of Rab8a was identified as a 
major binding site, this mechanism can attribute to the structural preference of the 
Switch I region for αS binding. Furthermore, we identified that the phosphorylation of 
αS Ser129 could enhance the binding between αS and Rab8a, which is as a specific 
indication of the functional relevance of the Serr129 phosphorylation of αS.  
In concert with our in vitro investigation, the in vivo assays have been 
undertaken by our collaborator Prof. Dr. Tiago F. Outeiro in his lab. Both αS and Rab8a 
were co-expressed in the model system of H4 neuroglioma cells (McLean et al, 2000) 
and co-localization of these two proteins has been observed. Hence, the co-localization 
suggests that these two proteins have potential interactions in the cells, which is in 
agreement with our in vitro finding. Furthermore, to identify the deeper mechanism that 
the Ser129 phosphorylation mediates the interplay between αS and Rab8a, one 
phosphorylation mimic S129D αS has been proposed by us to test its co-localization 
with Rab8a in vivo and interaction with Rab8a in vitro. 
Up to now, the specific protein-protein interactions characterized from both 
interaction partners at atomic resolution for αS are still rare. Thus, our studies are not 
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only helpful in understanding the rescuing mechanism of Rab8a against the αS 
toxicities, but also extend our knowledge respecting to general principles for the αS-
participating protein-protein/ligand interactions.  
4.2.2 Rab proteins modulate the αS aggregation 
Investigating α-Synuclein aggregation is one important approach to evaluate the 
physiologic and pathologic relevance of αS under the given conditions. We found that 
Rab1b and Rab3a didn’t bind to αS monomers but modulated αS aggregation. Rab8a 
can bind to αS as well as modulate αS aggregation. The effect of Rab8a on αS 
aggregation could be reproduced by its C-terminal peptide. Moreover, these 3 Rabs 
adjusted αS aggregation mainly in a dose-independent manner. To analyze the 
molecular mechanism of the 3 Rab proteins underlying their aggregation modulation 
effects, we take into account two types of molecular interactions: 1) the interaction of 
Rabs with monomeric αS; 2) the interaction of Rab with aggregation intermediates of 
αS.  
4.2.2.1 Rab8a modulates αS aggregation  
Firstly, our titrations indicate that both GDP-bound and GTP-bound Rab8a can bind to 
αS C-terminal and introduce the structural perturbation to the local conformation of αS 
C-terminal. At the same time, Rab8a can offer multiple binding sites, Switch I and C-
terminus for αS, suggesting that Rab8a likely interact with αS by 1:2 ratio of Rab8a/αS. 
Thus, local concentration of αS around Rab8a might be increased due to this binding. 
The increase of αS local concentration could ficiliate nucleation and thereby shortening 
the lag phase.    
Furthermore, the binding of Rab8a to αS C-terminus might modify the long-
range interactions between N and C termini of αS. As the long-rang interactions are 
important to maintain the protein conformation and inhibit aggregation of αS 
(Bertoncini et al, 2005b; Dedmon et al, 2005c), the presence of Rab8a might affect αS 
aggregation by modifying the long-range interactions due to its binding. In particular, 
this aggregation modulation mechanism of Rab8a by interacting with αS C-terminal 
through the electrostatic interactions was confirmed by the aggregation assay of αS with 
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the addition of the positively charged Rab8a C-terminal peptide [Figure 3.2.10]. This 
modulation mechanism is similar to the case that αS aggregation is mediated by 
positively charged polyamines (Fernandez et al, 2004). Furthermore, consistent with the 
observations by W. Hoyer et al. (Hoyer et al, 2004), our results indicate that C-terminal 
is important in modulating αS aggregation although it’s disordered and absent in fibril 
core.     
The distinction between polyamines and Rab8a should be noticed. Polyamines 
are small molecules but Rab8a is a protein relatively larger than αS. This suggests that 
even Rab8a impacts on αS aggregation in a polyamines-like manner, it also possessed 
some other characters specially modulating the aggregation in the way different to 
polyamines. Correlating with the binding of Rab8a to αS, C-terminus of Rab8a might 
act in a polyamine-like manner to modulate αS aggregation. In addition, the globular 
part can also bind to αS C-terminus and potentially affect the aggregation as well. Thus 
the full-length Rab8a that is a combination of its globular part and C-terminal loop 
might interact with αS and adjust its aggregation by a more collective way.  
4.2.2.2 Rab1b and Rab3a modulate αS aggregation  
From the interaction studies by NMR, we found that no molecular interactions between 
monomeric αS and Rab1b/Rab3a. But, they did enhance the αS aggregation by 
shortening the lag phase and significantly prompting the elongation. In addition, when 
the fibrillar αS was titrated into 15N-Rab1b-δC we did not observe the pronounced 
perturbation to Rab1b either. Therefore, it’s likely that Rab1b binds to αS aggregation 
intermediates. This interaction might rely on the fact that surface or shape of Rab1b fit 
to conformation of αS oligomers, which enables Rab1b to interact with the αS 
oligomers. Similarly, HSP70 were reported to selectively interact with αS aggregation 
intermediates and affect the αS aggregation (Dedmon et al, 2005a; Huang et al, 2006; 
Roodveldt et al, 2009).  
At the same time, we observed that all 3 Rabs could enhance the elongation rate 
of αS significantly. This might originate from the specific protein conformation which 
is conserved amongst the members of Rab-GTPases family. The aggregation control of 
αS with BSA also suggests that the aggregation mediation effects of Rab1b should be a 
4.2  Rab proteins bind to alpha-Synuclein and modulate its aggregation 119 
result specifically from Rab1b. Furthermore, 3 Rabs affected the αS aggregation mainly 
by a dose-independent manner within the concentration ranges that we applied. The 
addition of 0.3 to 3 molar equivalents of Rabs did not cause significantly difference in 
the aggregation behavior of αS. As Rab1b and Rab3a were suggested to selectively 
interact with αS aggregation intermediates, the concentration of Rabs even as half of the 
αS monomer concentration is still likely beyond the concentration of the αS 
intermediates because the oligomeric species of αS is populated much less than 
monomers in solution (Conway et al, 2000). Therefore, similar to the case of HSP70 
(Dedmon et al, 2005a), there is putatively a critical concentration for Rabs with respect 
to αS concentration to play its role in modulating αS aggregation, particularly for 
Rab1b and Rab3a. If the concentration of Rabs is higher than this critical value, it is 
speculated that the amount of Rabs is enough to catalyze the fibril growth of αS through 
binding to the αS oligomers formed during the lag phase.     
 
Figure 4.2.1 Putative role of Rab1b in modulating αS aggregation. The aggregation pathway 
consisting of the oligomerization and fibrillization has bee depicted, in where Rab1b selectively binds to 
the oligomeric species and favors the assembly of the oligomers into fibrils. 
 Taken together, we speculate that Rab1b and Rab3a modulate αS aggregation 
by interacting with αS oligomers and facilitate the assembly of oligomers to larger 
oligomeric species or directly into the fibrils [Figure 4.2.1]. This can explain why the 
Rabs could modify aggregation by both shortening lag phase and prompting fibril 
growth. Rab8a due to its binding to monomeric αS might perform a different 
mechanism in modulating αS aggregation in comparison to Rab1b and Rab3a.   
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4.2.2.3 Pathological implications of Rabs modulating αS aggregation 
Vesicle trafficking deficits caused by αS have been implicated in the Synucleinopathies. 
Elevated expression of αS was reported to affect the vesicle trafficking from ER to 
Golgi as the vesicle docking and fusion to Golgi membrane were blocked and the 
accumulation of undocked vesicles grew into massive intracellular clusters (Cooper et al, 
2006; Gitler et al, 2008).  Rab1 is responsible for modulating the vesicle trafficking 
between ER and Golgi. The overproduction of Rab1 gene in vivo was observed to 
suppress the trafficking disruption casued by αS. (Cooper et al, 2006) In addition, 
Rab8a, which is located at the post-Golgi vesicles and Rab3a, which is expressed 
specifically in neurons, could also suppress this cellular toxicity of αS by their 
overexpression, suggesting that αS broadly affects multiple steps of vesicle trafficking 
in cells (Gitler et al, 2008). Furthermore, recent study points out that αS aggregation 
induced the aggregation of many Rab-GTPases in the model system of S. cerevisiae 
(Soper et al, 2011), as the direct evidence of the interactions between αS and Rab 
proteins in vivo. Thus, the tight interplays between αS and the Rab proteins have been 
implicated in the scenario of vesicular trafficking.  
Both the Rab1 mutation (Wilson et al, 1994) and the overexpression of αS 
(Gosavi et al, 2002) could cause the Golgi fragmentation (Cooper et al, 2006). This 
reflects a deleterious relationship that αS can reproduce the harmful effects of the Rab1 
malfunction caused by the critical mutation. Conversely, this also partially explains that 
Rab1 was capable of rescuing the toxic effects of αS involved in the ER-Golgi transport. 
The mechanism of αS-induced deficits of vesicle trafficking and cellular compartment 
fragmentation might be attributed to the high affinity of αS to acidic phospholipid-rich 
membranes and the prone of misfolding and oligomerization (Cooper et al, 2006). In 
vitro biophysical studies found that the binding of αS monomers to the artificial vesicle, 
SUV, can render the deformation of SUV membrane (Bodner et al, 2009), implicating 
that the attenuated membrane intactness likely account for the vesicle dysfunction 
induced by αS. Meanwhile, αS oligomers have been reported to possess pore-forming 
propensity in the membranes (Kim et al, 2009). The mitochondria fragmentation has 
been observed as a result of the αS oligomerization as well (Exner et al, 2012; Kamp et 
al, 2010), which the fragmentation is probably similar in the toxic mechanism leading to 
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the Golgi fragmentation by αS and speculated as one general phenotype of αS 
oligomers-induced toxicities. Thus, the vesicle trafficking disruptions caused by αS 
(Cooper et al, 2006; Gitler et al, 2008) might be as the results of αS binding to the 
vesicle membranes and the pore-forming effects of αS oligomers.  
Comparing to the soluble monomers and oligomers of αS, αS fibrils possesses 
lower affinity to membrane and less cellular toxicity than the oligomeric species. Taken 
together, therefore, one molecular mechanism for the αS-toxicity suppression by the 
Rabs is proposed: Rabs lowered the populations of αS oligomers by enhancing their 
conversation into fibrils and thereby the toxicity of αS was reduced.  
4.3 Conserved fibril core and its implications to the conformation of 
alpha-Synuclein oligomers 
4.3.1 Molecular structure and supermolecular assembly of αS fibrils 
One central question of our study is to find the impact of 3 mutations A30P, 
E46K and A53T on the αS fibril structure. To address this question, we need to 
determine if these 3 mutation sites are located in a structured β-sheet or in loop. At the 
same time, it also needs to answer if the arrangement of β-sheets inside fibril core 
would be changed by these 3 mutations.  
The locations of the 46th and 53rd residue inside αS fibrils 
 Herein, we determine a conserved fibril core which exists between E46K and 
A53T αS fibrils by using solution NMR based H/D exchange. Particularly, for both 
mutants, the 46th residue was likely located in a loop region that between the first and 
second β-sheet. This is close to the observation for wt and A30P αS fibrils by 
combination of H/D exchange and HR-MARS (Cho et al, 2011). Riek group used 
solution NMR based H/D exchange together with ssNMR for rigid core region and 
cryo-EM for assembly of filaments depicted the inner arrangement of β-sheets inside 
core and the possible fold of wt αS fibrils of both twisted and straight type of fibrils 
(Vilar et al, 2008). In this comprehensive study, the location of E46 was also identified 
in a loop region. Similar speculation that E46K was located in a loop region was 
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proposed based on the ssNMR experiments for the fibrils of wt αS as well (Heise et al, 
2005). However, the indication from this ssNMR analysis is less unambiguous due to 
the incomplete assignments especially for the E46 and its neighbor region.  
With improved resolution, the residues located in ambient region of E46 in wt 
αS fibrils and K46 in E46K αS fibrils were assigned by ssNMR (Comellas et al, 2011). 
Based on the analysis of carbon chemical shifts of the ambient region for both wt and 
E46K αS, the mutation site of E46K was located in a structured region, the first β-sheet 
of fibril core. Meanwhile, the sequence for residue 40-51 completely conserved between 
human αS and mouse αS. With improved resolution achieved by uniformly [13C, 15N], 
[1-13C]glucose and [2-13C]glucose labeled mouse αS fibrils, this segment was fully 
assigned and the result also demonstrated that residue E46 was located in first β-sheet 
inside fibril core (Lv et al). Thus, the agreement has still been not reached for the 
location of 46th residue inside αS fibrils. The related reasons that need to be considered 
for this discrepancy can be listed as: 1) the fibril samples for NMR measurements were 
generated under different solution conditions and thus might be differed partially 
between each other (Hoyer et al, 2002); 2) significantly structural heterogeneity of αS 
fibrils has been witnessed by biphasic H/D exchange curves by solution NMR (Vilar et 
al, 2008) and doubling peaks for certain residues by ssNMR (Heise et al, 2005; Vilar et 
al, 2008), which is highly correlated different fibril morphologies. Especially, the region 
44-75 where E46 is located was indicated with more flexibility and less structural 
homogeneity in recent ssNMR study on αS fibril structure (Gath et al, 2012); 3) the 
methodological differences. For solution NMR based H/D exchange, the essence is to 
distinguish the solvent-exposured/protected regions of fibrils. But some structured parts 
in the fold of αS fibrils might enjoy a interface with solvent and some loop regions 
might locate between the interface of two protofilaments and thereby less accessible by 
solvents (Comellas et al, 2011). ssNMR can achieve the in-situ analysis of fibril 
structure which is superior to H/D exchange method based on solution NMR, but the 
resolution and sensitivity of ssNMR can be affected by internal dynamics and 
heterogeneity of fibrils (Kloepper et al, 2007).    
Different with the case of E46K, a better agreement for the location of mutation 
A53T in the fibril core has been reached. We identify that, for fibrils of both E46K and 
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A53T αS mutants, the locations of 53rd residue are in second β-sheets in fibril core. This 
observation is close to other structural studies mentioned above (Cho et al, 2011; 
Comellas et al, 2011; Heise et al, 2005; Lv et al; Vilar et al, 2008).  
The impacts of the familiar mutations on αS fibril core structures  
The structural comparison for E46K and A53T αS fibrils are based on our H/D 
exchange results which point out that a conserved fibril core for them with respect to the 
basic arrangement of β-sheets and the boundaries of core. A very similar observation 
was obtained for wt and A30P methods by similar method (Cho et al, 2011). This 
indicates that fibril core region is conserved between wt αS and 3 familiar mutants. For 
the residues located at the starting and ending boundaries of fibril core, most of 
structural studies figure out fairly close result as we observed. And the boundaries 
which were started at ~37th residue and ended at ~97 residue were also further 
confirmed by the other techniques like EPR (Chen et al, 2007), Mass spectrum (Del 
Mar et al, 2005).  
The central question of our study is to address that how the familiar mutations 
affect fibril structure. Particularly, E46K and A53T are in the core region of fibrils, 
unlike A30P is located in N-terminal loop. Our data suggest that there are minor 
changes caused by these two mutations on fibril structures. According to the chemical 
shift analysis, E46K and A53T mutations were reported to induce major and minor 
perturbation to fibril structure and attributed to their different side chains (Comellas et 
al, 2011). But, there was no further evidence from this work to point out mutation-
induced change of β-sheets arrangement, suggesting that these two mutations probably 
impacted more on the local conformation around the single mutation points. One early 
result suggested that mutation A53T significantly affected on the fibril structure in 
comparison to wt-αS (Heise et al, 2008). However, the critical regions for plausible 
comparison like residue50-60, 76-80 were not assigned for A53T fibrils.   
The role of different segments in the fibril formation 
Inspecting the H/D exchange results, we found that the 4th β-sheet(70-81) 
experienced relatively stronger protection against solvent, indicating that this region is 
located in the center of the fibril fold. Meanwhile, the short β-sheet (63-65) and the fifth 
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β-sheet (86-96) as the neighboring region of 4th β-sheet also displayed stronger 
protections [Figure 3.3.3]. These regions occupy most of NAC region of αS known as 
pivot area responsible for aggregation. Particularly the β3 and β4 defined by our H/D 
exchange are highly overlapped with the β3 and β4 defined by Riek group (Vilar et al, 
2008), where they indicated these two β-sheets are pivotal for fibril formations. The 
similar conclusions by other methods also point to that the certain segments in this 
region are centrally responsible for fibrillization(el-Agnaf & Irvine, 2002; El-Agnaf et 
al, 1998; Giasson et al, 2001; Madine et al, 2008).   
Interestingly, in our studies although N-terminal residues (1-35) adopts a random 
coil conformation out of rigid fibril core, part of these residues still showed more 
protection compared to C-terminal, particularly the region 18~25. A recently ssNMR 
study on αS fibrils suggested that the fibril core started from the first residue of N-
terminus (Gath et al, 2012). Although this finding is drastic to other structural 
investigation for αS fibrils performed before, it still implicates the presence of 
potentially tight contact between N-terminal residues and fibril core. In agreement to 
this, Rienstra group recently evaluated the impact of A30P mutation on αS fibril 
structure by ssNMR and identified that the fibril structure was mostly conserved 
between A30P and αS fibril. Nevertheless, this study found that due to mutation from 
Ala to Pro at 30th residue, the non-ignorable chemical shift perturbation with a average 
value of 0.5ppm was observed for Val55-Val63 (Lemkau et al, 2012), suggesting  that 
A30P interacts with this region either intra or intermolecularly or by some indirect 
means. Moreover, correlated with this observation, N-terminally truncated αS was 
found to have a longer lag phase compared with wt αS (Zibaee et al, 2007). 
Except molecular structure of single αS present in the fibrils, another intriguing 
question is how amino acid sequence affects the morphology of amyloid fibrils. As 
shown in Figure 3.3.1, the morphologies of E46K and A53T αS fibrils reflected by EM 
were fairly different. However, according to our H/D exchange data, the molecular 
structures of two mutants in the fibrils are similar. Although, EM images and H/D 
exchange address the structural arrangement at different level, they collectively suggest 
that familiar mutation impacts on ultrastructural arrangement of protofilaments rather 
than molecular structure of single protein. Therefore, at the end, several progress still 
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need to be made in 1) determining side chain conformation of the key residues in fibril 
core; 2) determining the N-terminal conformation of αS in fibril sample and map the 
potential contacts between N-terminal and fibril core region of αS since N-terminus of 
αS play an important role in modulating fibril formation; 3) clearly identifying the 
polymorphism existing in the fibrils.    
4.3.2 Structural relationship of αS fibrils and oligomers and the prospective for 
structural study of αS oligomers 
Structural correlation between αS fibrils and oligomers 
As discussed above, N-terminus of αS potently act as a role in promoting the fibril 
formation as the tight interplay between it and fibril core has been implied by structural 
analysis and aggregation kinetics. And, vice versa, αS N-terminus is important for the 
fibrillization and might reduce the oligomeric species by assembling them into fibrils, 
which accordingly the N-terminal truncation led to longer lag phase (Zibaee et al, 2007). 
Therefore, it’s more likely that N-terminus of αS is capable to regulate fibril formation 
of αS.  
Low resolution model of αS oligomers and fibrils indicates that on-pathway 
oligomers of αS are the building blocks for αS fibrils (Giehm et al, 2011a). Our H/D 
exchange data for the oligomers also tentatively indicated the residues involved in the 
structured regions of fibril core could show certain degree of protection in the oligomer 
sample. Similar to this observation on the αS oligomers, recent progress in structural 
study of Aβ aggregates collectively by solution NMR and ssNMR revealed that there is 
close structural relationship amongst Aβ oligomers, protofilaments and mature fibrils 
(Fawzi et al, 2011; Lopez Del Amo et al, 2012; Scheidt et al, 2012). Therefore, there 
might be correlation of αS oligomer conformation and fibril structure as well. However, 
until now, there is no clear model to define the details that how oligomers are converted 
into fibrils. Particularly, the lack of structural information of αS oligomers at atomic 
resolution largely hampers to set reasonable link between oligomers and fibrils. In our 
H/D exchange experiment which was optimized for the compounds-stabilized αS 
oligomers, one major obstacle is presence of the oligomers as a mixture with αS 
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monomers and thus hard to be purified, concentrated. At the same time, the 
polymorphisms of the oligomers present in terms of size distribution and structural 
heterogeneity. Both characters render our experiment with lower sensitivity specific to 
the oligomers and experimental design.  
 
 
Prospective for structural study of αS oligomers 
As the predominant advantage of NMR is revealing the atomic resolution, probing αS 
oligomer conformation with at least residue-specific resolution is still of the core tasks 
pursued in the future research. Based on the experience I attained for structural study of 
αS oligomers, several envisions would be made for the following-up studies. 1) Further 
optimization of H/D exchange for the oligomers by searching proper solution conditions 
and time span for forward exchange period and improving data processing to enhance 
data sensitivity for the data fraction that encods information of the oligomer 
conformation. 2) Performing the relaxation dispersion experiments to catch wider time 
scale dynamics involved in conformational exchange between αS oligomers and 
monomers.      
Alternatively, other methods would also be of options to access this end. 
Considering the relative lower population of the oligomers in the mixture of monomers 
and oligomers, reasonable purification and separation for oligomers are still desirable. 
Lashuel’s group purified αS oligomers by Superose 6 column of size exclusion 
chromatography and obtained homogeneous, stable and off-pathway oligomers with 
size of 10~14mer and diameter of ~21nm (Hinault et al, 2010). Another feasible 
approach is to generate oligomers from mature fibrils. αS fibrils can be reverted back to 
oligomers through cold-dissociation approach, which was capable to reach ~70% of 
total amount staying at oligomeric state under super-cooling condition (Kim et al, 2009; 
Kim et al, 2008). Moreover, other compounds such as Dopamine (Cappai et al, 2005), 
EGCG (Ehrnhoefer et al, 2008) which were able to inhibit fibril formation and stabilize 
αS oligomers can also be the choices to generate αS oligomers for structural analysis.  
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With optimal sample condition, the following issue is to choose experimental 
strategy of NMR spectroscopy to characterize conformation of αS oligomers. In recent 
years, Clore group characterize amyloid-β oligomers by applying selective saturation 
oligomer-bound monomer together with comparison of apparent R2 values between the 
bound and free monomers. Thereby chemical exchange process up to 1 second 
timescale between observable monomers and NMR-invisible oligomers can be mapped 
and residue-specific dynamics containing oligomer conformation can be probed (Fawzi 
et al, 2011; Fawzi et al, 2010; Fawzi et al, 2012). This is an option to test our oligomer 
sample. But, the difference for Aβ and αS should be noticed. Aβ is a short peptide with 
high hydrophobicity, however αS comprises not only hydrophobic region i.e. NAC but 
also amphiphilic N-terminal and acidic C-terminal which effectively modulate the 
oligomerization and fibrillization. Thus, the association of αS monomers to the 
oligomers is likely not tight as Aβ. Hence kinetics of the chemical exchange process 
between αS monomers and oligomers could largely be different with the Aβ case, 
which might be out the time scale of ~10ms-1s allowing to be detected by the method of 
Clore (Fawzi et al, 2012).  
Complementary to this method, relaxation dispersion as mentioned is one option 
to describe the dynamics within a wider timescale (50μs-10ms) (Ishima & Torchia, 
2006). Another choice is paramagnetic relaxation enhancement (PRE) to detect the 
transient complex formation within time scale 250-500μs (Clore & Iwahara, 2009). 
Intermolecular PRE was already been detected between N-terminal of one αS and C-
terminal of another αS in concentration-dependent manner (Wu & Baum). The 
intermolecular PRE has been identified by placing paramagnetic tag MTSL at A19C 
and G132C of αS, which 15N-labelled αS mixed with unlabeled αS with MTSL tag. A 
position-dependence of this intermolecular PRE has also been indicated by less 
significant effect for MTSL at A90C position since it’s located at the distal side of the 
interface of intermolecular contact. Recently, the groups of Klenerman and Dobson 
successfully accessed the structural information of αS oligomers and identified the 
conversation between oligomers of different size by placing fluorescence tag at the 90th 
residue (Cremades et al, 2012). Therefore, it’s likely to detect dynamics of chemical 
exchange between αS monomers and oligomers by placing paramagnetic tag at proper 
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position. For instance, placing MTSL tag at A90C of αS would not cause significant 
PRE at neighboring αS monomers. But, after the preliminary aggregation for mixture of 
14N-A90C αS with MTSL and 15N-αS, the hydrophobic segments of αS would get close 
to neighboring αS during oligomerization and 15N-αS would feel the PRE from 
neighboring 14N-A90C αS with MTSL within oligomers. If free αS monomers are 
experiencing intensive chemical exchange with oligomer-bound monomers, there would 
be possibility that the PRE effect on bound αS is detectable after it quickly dissociates 
from oligomers assuming the time scale of this process fits to detect the encoded PRE 
effects.  
4.4 Structural and functional importance of alpha-Synuclein C-
terminus 
The C-terminus of αS (98-140) displays distinct structural properties and functional 
significance within the scope of this dissertation. Therefore, herein a brief summary is 
exerted by linking the roles of αS C-terminal defined in different topics of this 
dissertation. The further implications respecting to the previously less-highlighted 
features of the C-terminal thereby would be proposed.  
Structural reasons for the hyperphosphorylation at Ser129 of αS 
In the first section, the phosphorylation of αS, we studied the Ser 
phosphorylation at Ser87 and Ser129. Kinetic studies of the phosphorylation by both 
CKI and PLKs points out that the 3 familiar mutations of αS didn’t alter the 
phosphorylation kinetics of Ser87, but slightly modified the kinetics of Ser129. 
Comparing with CKI, the PLK family kinases phosphorylated αS specifically at Ser129, 
particularly PLK2 and PLK3 display high efficiency in phosphorylation kinetics both in 
vitro and in vivo. Furthermore, we performed the aggregation assays for the 
phosphorylated-Ser129 αS and for the two Ser-to-Glu mutants that mimic the Ser129 
phosphorylation. Our results indicated that the aggregation propensity of αS was not 
significantly modified by the phosphorylation at Ser129, drastically in contrast to the 
aggregation of αS with the Ser87 phosphorylation (Paleologou et al). The related 
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evidences also point out that PLKs are capable of phosphorylating the αS fibrils at 
Ser129 (Mbefo et al).  
Linking to our H/D exchange data for the fibrils of the two familiar mutants of 
αS, C-terminal of αS is a special region that doesn’t participate in the fibril formation 
and maintains in highly disordered conformation in both monomers and fibrils. This 
structural feature can address that why approximately 90% αS was identified with the 
Ser129 phosphorylation in the Lewy body (Fujiwara et al, 2002), which is because the 
αS C-terminal can be readily accessed and recognized by the kinases at both monomeric 
and fibrillar states. Furthermore, the fact that the post-translational modifications are 
enriched in C-terminal region (Oueslati et al, 2010b) might be as a consequence of the 
evolution, where the probability of the posttranslational modifications was maximized 
for αS as the sites located in  the C-terminal which could be readily accessed even for 
αS fibrils.  
C-terminus of αS is important in the protein-protein interactions 
The dominant negative charges at the C-terminus of αS are recognized to be 
important for stabilizing monomer conformation and modulating the fibril formation 
(Levitan et al, 2011). Our interaction studies for αS and the Rab proteins provide a solid 
case to understand the role of C-terminal charges in modulating the protein-protein 
interactions. For instance, Rab8a performs a polyamines-like manner (Fernandez et al, 
2004) to interact with αS C-terminal mainly through the electrostatic interaction. 
Moreover, it’s reported that PLKs possess dominantly positive net-charge over the 
whole proteins (PLK1: +15, PLK2: +19, PLK3: +15.5, PLK4: +8) (Johnson et al, 2007). 
At the same time, as described in section 4.1, PLK1 to -3 have a preference for 
substrates in which at least one of the three residues flanking the serine residue is 
negatively charged. These two points might shed light to the phosphorylation specificity 
of PLKs to the C-terminal Ser129 but not the NAC Ser87.   
Except the positively charged C-terminus of Rab8a, its folded part can also bind 
to αS C-terminus in conformational preference mechanism that Rab8a-GDP displays a 
stronger affinity than Rab8a-GppNHp binding to αS. This indicates that αS prefers to 
bind to GDP-state Rab8a and can be attributed to significant nucleotide-dependence of 
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Rab-GTPases conformation, particularly on the Switch regions (Itzen & Goody, 2011; 
Lee et al, 2009). Thus, this observation extends our understanding that αS C-terminus 
binds to other proteins not only upon the charges but also the structural preference.  
The role of αS C-terminus in modulating the aggregation 
Due to the binding of Rab8a to αS C-terminus, the aggregation of αS was improved by 
the presence of Rab8a in a polyamine-like manner that the lag phase was significantly 
shortened and fibril formation was also enhanced (Fernandez et al, 2004). The same 
effects have been achieved previously by C-terminal truncation of αS (Hoyer et al, 2004; 
Kim et al, 2002; Levitan et al, 2011), which is in contrast to that the N-terminal 
truncation would increase lag phase of aggregation (Zibaee et al, 2007). Taken together, 
these evidences collectively suggest that the αS C-terminus potentially plays a role in 
modulating the αS oligomerization.  
 
5 Summary and outlook 
In this study, we investigated the serine phosphorylation of αS, interactions of 
αS with three Rab-GTPases, and the structure of αS aggregates.  
Summary 
1. Serine phosphorylation 
(1) Three familial mutations A30P, E46K, and A53T slightly affect the 
phosphorylation kinetics of Ser129, but do not affect that of Ser87. 
(2) PLKs selectively and efficiently phosphorylate αS at Ser129. PLK3 fully 
phosphorylate αS at Ser129 within 2.5 hours under our assay conditions. 
(3) Phosphorylation of Ser129 does not affect αS aggregation. 
2. Interactions of αS with three Rab-GTPases 
(1) Rab8a at both GDP- and GppNHp-bound states binds to monomeric αS at 
its C-terminus in solution. 
               (2) Both Rab8a-δC and the C-terminal peptide of Rab8a bind to αS C-
terminus as well. 
               (3) Rab8a(GDP) binds to αS more strongly than Rab8a(GppNHp) and this is 
reproduced by Rab8a-δC. 
               (4) The Switch I region and the C-terminal loop of Rab8a are two major 
binding sites for αS.  
               (5)  Both Rab8a and its C-terminal peptide can enhance αS aggregation. 
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               3. Structure of αS aggregates 
                (1)  H/D exchange for fibrils of E46K and A53T αS indicates a conserved 
fibril core. 
                (2)  H/D exchange for the compounds-stabilized oligomers of αS suggests 
that these oligomers do not contain large amount of hydrogen-bonded 
regions like αS fibrils.  
Outlook 
To further characterize the comprehensive interplays between αS and the Rab 
proteins, we propose to implement:  
1) αS aggregation assays in the presence of the C-terminal peptides of Rab1b, 
Rab3a and Rab3a, to clarify the role of each fragment of the protein in modulating 
aggregation;  
2) αS aggregation assays with Rab8a-δC to exactly determine its role in 
aggregation modulation;  
3) NMR titration of Rab8a and S129D αS to evaluate the effect of the Ser129 
phosphorylation on molecular interaction;  
4) aggregation assays of phosphorylated Ser129 αS in the presence of Rab8a;  
5) related in vivo assays to study the αS-Rab8a co-localization, the aggregation 
of αS in the presence of Rab8a and the impacts of Ser129 phosphorylation on the 
interplay between αS and Rab8a (undertaken in Prof. Dr. Tiago F. Outeiro’s lab);    
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I. Backbone assignment of Rab1b(1-175)-GDP 
RES N HN CO CA CB 
GLY_1           
HIS_2           
MET_3           
PRO_4           
GLU_5 120.9 8.492 175.3 57.1 30.24
TYR_6 113.7 7.042 173.6 55.72 38.81
ASP_7 119.3 8.964 175.4 56.74 43.51
TYR_8 114.8 7.703 172.7 56.45   
LEU_9 125 8.325   54.04 43.92
PHE_10 123.9 8.662 174.1 51.08 40.71
LYS_11 128.5 11.64 175.8 55.8   
LEU_12 127.4 9.556   52.63 46.07
LEU_13 119.1 8.064   53.51   
LEU_14           
ILE_15      
GLY_16           
ASP_17 122.4 9.038 176.9 55.85 40.81
SER_18 115.5 8.805 176.1 60.33 63.44
GLY_19 116.4 11.17 174.5 45.82   
VAL_20 123.8 10.43 178.3 61.04 29.68
GLY_21      
LYS_22           
SER_23 117.8 8.333   61.49 55.27
CYS_24 120.9 9.648 179.1 64.64 26.84
LEU_25 125.9 9.286 177.9 59.47 42.7
LEU_26 119.3 7.979   59.01 41.84
LEU_27 119 8.82 180.1 58.47 41.3
ARG_28 119 8.514 178 57.77 27.42
PHE_29 119 8.198 178.4 60.17 40.52
ALA_30      
ASP_31 113.9 7.734   53.95 42.75
ASP_32 120.5 7.751 174.6 55.24 40.01
THR_33 106.9 7.048 173 59.59 71.75
TYR_34 119 8.062 173.3 58.88 41.61
THR_35 122.7 7.447 171 58.96 70.13
GLU_36 122.8 8.251 177 56.36 29.53
SER_37 117.2 7.934 173 58.64 63.6
158   Appendix 
TYR_38 123.3 8.314 175.7 58.78 38.3
ILE_39 129.8 8.554 175.2 60.05 38.95
SER_40           
THR_41           
ILE_42           
GLY_43 111.6 8.511 172.7 45.74   
VAL_44 113.7 7.21 175.1 59.66 35
ASP_45      
PHE_46 109.5 6.54 173.7 54.27 40.47
LYS_47 116.4 8.451 174.6 53.87 36.53
ILE_48 118.9 8.534 176.1 58.54 40.72
ARG_49 125 8.464 174.1 55.63 34.1
THR_50 123.2 8.733   62 69.21
ILE_51 121 9.223 173.3 59.16 42.29
GLU_52 121.2 8.31   54.66 32.07
LEU_53 124.5 8.734 176 54.44 45.95
ASP_54 124.6 9.385   55.16 39.88
GLY_55 104.2 8.87 173.9 45.47   
LYS_56 119.9 8.048 175.4 52.74 33.7
THR_57 119.6 9.87 174.6 63 69.41
ILE_58 129.7 9.416   59.62 40.2
LYS_59 128.9 8.812   55.81 33.74
LEU_60 125.4 8.743   52.95 43.01
GLN_61 124.7 8.971   54.66 30.96
ILE_62 126.8 9.185   61.28 39.44
TRP_63 128 9.199   58.2   
ASP_64 120.7 8.155   52.17 45.15
THR_65           
ALA_66           
GLY_67           
GLN_68           
GLU_69           
ARG_70      
PHE_71      
ARG_72           
THR_73           
ILE_74           
THR_75           
SER_76 129.7 9.375   59.55   
SER_77 113.4 7.653   59.11   
TYR_78      
TYR_79 129.3 9.103   60.96 31.93
ARG_80           
GLY_81           
ALA_82 120.2 7.129 177.2 52.68 18.04
HIS_83 122.1 9.697 175.8 59.8 33.37
GLY_84 103.4 7.679 171.3 45.4   
    I. Backbone assignment of Rab1b(1-175)-GDP 159 
ILE_85 122.9 8.876 173.2 60.26 41.42
ILE_86      
VAL_87           
VAL_88 127.1 8.84 175.3     
TYR_89 122.3 9.094 170.5 55.55 40.01
ASP_90 121.5 8.856   51.31 43.41
VAL_91 118.5 8.722 176.3 64.24 30.82
THR_92 113 9.481 173.4 61.9 70.05
ASP_93 124 8.288   52.51 43.14
GLN_94 126.8 9.175 178 59.04 28.33
GLU_95 120.6 8.291   59.62 28.61
SER_96 116.1 7.959 176.2 61.27 63.46
TYR_97 123 7.188 178.5 60.13 39.21
ALA_98 126.4 8.666 181.2 55.28 17.55
ASN_99 113.9 8.374 177.4 54.14 38.15
VAL_100 123.2 7.946   67.77 30.9
LYS_101 116 7.378 178.7 60.62 31.99
GLN_102 119.2 7.265 179.1 58.64 27.84
TRP_103 121.5 7.83 178.8 60.46 29.43
LEU_104 117.7 8.758 179.1 58.36 40.79
GLN_105 118.6 7.49 178.6 58.96 28.39
GLU_106 121.1 7.753 178 59.99 29.76
ILE_107 118.8 7.984   65.88 38.25
ASP_108 118.2 7.72   56.99 40.39
ARG_109 117.1 7.385 178.3 58.55 30.54
TYR_110 113.9 7.488 176.3 57.7 41.31
ALA_111 121.8 8.629 176.6 51.2 21.61
SER_112 115 8.707 175.6 59.16 64
GLU_113 123.8 8.995 176.8 58.59 29.48
ASN_114 115.4 8.304 174.3 52.83 38.18
VAL_115 118.7 7.057 174.2 62.44 31.98
ASN_116 124.2 7.717 174.6 55.84 41.01
LYS_117 120.1 8.418   55.13 37.06
LEU_118 120.4 7.673 172.8 55.18 47.26
LEU_119 128.2 8.656   53.74 45.03
VAL_120 125.7 9.325 174 59.55 36.06
GLY_121 112.3 8.105 171.9 44.42   
ASN_122 123.1 9.075 174 51.52 41.47
LYS_123 111.8 7.232 177.6 57.56 29.26
SER_124 113.9 8.933 173.8 60.7 63.15
ASP_125 116.1 8.495 176.8 54.36 41.18
LEU_126 120.7 7.829       
THR_127 112.4 7.809 177.6 65.87 68.4
THR_128           
LYS_129 119.2 7.278 175.1 54.75 33.61
LYS_130 121.2 7.01 176.2 58.89 33.56
VAL_131 119.7 8.768 175.2 61.34 33.8
160   Appendix 
VAL_132 123.4 7.548   61.69 31.66
ASP_133 129.3 8.582 176.6 54.75 42.02
ASN_134      
THR_135 115.6 8.396 176.5 66.18 68.09
THR_136 120.1 7.365 176.1 66.05 68.73
ALA_137 125.1 7.186 178.5 54.74 20.21
LYS_138 109.4 7.712   59.35   
GLU_139 118.4 7.835 179.8 59.68 29.21
PHE_140 121.6 7.788 178.2 59.88 38.97
ALA_141 125.4 8.877 180.3 56.11 18.15
ASP_142 118.5 9.335   57.29 39.74
SER_143 118.2 8.003   61.51 62.46
LEU_144 121.5 7.167 177.4 54.51 43.79
GLY_145 109.7 7.989 174.9 46.27   
ILE_146 116 7.81 172.8 58.02 39.56
PRO_147           
PHE_148 119.7 7.877 174.7 55.31 43.89
LEU_149 128.2 8.015 173.5 54.7 47.07
GLU_150 117.3 7.992 177.5 54.39 32.31
THR_151 113.3 9.256 175.1 60.01 73.74
SER_152 111.4 8.19 175.8 56.8 64.47
ALA_153 133.3 9.043 178.1 56.15 18.16
LYS_154 117.8 7.104 176.8 58.46 33.91
ASN_155 114.2 7.956 175.2 52.21 38.05
ALA_156 118.8 7.744 176.2 55.08 17.31
THR_157 117.3 8.083 174.9 64.44 68.96
ASN_158 120.9 9.358 174.5 54.48 37.01
VAL_159 121.9 7.664 177.1 68.48 30.75
GLU_160 119.4 8.746 178.8 60.57 29.17
GLN_161 116.8 8.483 178.5 59.23 27.58
ALA_162 124.2 8.172 177.9 55.82 16.55
PHE_163 113.9 7.014 178.2 62.92 39.95
MET_164 117.8 8.831 179.2 58.22 31.12
THR_165 118.2 8.557   67.12 68.35
MET_166 119.8 7.465 176.9 58.28 32.33
ALA_167 119.6 8.384 178.1 55.73 18.82
ALA_168 119.2 8.338 180.9 55.25 18.33
GLU_169 119.1 8.165 179.3 59.14 29.39
ILE_170 120.8 7.917 178.3 64.66 38.64
LYS_171 118.9 8.208   60.22 32.2
LYS_172 117.9 7.721 178 59.31 32.55
ARG_173 117.2 7.466 177.4 57.36 30.38
MET_174 118.2 8.003   56.12 32.94
GLY_175 113.8 7.861 179.3 46.49   
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RES N HN CA CB 
GLY_1         
HIS_2 120.7 8.173 54.97   
MET_3         
ALA_4         
LYS_5 130.4 8.835 56.18 33.34
THR_6 125.7 8.811 61.83 68.69
TYR_7 122.6 8.958 58.91   
ASP_8 122.1 8.327 54.7 39.95
TYR_9         
LEU_10         
PHE_11         
LYS_12         
LEU_13      
LEU_14         
LEU_15 124.9 8.874 52 39.97
ILE_16 125.5 9.179 60.08 40.68
GLY_17         
ASP_18 122.9 9.033 55.6 40.56
SER_19 116.5 8.873 60.31 63.23
GLY_20 116.9 11.21 45.72   
VAL_21 113.7 7.543 62.7 32.03
GLY_22         
LYS_23         
THR_24      
CYS_25      
VAL_26 126.3 9.384 68.92 31.22
LEU_27 121.2 8.361 58.58   
PHE_28 121.1 9.115 62.35 38.82
ARG_29 121.8 8.699 57.88 27.71
PHE_30         
SER_31 110.7 8.444 61.42 64.06
GLU_32 119.1 7.697 55.36 30.97
ASP_33 120.8 7.631 55.14 39.6
ALA_34 118.9 7.035 50.86 23.34
PHE_35 119.4 8.39 57.96   
ASN_36         
SER_37         
THR_38 128.2 8.956 61.18   
PHE_39     
ILE_40 122.8 7.645 60.89 38.89
SER_41         
THR_42         
ILE_43 122.9 7.775 61.52 38.53
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GLY_44 114 8.486 45.68   
ILE_45 121.3 7.775 59.84 38.38
ASP_46 125.4 8.259 55.43 42.06
PHE_47         
LYS_48 125.1 8.318 56.35 33.8
ILE_49         
ARG_50         
THR_51         
ILE_52         
GLU_53         
LEU_54         
ASP_55 124.1 9.305 55.12 39.73
GLY_56 104.5 8.756 45.46   
LYS_57 120.4 7.979 52.77 34.21
ARG_58 122.5 9.749 55.76   
ILE_59 129 9.456 59.35 38.73
LYS_60         
LEU_61      
GLN_62         
ILE_63         
TRP_64         
ASP_65         
THR_66         
ALA_67         
GLY_68         
GLN_69         
GLU_70         
ARG_71         
PHE_72         
ARG_73         
THR_74         
ILE_75         
THR_76         
THR_77         
ALA_78 118.4 8.409 55.66 18.73
TYR_79       
TYR_80 125.5 8.699 60.08 40.5
ARG_81         
GLY_82         
ALA_83 121.7 7.718 53.13 18.17
MET_84 119.9 9.069 56.17   
GLY_85 106.4 7.561 45.18   
ILE_86 124.3 9.024 60.11   
MET_87 124.8 8.671 53.16   
LEU_88         
VAL_89 123.5 8.701 60.78 33.51
TYR_90 123.5 9.057 55.38 39.52
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ASP_91         
ILE_92 121.3 8.817 64.78   
THR_93 114.5 9.379 61.82 69.89
ASN_94 120.3 8.194 51.14 39.48
GLU_95 128.1 9.549 59.56 29.94
LYS_96         
SER_97 115.6 7.458 61.12 63.99
PHE_98 125.4 7.083 59.7 40.11
ASP_99 123.2 8.629 57.45 40.29
ASN_100 114.8 7.916 54.15 38.41
ILE_101 124.5 8.008 62.72 34.06
ARG_102         
ASN_103     
TRP_104     
ILE_105 119.5 8.534 65.82 37.13
ARG_106 113.2 7.452 61.85   
ASN_107         
ILE_108         
GLU_109 120.2 7.236 59.17 29.46
GLU_110 116.9 7.573 58.46 30.05
HIS_111 114 7.308 57.41 33.34
ALA_112 122.9 8.466 50.98 20.59
SER_113 115.5 8.417 58.59 63.75
ALA_114 127.1 8.68 54.21 18.68
ASP_115 114.9 8.042 53.5 40.77
VAL_116 121 7.138 62.7 32.52
GLU_117 127.4 7.435 55.42 31.46
LYS_118 122.6 8.611 54.68 35.95
MET_119     
ILE_120 118.6 8.319 58.5 40.99
LEU_121         
GLY_122         
ASN_123 123.1 8.697 52.28 40.97
LYS_124 111.1 7.044 57.7   
CYS_125 115.3 8.716 59.77 27.05
ASP_126 117.4 8.713 54.12 40.98
VAL_127 123.4 7.877 60.45 28.82
ASN_128         
ASP_129 112.3 6.923 54.9 40.6
LYS_130 129.7 7.689 56.56   
ARG_131         
GLN_132         
VAL_133 120.6 7.537 61.01 33.35
SER_134 125.7 8.462 58.17 63.8
LYS_135 127.3 9.017 60.24 32.49
GLU_136 116.6 8.6 59.82 28.83
ARG_137 120.8 7.648 59.74 30.56
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GLY_138 109.9 7.287 47.92   
GLU_139         
LYS_140 125.3 9.38 58.54 31.95
LEU_141 121.7 7.473 58.44 41.48
ALA_142 119.6 7.655 55.66 19.03
LEU_143 120.4 8.108 58.09 41.86
ASP_144 121.9 8.327 57.24   
TYR_145 116 7.437 59.07   
GLY_146 112.8 8.176 46.85   
ILE_147 115.6 8.018 59.73 40.91
LYS_148      
PHE_149         
MET_150      
GLU_151 119.8 8.261 55.78 30.57
THR_152         
SER_153 112.1 8.761 57.27 65.09
ALA_154 134.1 9.023 55.34 18.87
LYS_155 120 7.07 58.85 34.58
ALA_156 118.3 8.123 51.14 19.04
ASN_157 116.8 7.208 53.18 36.26
ILE_158 119.1 8.239 60.55 40
ASN_159         
VAL_160 113.9 6.975 69.17   
GLU_161       
ASN_162 118 7.156 55.59 37.54
ALA_163 125.2 8.149 56.48 18.34
PHE_164 114.9 7.203 63.19 40.96
PHE_165 118.9 9.079 62.25 37.94
THR_166 117 8.169 67.47   
LEU_167       
ALA_168         
ARG_169 119.5 8.395 60.39 29.88
ASP_170 123 8.081 57.49 39.04
ILE_171 122.4 8.199 65.56   
LYS_172         
ALA_173 120.2 8.268 55.1 18.09
LYS_174 118 7.205 59.16 32.16
MET_175         
ASP_176 120.8 8.884 56.77 39.72
LYS_177 119.7 7.493 58.1 32.41
LYS_178 120.1 7.651 58   
LEU_179 120.8 7.887 55.92 42.12
GLU_180 120.8 7.958 57.38 30.1
GLY_181 109.1 8.147 45.52   
ASN_182         
SER_183         
PRO_184         
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GLN_185         
GLY_186         
SER_187         
ASN_188         
GLN_189         
GLY_190         
VAL_191         
LYS_192 126.5 8.352 56.03   
ILE_193 124 8.195 60.72 42.03
THR_194 121.3 8.221 59.7   
PRO_195         
ASP_196         
GLN_197         
GLN_198         
LYS_199         
ARG_200         
SER_201         
SER_202         
PHE_203 120.6 8.061 55.72   
PHE_204         
ARG_205         
CYS_206         
VAL_207         
LEU_208         








Mbefo MK, Paleologou KE, Boucharaba A, Oueslati A, Schell H, Fournier M, 
Olschewski D, Yin G, Zweckstetter M, Masliah E, Kahle PJ, Hirling H, Lashuel HA, 
Phosphorylation of synucleins by members of the Polo-like kinase family., J. Biol. 
Chem. 285:2807-22. 2010. 
 
Di Giovanni S, Eleuteri S, Paleologou KE, Yin G, Zweckstetter M, Carrupt PA, 
Lashuel HA., Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, 
block fibril formation of alpha-synuclein and beta-amyloid and protect against amyloid-
induced toxicity, J. Biol. Chem. 285, 14941-53, 2010.  
 
Salmon L, Nodet G, Ozenne V, Yin G, Jensen MR, Zweckstetter M, Blackledge M., 
NMR characterization of long-range order in intrinsically disordered proteins, J Am 
Chem Soc. 132: 8407-18. 2010. 
 
Paleologou KE*, Mbefo MK, Yin G*, Oueslati A, Fares MB,  Zweckstetter M, Lashuel 
HA. The PD mutant E46K, but not A30P or A53T, enhances alpha-Synuclein 
phophorylation at S129, Submitted. *Equal contribution  
 
 
 
 
